Amedeo Smart

Free Medical Literature Service

 

Amedeo

COVID-19
  Free Subscription

Articles published in
J Infect
    September 2024
  1. MCDONALD E, Pittet LF, Barry SE, Bonten M, et al
    Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: insights from prospectively collected data in the BRACE trial.
    J Infect. 2024 Sep 6:106267. doi: 10.1016/j.jinf.2024.106267.
    >> Share

  2. CHAPMAN ME, Brendish NJ, Morris M, Spalluto CM, et al
    Real-world performance of a single-use, analyser-free, molecular point-of-care test for COVID-19 used in the emergency department: results of a prospective trial (ED-POC).
    J Infect. 2024 Sep 5:106264. doi: 10.1016/j.jinf.2024.106264.
    >> Share

    August 2024
  3. AZIZ AB, Sugimoto JD, Hong SL, You YA, et al
    Indirect effectiveness of a novel SAR-COV-2 vaccine (SCB-2019) in unvaccinated household contacts in the Philippines: a cluster randomised analysis.
    J Infect. 2024 Aug 30:106260. doi: 10.1016/j.jinf.2024.106260.
    >> Share

  4. GRAM MA, Thiesson EM, Pihlstrom N, Perala J, et al
    Comparative effectiveness of bivalent BA.4-5 or BA.1 mRNA booster vaccines among immunocompromised individuals across three Nordic countries: A nationwide cohort study.
    J Infect. 2024;89:106261.
    >> Share

  5. HASAN T, Zhu NJ, Pearson C, Aylin P, et al
    Increased 30-day all-cause mortality associated with Gram-negative bloodstream infections in England during the COVID-19 pandemic.
    J Infect. 2024 Aug 29:106256. doi: 10.1016/j.jinf.2024.106256.
    >> Share

  6. HOBBS FR, Gbinigie OA, Shanyinde M, Yu LM, et al
    Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.
    J Infect. 2024 Aug 29:106248. doi: 10.1016/j.jinf.2024.106248.
    >> Share

  7. FOULKES S, Evans J, Neill C, Bishop J, et al
    Prevalence and impact of persistent symptoms following SARS-CoV-2 infection among healthcare workers: a cross-sectional survey in the SIREN cohort.
    J Infect. 2024 Aug 28:106259. doi: 10.1016/j.jinf.2024.106259.
    >> Share

  8. GOTTLIEB RL, Clement M, Cook P, Deveikis A, et al
    The IL-6 Hypothesis in COVID-19: A Phase 2, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Free IL-6 Sequestration by the Monoclonal Antibody Sirukumab in Severe and Critical COVID-19.
    J Infect. 2024 Aug 23:106241. doi: 10.1016/j.jinf.2024.106241.
    >> Share

  9. FRYER HA, Geers D, Gommers L, Zaeck LM, et al
    Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants.
    J Infect. 2024 Aug 8:106246. doi: 10.1016/j.jinf.2024.106246.
    >> Share

  10. MESSINA NL, Pittet LF, McDonald E, Moore C, et al
    BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial.
    J Infect. 2024 Aug 8:106245. doi: 10.1016/j.jinf.2024.106245.
    >> Share

  11. WANG HI, Doran T, Crooks MG, Khunti K, et al
    Prevalence, risk factors and characterisation of individuals with long COVID using Electronic Health Records in over 1.5 million COVID cases in England.
    J Infect. 2024;89:106235.
    >> Share

  12. QUEK AML, Wang S, Teng O, Shunmuganathan B, et al
    Hybrid immunity augments cross-variant protection against COVID-19 among immunocompromised individuals.
    J Infect. 2024 Aug 7:106238. doi: 10.1016/j.jinf.2024.106238.
    >> Share

  13. SILVA-COSTA C, Gomes-Silva J, Pinho M, Friaes A, et al
    Rebound of pediatric invasive pneumococcal disease in Portugal after the COVID-19 pandemic was not associated with significant serotype changes.
    J Infect. 2024 Aug 6:106242. doi: 10.1016/j.jinf.2024.106242.
    >> Share

  14. YANG C, Sun JY, Li XL, Cheng N, et al
    Emerging and re-emerging genotype 2c porcine epidemic diarrhoea virus with high pathogenicity in China.
    J Infect. 2024;89:106192.
    >> Share

    July 2024
  15. LI J, Zhang Y, Liu Z, Yang Z, et al
    Increased SARS-CoV-2 reinfection frequency, attenuated severity, and risk factor analysis in patients with hematological malignancies.
    J Infect. 2024;89:106233.
    >> Share

  16. BECHMAN K, Green A, Russell MD, Yang Z, et al
    The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19.
    J Infect. 2024 Jul 15:106227. doi: 10.1016/j.jinf.2024.106227.
    >> Share

  17. HU Y, Shi W, Meng Q, Yuan L, et al
    Detection of Bordetella spp. in children with pertussis-like illness from 2018 to 2024 in China.
    J Infect. 2024;89:106222.
    >> Share

  18. ANDREWS N, Osuntoki I, Stowe J, Kirsebom FCM, et al
    The impact of Covid-19 vaccine spring boosters on Covid-19 hospital admissions in England 2022/23.
    J Infect. 2024 Jul 10:106221. doi: 10.1016/j.jinf.2024.106221.
    >> Share

  19. KADAMBARI S, Abdullahi F, Celma C, Ladhani S, et al
    Epidemiological trends in viral meningitis in England: prospective national surveillance, 2013-2023.
    J Infect. 2024 Jul 8:106223. doi: 10.1016/j.jinf.2024.106223.
    >> Share

  20. STARKE KR, Kaboth P, Rath N, Reissig D, et al
    Cardiovascular disease risk after a SARS-CoV-2 infection: a systematic review and meta-analysis.
    J Infect. 2024 Jul 4:106215. doi: 10.1016/j.jinf.2024.106215.
    >> Share

  21. HALME ALE, Laakkonen S, Rutanen J, Nevalainen OPO, et al
    Short- and long-term effects of imatinib in hospitalised COVID-19 patients: A randomised trial.
    J Infect. 2024 Jul 3:106217. doi: 10.1016/j.jinf.2024.106217.
    >> Share

    June 2024
  22. BOOM TT, de Hoog MLA, Westerhof I, Jaddoe V, et al
    Age-specific SARS-CoV-2 transmission differed from human rhinovirus in households during the early COVID-19 pandemic.
    J Infect. 2024 Jun 29:106218. doi: 10.1016/j.jinf.2024.106218.
    >> Share

  23. BOYS R, Plank J, Bird P, Fletcher O, et al
    Impact of COVID-19 restrictions on the incidence of respiratory viruses in two British Antarctic Survey bases.
    J Infect. 2024;89:106196.
    >> Share

  24. CHAKA A, Pan D, Irshad M, Piranie H, et al
    Inclusion of racial and ethnic groups in clinical trials for COVID-19 and post-acute COVID-19 syndrome: an analysis of studies registered on ClinicalTrials.gov.
    J Infect. 2024 Jun 20:106207. doi: 10.1016/j.jinf.2024.106207.
    >> Share

  25. GONG X, Peng L, Wang F, Liu J, et al
    Repeated Omicron infection dampens immune imprinting from previous vaccination and induces broad neutralizing antibodies against Omicron sub-variants.
    J Infect. 2024;89:106208.
    >> Share

  26. PEREZ-GARCIA C, Sempere J, de Miguel S, Hita S, et al
    Surveillance of invasive pneumococcal disease in Spain exploring the impact of the COVID-19 pandemic (2019-2023).
    J Infect. 2024;89:106204.
    >> Share

  27. LIU B, Xu L, Ma Y, Wang H, et al
    Evidence of immunity gap: Decline in antibodies against M. pneumoniae during the COVID-19 pandemic.
    J Infect. 2024 Jun 18:106209. doi: 10.1016/j.jinf.2024.106209.
    >> Share

  28. KAJIHARA T, Yahara K, Kamigaki T, Hirabayashi A, et al
    Effects of coronavirus disease 2019 on the spread of respiratory-transmitted human-to-human bacteria.
    J Infect. 2024 Jun 17:106201. doi: 10.1016/j.jinf.2024.106201.
    >> Share

  29. MIKOLAJCZYK R, Diexer S, Klee B, Pfrommer L, et al
    Likelihood of Post-COVID Condition in people with hybrid immunity; data from the German National Cohort (NAKO).
    J Infect. 2024 Jun 17:106206. doi: 10.1016/j.jinf.2024.106206.
    >> Share

  30. AUDRAN R, Karoui O, Donnet L, Soumas V, et al
    Randomized, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route.
    J Infect. 2024 Jun 17:106205. doi: 10.1016/j.jinf.2024.106205.
    >> Share

  31. JIANG J, Li Y, Jiang Q, Jiang Y, et al
    Early use of oral antiviral drugs and the risk of post COVID-19 syndrome: a systematic review and network meta-analysis.
    J Infect. 2024 Jun 2:106190. doi: 10.1016/j.jinf.2024.106190.
    >> Share

  32. PATERNINA-CAICEDO A, Quevedo DS, Rios DS, Moyano D, et al
    Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron.
    J Infect. 2024;88:106165.
    >> Share

    May 2024
  33. HAN B, Li XM, Li R, Ning W, et al
    Epidemiological Surveillance of Acute Respiratory Infections Based on Targeted Metagenomic Next Generation Sequencing During the Flu Season after COVID-19 Pandemic in Beijing.
    J Infect. 2024 May 22:106188. doi: 10.1016/j.jinf.2024.106188.
    >> Share

  34. YANG X, Li X, Qiu S, Liu C, et al
    Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: a systematic review and meta-analysis of aggregated participant data.
    J Infect. 2024 May 14:106183. doi: 10.1016/j.jinf.2024.106183.
    >> Share

  35. AMANO M, Ichikawa Y, Matsumoto S, Higashi-Kuwata N, et al
    Neutralization activity of HCWs' sera after Omicron XBB.1.5-adapted monovalent COVID-19 mRNA vaccination.
    J Infect. 2024;89:106179.
    >> Share

  36. PANG CWK, Vale R, Lao KS, Khan AT, et al
    Increased Incidence of Invasive Pneumococcal Disease in Hong Kong in 2023.
    J Infect. 2024 May 11:106178. doi: 10.1016/j.jinf.2024.106178.
    >> Share

  37. KIRSEBOM FCM, Stowe J, Lopez Bernal J, Allen A, et al
    Effectiveness of Autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study.
    J Infect. 2024 May 6:106177. doi: 10.1016/j.jinf.2024.106177.
    >> Share

  38. HALVORSEN B, Viermyr HK, Ueland T, Sagen EL, et al
    IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement.
    J Infect. 2024 May 6:106176. doi: 10.1016/j.jinf.2024.106176.
    >> Share

    April 2024
  39. ZHOU J, Lan L, Ai S, Lin J, et al
    Corrigendum to: "People living with HIV who have poor immune status are a key population for SARS-CoV-2 prevention" Journal of Infection, Volume 88, Issue 3, March 2024, 106122.
    J Infect. 2024 Apr 24:106157. doi: 10.1016/j.jinf.2024.106157.
    >> Share

  40. CHUN JY, Jeong SJ, Kim S, Choi S, et al
    Performance of the Galactomannan Test for the Diagnosis of Invasive Pulmonary Aspergillosis using Non-invasive Proximal Airway Samples.
    J Infect. 2024 Apr 17:106159. doi: 10.1016/j.jinf.2024.106159.
    >> Share

  41. PINANA M, Gonzalez-Sanchez A, Andres C, Vila J, et al
    Genomic evolution of human respiratory syncytial virus during a decade (2013-2023): bridging the path to monoclonal antibody surveillance.
    J Infect. 2024 Apr 6:106153. doi: 10.1016/j.jinf.2024.106153.
    >> Share

  42. COLSON P, Chaudet H, Delerce J, Pontarotti P, et al
    Role of SARS-CoV-2 mutations in the evolution of the COVID-19 pandemic.
    J Infect. 2024 Apr 1:106150. doi: 10.1016/j.jinf.2024.106150.
    >> Share

    March 2024
  43. NG M, S D, L W, R B, et al
    Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiology.
    J Infect. 2024 Mar 27:106145. doi: 10.1016/j.jinf.2024.106145.
    >> Share

  44. GAYLIS NB, Yang OO
    Understanding immune dysregulation in post-acute sequelae of COVID-19 (PASC) - The hunt for effective treatments.
    J Infect. 2024 Mar 24:106146. doi: 10.1016/j.jinf.2024.106146.
    >> Share

  45. SALMAN M, Rana MS, Usman M, Tahir M, et al
    Re-emergence of Diphtheria after COVID-19 Pandemic in Pakistan: time to consider booster vaccination strategies.
    J Infect. 2024 Mar 19:106141. doi: 10.1016/j.jinf.2024.106141.
    >> Share

  46. SUN L, Man Q, Zhang H, Xia S, et al
    Strong cross immune responses against sarbecoviruses but not merbecoviruses in SARS-CoV-2 BA.5/BF.7-infected individuals with or without inactivated COVID-19 vaccination.
    J Infect. 2024;88:106138.
    >> Share

  47. MORENO-TORRES V, Martinez-Urbistondo M, Calderon-Parra J, de Mendoza C, et al
    COVID-19 Mortality Amongst the Immunosuppresed.
    J Infect. 2024 Mar 11:106137. doi: 10.1016/j.jinf.2024.106137.
    >> Share

  48. POWELL AA, Dowell AC, Moss P, Ladhani SN, et al
    Current state of COVID-19 in children: 4 years on.
    J Infect. 2024 Mar 1:106134. doi: 10.1016/j.jinf.2024.106134.
    >> Share

  49. FATLY ZA, Betjes MGH, Dik WA, Fouchier RAM, et al
    Mycophenolate mofetil hampers antibody responses to a broad range of vaccinations in kidney transplant recipients: results from a randomized controlled study.
    J Infect. 2024 Mar 1:106133. doi: 10.1016/j.jinf.2024.106133.
    >> Share

    February 2024
  50. MEERAUS W, Joy M, Ouwens M, Taylor KS, et al
    AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: the RAVEN cohort study.
    J Infect. 2024 Feb 29:106129. doi: 10.1016/j.jinf.2024.106129.
    >> Share

  51. HAYWARD G, Yu LM, Little P, Gbinigie O, et al
    Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.
    J Infect. 2024 Feb 29:106130. doi: 10.1016/j.jinf.2024.106130.
    >> Share

  52. LIU P, Cai J, Tian H, Li J, et al
    Intra-host genetic diversity of SARS-CoV-2 Omicron variants in children.
    J Infect. 2024 Feb 29:106132. doi: 10.1016/j.jinf.2024.106132.
    >> Share

  53. ZHOU J, Lan L, Ai S, Lin J, et al
    People Living with HIV who have poor immune status are a key population for SARS-CoV-2 prevention.
    J Infect. 2024 Feb 15:106122. doi: 10.1016/j.jinf.2024.106122.
    >> Share

  54. HITES M, Massonnaud CR, Jamard S, Goehringer F, et al
    Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): a phase 3, randomized, double-blind, placebo-controlled trial.
    J Infect. 2024 Feb 15:106120. doi: 10.1016/j.jinf.2024.106120.
    >> Share

  55. YAO Z, Zhang L, Duan Y, Tang X, et al
    Molecular Insights into the Adaptive Evolution of SARS-CoV-2 Spike Protein.
    J Infect. 2024 Feb 15:106121. doi: 10.1016/j.jinf.2024.106121.
    >> Share

  56. KALKERI R, Zhu M, Cloney-Clark S, Plested JS, et al
    Altered IgG4 Antibody Response to Repeated mRNA versus Recombinant Protein SARS-CoV-2 Vaccines.
    J Infect. 2024 Feb 13:106119. doi: 10.1016/j.jinf.2024.106119.
    >> Share

  57. XIE L, Luo G, Yang Z, Wu WC, et al
    The clinical outcome of COVID-19 is strongly associated with microbiome dynamics in the upper respiratory tract.
    J Infect. 2024 Feb 9:S0163-4453(24)00036-7. doi: 10.1016/j.jinf.2024.
    >> Share

  58. HUNG KC, Chen IW, Sun CK
    Pulmonary dysfunction severity may impact optimal dexamethasone dosing in patients with COVID-19.
    J Infect. 2024 Feb 1:S0163-4453(24)00031-8. doi: 10.1016/j.jinf.2024.
    >> Share

    January 2024
  59. LESTON M, Elson W, Ordonez-Mena JM, Kar D, et al
    Disparities in COVID-19 Mortality Amongst the Immunosuppressed: A Systematic Review and Meta-analysis for Enhanced Disease Surveillance.
    J Infect. 2024 Jan 30:S0163-4453(24)00028-8. doi: 10.1016/j.jinf.2024.
    >> Share

  60. MURRAY JM, Murray DD, Schvoerer E, Akand EH, et al
    SARS-CoV-2 Delta and Omicron community transmission networks as added value to contact tracing.
    J Infect. 2024 Jan 17:S0163-4453(24)00023-9. doi: 10.1016/j.jinf.2024.
    >> Share

  61. CORNISH EF, van der Meeren LE, van der Hoorn MP, Schoenmakers S, et al
    Stillbirths due to placental COVID infection associated with chronic histiocytic intervillositis do not recur in subsequent pregnancies.
    J Infect. 2024 Jan 11:S0163-4453(24)00020-3. doi: 10.1016/j.jinf.2024.
    >> Share

  62. ZHANG H, Zhou K, Peng F, Gao Z, et al
    Novel small-molecule inhibitors of SARS-CoV-2 main protease with nanomolar antiviral potency.
    J Infect. 2024 Jan 6:S0163-4453(23)00600-X. doi: 10.1016/j.jinf.2023.
    >> Share

    December 2023
  63. ZONG K, Yuan P, Wang R, Luo Q, et al
    Characteristics of innate, humoral and cellular immunity in children with non-severe SARS-CoV-2 infection.
    J Infect. 2023 Dec 13:S0163-4453(23)00589-3. doi: 10.1016/j.jinf.2023.
    >> Share

  64. FERNANDEZ-DE-LAS-PENAS C, Notarte KI, Macasaet R, Velasco JV, et al
    Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: A systematic review and meta-analysis.
    J Infect. 2023 Dec 13:S0163-4453(23)00590-X. doi: 10.1016/j.jinf.2023.
    >> Share

  65. STRAHM C, Kahlert CR, Gusewell S, Vuichard-Gysin D, et al
    Evolution of symptoms compatible with post-acute sequelae of SARS-CoV-2 (PASC) after Wild-type and/or Omicron BA.1 infection: A prospective healthcare worker cohort.
    J Infect. 2023 Dec 7:S0163-4453(23)00588-1. doi: 10.1016/j.jinf.2023.
    >> Share

  66. AO G, Li T, Nasr B, Wang Y, et al
    The effect of dupilumab on clinical outcomes in patients with COVID-19: A meta-analysis.
    J Infect. 2023;87:e107-e109.
    >> Share

  67. LIU Y, Sun R, Zhang H, Huang J, et al
    Trends and predictions of tuberculosis notification in mainland China during and after the COVID-19 pandemic.
    J Infect. 2023;87:e100-e103.
    >> Share

    November 2023
  68. PHAN J, Eslick GD, Elliott EJ
    Demystifying the global outbreak of severe acute hepatitis of unknown aetiology in children: A systematic review and meta-analysis.
    J Infect. 2023 Nov 24:S0163-4453(23)00580-7. doi: 10.1016/j.jinf.2023.
    >> Share

  69. GRAU S, Vela JM, Gurt A, Barcelo-Vidal J, et al
    Efficacy of SIGMAR1-based therapy in the early treatment of confirmed mild symptomatic COVID-19 patients.
    J Infect. 2023 Nov 20:S0163-4453(23)00562-5. doi: 10.1016/j.jinf.2023.
    >> Share

  70. DIEP AN, Schyns J, Gourzones C, Goffin E, et al
    How do successive vaccinations and SARS-CoV-2 infections impact humoral immunity dynamics: an 18-month longitudinal study.
    J Infect. 2023 Nov 17:S0163-4453(23)00558-3. doi: 10.1016/j.jinf.2023.
    >> Share

  71. BRENDISH NJ, Davis C, Chapman ME, Borca F, et al
    Emergency Department point-of-care antiviral host response testing is accurate during periods of multiple respiratory virus co-circulation.
    J Infect. 2023 Nov 15:S0163-4453(23)00556-X. doi: 10.1016/j.jinf.2023.
    >> Share

  72. LIECHTI FD, Bijlsma MW, Brouwer MC, van Sorge NM, et al
    Impact of the COVID-19 pandemic on incidence and serotype distribution of pneumococcal meningitis - A prospective, nationwide cohort study from the Netherlands.
    J Infect. 2023 Nov 8:S0163-4453(23)00555-8. doi: 10.1016/j.jinf.2023.
    >> Share

  73. HALL VJ, Insalata F, Foulkes S, Kirwan P, et al
    Effectiveness of BNT162b2 mRNA vaccine third doses and previous infection in protecting against SARS-CoV-2 infections during the Delta and Omicron variant waves; the UK SIREN cohort study September 2021 to February 2022.
    J Infect. 2023 Nov 3:S0163-4453(23)00553-4. doi: 10.1016/j.jinf.2023.
    >> Share

  74. LUNT R, Quinot C, Kirsebom F, Andrews N, et al
    The Impact of Vaccination and SARS-CoV-2 Variants on the Virological Response to SARS-CoV-2 Infections during the Alpha, Delta, and Omicron waves in England.
    J Infect. 2023 Nov 3:S0163-4453(23)00547-9. doi: 10.1016/j.jinf.2023.
    >> Share

    October 2023
  75. BRUHN M, Obara M, Chiyyeadu A, Costa B, et al
    Memory B cells anticipate SARS-CoV-2 variants through somatic hypermutation.
    J Infect. 2023 Oct 30:S0163-4453(23)00551-0. doi: 10.1016/j.jinf.2023.
    >> Share

  76. JIANG W, Xu L, Wang Y, Hao C, et al
    Exploring immunity debt: Dynamic alterations in RSV antibody levels in children under 5 years during the COVID-19 pandemic.
    J Infect. 2023 Oct 29:S0163-4453(23)00550-9. doi: 10.1016/j.jinf.2023.
    >> Share

  77. JIN Z, Wu J, Wang Y, Huang T, et al
    Safety and immunogenicity of the COVID-19 mRNA vaccine CS-2034: A randomized, double-blind, dose-exploration, placebo-controlled multicenter Phase I clinical trial in healthy Chinese adults.
    J Infect. 2023 Oct 26:S0163-4453(23)00543-1. doi: 10.1016/j.jinf.2023.
    >> Share

  78. HA L, Levian C, Greene N, Goldfarb I, et al
    Association between acceptance of routine pregnancy vaccinations and COVID-19 vaccine uptake in pregnant patients.
    J Infect. 2023 Oct 19:S0163-4453(23)00541-8. doi: 10.1016/j.jinf.2023.
    >> Share

  79. MARJANEH MM, Challenger JD, Salas A, Gomez-Carballa A, et al
    Analysis of blood and nasal epithelial transcriptomes to identify mechanisms associated with control of SARS-CoV-2 viral load in the upper respiratory tract.
    J Infect. 2023 Oct 18:S0163-4453(23)00540-6. doi: 10.1016/j.jinf.2023.
    >> Share

  80. FENWICK C, Turelli P, Duhoo Y, Lau K, et al
    Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys.
    J Infect. 2023 Oct 16:S0163-4453(23)00539-X. doi: 10.1016/j.jinf.2023.
    >> Share

  81. BEARD KR, Borca F, Phan H, Brown E, et al
    Routine, molecular point-of-care testing for SARS-CoV-2 and other respiratory viruses within an acute oncology service improves patient care.
    J Infect. 2023 Oct 4:S0163-4453(23)00514-5. doi: 10.1016/j.jinf.2023.
    >> Share

  82. TIAN S, Liu T, Zhao XJ, Liu XL, et al
    Neutralization against emerging Omicron subvariants after SARS-CoV-2 reinfection.
    J Infect. 2023 Oct 4:S0163-4453(23)00515-7. doi: 10.1016/j.jinf.2023.
    >> Share

    September 2023
  83. VELLAS C, Latour J, Tremeaux P, Ranger N, et al
    Molecular Evolution of Omicron Variant in Immunocompromised Individuals with Chronic SARS-CoV-2 Infection.
    J Infect. 2023 Sep 30:S0163-4453(23)00513-3. doi: 10.1016/j.jinf.2023.
    >> Share

  84. ANTONELLI M, Penfold RS, Canas LDS, Sudre C, et al
    SARS-CoV-2 infection following booster vaccination: illness and symptom profile in a prospective, observational community-based case-control study.
    J Infect. 2023 Sep 28:S0163-4453(23)00461-9. doi: 10.1016/j.jinf.2023.
    >> Share

  85. GAO Y, Zhang Y, Mou K, Man S, et al
    Alterations in the outer retina and choroid in patients after COVID-19 infection.
    J Infect. 2023 Sep 27:S0163-4453(23)00512-1. doi: 10.1016/j.jinf.2023.
    >> Share

  86. YAMAMOTO S, Mizoue T, Konishi M, Oshiro Y, et al
    Kinetics and durability of nucleocapsid-specific antibodies after SARS-CoV-2 reinfection.
    J Infect. 2023 Sep 26:S0163-4453(23)00511-X. doi: 10.1016/j.jinf.2023.
    >> Share

  87. SNOW TAC, Arulkumaran N, Singer M, Choi SH, et al
    Effect of dexamethasone dose on outcomes in acute COVID-19 disease: a systematic review and meta-analysis.
    J Infect. 2023 Sep 25:S0163-4453(23)00510-8. doi: 10.1016/j.jinf.2023.
    >> Share

  88. MATSUO OM, Lindoso L, Sousa Marques HH, Polanczyk GV, et al
    Mental health among children and adolescents after SARS-CoV-2 infection: a prospective study in a tertiary university hospital.
    J Infect. 2023 Sep 20:S0163-4453(23)00507-8. doi: 10.1016/j.jinf.2023.
    >> Share

  89. ALPIZAR SA, Accini J, Anderson DC, Eysa B, et al
    Molnupiravir for Intra-Household Prevention of COVID-19: the MOVe-AHEAD Randomized, Placebo-Controlled Trial.
    J Infect. 2023 Sep 8:S0163-4453(23)00500-5. doi: 10.1016/j.jinf.2023.
    >> Share

  90. CLARK SA, Campbell H, Ribeiro S, Bertran M, et al
    Epidemiological and strain characteristics of invasive meningococcal disease prior to, during and after COVID-19 pandemic restrictions in England.
    J Infect. 2023 Sep 7:S0163-4453(23)00504-2. doi: 10.1016/j.jinf.2023.
    >> Share

  91. ATTI A, Insalata F, Carr EJ, Otter AD, et al
    Antibody correlates of protection against Delta infection after vaccination: a nested case-control within the UK-based SIREN study.
    J Infect. 2023 Sep 7:S0163-4453(23)00380-8. doi: 10.1016/j.jinf.2023.
    >> Share

  92. AMANO M, Ichikawa Y, Matsumoto S, Matsushita S, et al
    Longitudinal analysis of neutralization in sera from HCWs receiving 2 doses of Omicron BA.4/5-adapted bivalent vaccine.
    J Infect. 2023 Sep 1:S0163-4453(23)00464-4. doi: 10.1016/j.jinf.2023.
    >> Share

  93. DOWELL AC, Tut G, Begum J, Bruton R, et al
    Nasal mucosal IgA levels against SARS-CoV-2 and seasonal coronaviruses are low in children but boosted by reinfection.
    J Infect. 2023 Sep 1:S0163-4453(23)00465-6. doi: 10.1016/j.jinf.2023.
    >> Share

    August 2023
  94. GUAN X, Huang Q, Dong M, Li M, et al
    SARS-CoV-2-specific antibody and T-cell immunity in convalescents after infection wave in Beijing in late 2022.
    J Infect. 2023 Aug 29:S0163-4453(23)00462-0. doi: 10.1016/j.jinf.2023.
    >> Share

  95. SHARMA SN
    Did the Black Death Give Birth to the Healthcare Hero?
    J Infect. 2023 Aug 25:S0163-4453(23)00460-7. doi: 10.1016/j.jinf.2023.
    >> Share

  96. CARCAILLON-BENTATA L, Makovski TT, Alleaume C, Decio V, et al
    Post-Covid-19 condition: A comprehensive analysis of the World Health Organisation definition.
    J Infect. 2023 Aug 19:S0163-4453(23)00458-9. doi: 10.1016/j.jinf.2023.
    >> Share

  97. WHITAKER HJ, Tsang RS, Byford R, Aspden C, et al
    COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study.
    J Infect. 2023 Aug 12:S0163-4453(23)00456-5. doi: 10.1016/j.jinf.2023.
    >> Share

  98. WAGENHAUSER I, Mees J, Reusch J, Lam TT, et al
    Determinants of Influenza A Infection Rate in Post-COVID-19 Era.
    J Infect. 2023 Aug 9:S0163-4453(23)00455-3. doi: 10.1016/j.jinf.2023.
    >> Share

  99. FAUSTINI SE, Cook A, Hill H, Al-Taei S, et al
    Saliva antiviral antibody levels are detectable but correlate poorly with serum antibody levels following SARS-CoV-2 infection and/or vaccination.
    J Infect. 2023 Aug 3:S0163-4453(23)00439-5. doi: 10.1016/j.jinf.2023.
    >> Share

    July 2023
  100. SUN B, Gao F
    Investigation of escape mechanisms of SARS-CoV-2 Omicron sub-lineages and exploration of potential antibodies for XBB.1.
    J Infect. 2023 Jul 26:S0163-4453(23)00387-0. doi: 10.1016/j.jinf.2023.
    >> Share

  101. PIERANGELI A, Nenna R, Fracella M, Scagnolari C, et al
    Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and -B bronchiolitis before and after pandemic restrictions in Rome.
    J Infect. 2023 Jul 24:S0163-4453(23)00381-X. doi: 10.1016/j.jinf.2023.
    >> Share

  102. THEODOSIOU AA, Read RC
    Artificial Intelligence, Machine Learning and Deep Learning: Potential Resources for the Infection Clinician.
    J Infect. 2023 Jul 17:S0163-4453(23)00379-1. doi: 10.1016/j.jinf.2023.
    >> Share

  103. KAMBOJ M, Laracy JC, Usiak S, Babady NE, et al
    Outcomes of hematologic malignancy patients with SARS-CoV-2 breakthrough infections after tixagevimab-cilgavimab during community transmission of monoclonal antibody resistant variants.
    J Infect. 2023 Jul 13:S0163-4453(23)00378-X. doi: 10.1016/j.jinf.2023.
    >> Share

  104. FEELISCH M, Clark AD, Cumpstey AF, Santolini J, et al
    Long COVID: Potential role of the Reactive Species Interactome.
    J Infect. 2023 Jul 11:S0163-4453(23)00376-6. doi: 10.1016/j.jinf.2023.
    >> Share

  105. RISSMANN M, Veldhuis Kroeze EJB, Tielens AGM, Rockx B, et al
    Influence of a chronic Schistosoma mansoni infection on the outcomes of a SARS-CoV-2 infection in the hamster model.
    J Infect. 2023 Jul 5:S0163-4453(23)00374-2. doi: 10.1016/j.jinf.2023.
    >> Share

  106. BAYHAN GI, Guner R, Yahsi A, Ozkul A, et al
    Evaluation of the neutralizing antibody response against the omicron variant produced by heterologous or hybrid immunity: How does the fifth dose of COVID-19 vaccine affect the neutralizing antibody response?
    J Infect. 2023 Jul 4:S0163-4453(23)00369-9. doi: 10.1016/j.jinf.2023.
    >> Share

  107. TAUCHER C, Lazarus R, Dellago H, Maurer G, et al
    Safety and Immunogenicity against Ancestral, Delta and Omicron Virus Variants Following a Booster Dose of an Inactivated Whole-Virus COVID-19 Vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COM
    J Infect. 2023 Jul 3:S0163-4453(23)00367-5. doi: 10.1016/j.jinf.2023.
    >> Share

    June 2023
  108. VARASI I, Lai A, Fiaschi L, Bergna A, et al
    Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID-19 vaccination.
    J Infect. 2023 Jun 30:S0163-4453(23)00342-0. doi: 10.1016/j.jinf.2023.
    >> Share

  109. WU JY, Hsu WH, Tsai YW, Liu TH, et al
    The association between zinc deficiency, and clinical outcomes of COVID-19.
    J Infect. 2023 Jun 29:S0163-4453(23)00343-2. doi: 10.1016/j.jinf.2023.
    >> Share

  110. DOWELL AC, Waiblinger D, Wright J, Ladhani SN, et al
    Nucleocapsid-Specific Antibodies as a Correlate of Protection against SARS-CoV-2 Reinfection in Children.
    J Infect. 2023 Jun 28:S0163-4453(23)00340-7. doi: 10.1016/j.jinf.2023.
    >> Share

  111. SU HC, Lai ZL, Chang YC, Cheng MY, et al
    Genomic characteristics of SARS-CoV-2 variants and their clinical impact on patients with COVID-19 in Taiwan.
    J Infect. 2023 Jun 27:S0163-4453(23)00341-9. doi: 10.1016/j.jinf.2023.
    >> Share

  112. KELLY E, Greenland M, de Whalley PCS, Aley PK, et al
    Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A Randomised Controlled Trial.
    J Infect. 2023 Jun 16:S0163-4453(23)00330-4. doi: 10.1016/j.jinf.2023.
    >> Share

  113. STANKUNAS M, Dziugys A, Skarbalius G, Misiulis E, et al
    AUTHORS' REPLY TO A COMMENTARY ON THE POTENTIAL IMPACT OF COVID-19 PASSPORTS TO EPIDEMIOLOGICAL SITUATION.
    J Infect. 2023 Jun 15:S0163-4453(23)00333-X. doi: 10.1016/j.jinf.2023.
    >> Share

  114. FALLET B, Foglierini M, Porret R, Alcaraz A, et al
    Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients.
    J Infect. 2023 Jun 13:S0163-4453(23)00329-8. doi: 10.1016/j.jinf.2023.
    >> Share

  115. BISHARAT N, Campisi-Pinto S
    Determinants of reinfection with SARS-CoV-2 Omicron variant.
    J Infect. 2023 Jun 9:S0163-4453(23)00325-0. doi: 10.1016/j.jinf.2023.
    >> Share

  116. CAI J, Ruan J, Lin Q, Ren T, et al
    China faces the challenge of influenza A virus, including H3N8, in the post-COVID-19 era.
    J Infect. 2023 Jun 7:S0163-4453(23)00324-9. doi: 10.1016/j.jinf.2023.
    >> Share

  117. MOHN KG, Bredholt G, Onyango TB, Brokstad KA, et al
    SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity.
    J Infect. 2023 Jun 7:S0163-4453(23)00302-X. doi: 10.1016/j.jinf.2023.
    >> Share

  118. PASCALL DJ, Vink E, Blacow R, Bulteel N, et al
    Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistent.
    J Infect. 2023 Jun 1:S0163-4453(23)00297-9. doi: 10.1016/j.jinf.2023.
    >> Share

    May 2023
  119. LIU P, Cheng F, Su L, Ye Z, et al
    An outbreak of influenza A in Shanghai after ending the zero-COVID policy in February-March 2023.
    J Infect. 2023 May 27:S0163-4453(23)00301-8. doi: 10.1016/j.jinf.2023.
    >> Share

  120. NG RW, Sze RK, Chong KC, Zhao S, et al
    Effectiveness of mRNA and inactivated COVID-19 vaccines: a test-negative study in an infection-naive Hong Kong population.
    J Infect. 2023 May 26:S0163-4453(23)00298-0. doi: 10.1016/j.jinf.2023.
    >> Share

  121. KANG SW, Kim JY, Park H, Lim SY, et al
    Corrigendum to "Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection" [J Infect 85 (2022) e69-e71].
    J Infect. 2023 May 25:S0163-4453(23)00294-3. doi: 10.1016/j.jinf.2023.
    >> Share

  122. FAVRESSE J, Cabo J, Douxfils J
    Cellular immunity against SARS-CoV-2 is predominantly boosted in vaccinated individuals with no history of infection.
    J Infect. 2023 May 19:S0163-4453(23)00292-X. doi: 10.1016/j.jinf.2023.
    >> Share

  123. DIAN Y, Meng Y, Sun Y, Deng G, et al
    Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities.
    J Infect. 2023 May 17:S0163-4453(23)00290-6. doi: 10.1016/j.jinf.2023.
    >> Share

  124. NAOURI D, Pham T, Dres M, Vuagnat A, et al
    Differences in clinical characteristics and outcomes between COVID-19 and influenza in critically ill adult patients: a national database study.
    J Infect. 2023 May 16:S0163-4453(23)00289-X. doi: 10.1016/j.jinf.2023.
    >> Share

  125. ZHONG X, Pate A, Yang YT, Fahmi A, et al
    The impact of COVID -19 on antibiotic prescribing in primary care in England: evaluation and risk prediction of appropriateness of type and repeat prescribing.
    J Infect. 2023 May 12:S0163-4453(23)00288-8. doi: 10.1016/j.jinf.2023.
    >> Share

  126. PINANA M, Gonzalez-Sanchez A, Andres C, Abanto M, et al
    The emergence, impact, and evolution of human metapneumovirus variants from 2014 to 2021 in Spain.
    J Infect. 2023 May 11:S0163-4453(23)00262-1. doi: 10.1016/j.jinf.2023.
    >> Share

  127. LV W, He J, Shao J, Chen Y, et al
    Causal relationships between short-chain fatty acids and L-isoleucine biosynthesis and susceptibility and severity of COVID-19: Evidence from Mendelian randomization.
    J Infect. 2023 May 5:S0163-4453(23)00258-X. doi: 10.1016/j.jinf.2023.
    >> Share

  128. GAO M, Ao G, Hao X, Xie B, et al
    Casirivimab-Imdevimab treatment is associated with reduced rates of mortality and hospitalization in patients with COVID-19: A systematic review with meta-analysis.
    J Infect. 2023 May 3:S0163-4453(23)00256-6. doi: 10.1016/j.jinf.2023.
    >> Share

    April 2023
  129. XU J, Mao D, Liang P, Du P, et al
    Undetectable intrauterine transmission during the first trimester of pregnancy in woman after COVID-19 infection.
    J Infect. 2023 Apr 26:S0163-4453(23)00255-4. doi: 10.1016/j.jinf.2023.
    >> Share

  130. AWAN UA, Hussain M, Qureshi M, Siddique Z, et al
    From COVID-19 to Measles: Prioritizing Immunization in Pakistan's Far-Flung Regions.
    J Infect. 2023 Apr 26:S0163-4453(23)00253-0. doi: 10.1016/j.jinf.2023.
    >> Share

  131. ZHOU Y, Yan H, Zhou Q, Feng R, et al
    Impact of COVID-19 control measures on Legionella pneumophila infections in children in Henan, China.
    J Infect. 2023 Apr 26:S0163-4453(23)00254-2. doi: 10.1016/j.jinf.2023.
    >> Share

  132. AZIZ NA, Nash SG, Zaidi A, Nyberg T, et al
    Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England.
    J Infect. 2023 Apr 24:S0163-4453(23)00249-9. doi: 10.1016/j.jinf.2023.
    >> Share

  133. FURUSE Y
    Estimation of excess cardiovascular deaths after COVID-19 in 2020.
    J Infect. 2023 Apr 24:S0163-4453(23)00251-7. doi: 10.1016/j.jinf.2023.
    >> Share

  134. LIU X, Munro APS, Wright A, Feng S, et al
    Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.
    J Infect. 2023 Apr 19:S0163-4453(23)00247-5. doi: 10.1016/j.jinf.2023.
    >> Share

  135. LUO J, Li A, Liu C, Wang Y, et al
    The effect of bebtelovimab on clinical outcomes in patients with COVID-19: a meta-analysis.
    J Infect. 2023 Apr 19:S0163-4453(23)00210-4. doi: 10.1016/j.jinf.2023.
    >> Share

  136. PIGHI L, Henry BM, De Nitto S, Salvagno GL, et al
    Cellular immunity against SARS-CoV-2 depends on the serological status.
    J Infect. 2023 Apr 13:S0163-4453(23)00203-7. doi: 10.1016/j.jinf.2023.
    >> Share

  137. TEYSSOU E, Marot S, Gothland A, Malet I, et al
    SARS-CoV-2 variant-dependent inflammasome activation.
    J Infect. 2023 Apr 13:S0163-4453(23)00205-0. doi: 10.1016/j.jinf.2023.
    >> Share

  138. LIU X, Munro AP, Feng S, Janani L, et al
    Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511].
    J Infect. 2023 Apr 11:S0163-4453(23)00198-6. doi: 10.1016/j.jinf.2023.
    >> Share

  139. MORRISON H, Perrin F, Dedicoat M, Ahmed R, et al
    Impact of COVID-19 on NHS Tuberculosis Services: Results of a UK-wide survey.
    J Infect. 2023 Apr 10:S0163-4453(23)00204-9. doi: 10.1016/j.jinf.2023.
    >> Share

  140. SHAW RH, Greenland M, Stuart AS, Aley PK, et al
    Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - a single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
    J Infect. 2023 Apr 5:S0163-4453(23)00199-8. doi: 10.1016/j.jinf.2023.
    >> Share

  141. ZHAO D, Yi H, Dian Y, Meng Y, et al
    Elevated troponin levels predict the reduced efficacy of Paxlovid in COVID-19 patients.
    J Infect. 2023 Apr 3:S0163-4453(23)00200-1. doi: 10.1016/j.jinf.2023.
    >> Share

  142. CHEN H, Zhang L, Zhang Y, Chen G, et al
    Prevalence and clinical features of long COVID from omicron infection in children and adults.
    J Infect. 2023;86:e97-e99.
    >> Share

    March 2023
  143. GAO Y, Luo Z, Ren S, Duan Z, et al
    Antiviral effect of azvudine and nirmatrelvir-ritonavir among hospitalized patients with COVID-19.
    J Infect. 2023 Mar 30:S0163-4453(23)00192-5. doi: 10.1016/j.jinf.2023.
    >> Share

  144. KELLENI MT
    SARS CoV-2 Genetic Jump to a New SARS CoV-3 Pandemic: Let's Be Prepared.
    J Infect. 2023 Mar 21:S0163-4453(23)00147-0. doi: 10.1016/j.jinf.2023.
    >> Share

  145. NAMGUNG SH, Jung J, Kim SK, Kim EO, et al
    Incidence of tuberculosis infection in healthcare workers in high-risk departments for tuberculosis after universal wearing of KF94 mask during COVID-19 pandemic.
    J Infect. 2023 Mar 21:S0163-4453(23)00146-9. doi: 10.1016/j.jinf.2023.
    >> Share

  146. HSU WH, Shiau BW, Tsai YW, Wu JY, et al
    The effect of molnupiravir on post-acute outcome of COVID-19 survivors.
    J Infect. 2023 Mar 21:S0163-4453(23)00145-7. doi: 10.1016/j.jinf.2023.
    >> Share

  147. DANIAL-FARRAN N, Khlaila M, Avraham-Kelbert M, Chazan B, et al
    Genetic Variant in Complement Receptor 1 (CR1, CD35) is Associated with A Cluster of Severe Fatal COVID-19 in a Family.
    J Infect. 2023 Mar 14:S0163-4453(23)00143-3. doi: 10.1016/j.jinf.2023.
    >> Share

  148. CLARK TW, Lindsley K, Wigmosta TB, Bhagat A, et al
    Rapid Multiplex PCR for Respiratory Viruses Reduces Time to Result and Improves Clinical Care: Results of a Systematic Review and Meta-Analysis.
    J Infect. 2023 Mar 9:S0163-4453(23)00134-2. doi: 10.1016/j.jinf.2023.
    >> Share

  149. GERETTI AM, Austin H, Villa G, Smith C, et al
    Hepatitis B virus infection in general practice across England: An analysis of the Royal College of General Practitioners Research and Surveillance Centre real-world database.
    J Infect. 2023 Mar 9:S0163-4453(23)00130-5. doi: 10.1016/j.jinf.2023.
    >> Share

  150. BHAT S, Das L, Maheshwari D, Badal D, et al
    Effect of Calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial.
    J Infect. 2023 Mar 6:S0163-4453(23)00131-7. doi: 10.1016/j.jinf.2023.
    >> Share

  151. WANG H, Liu Y, Li P, Liu C, et al
    Emergence of epidemic variants of SARS-CoV-2 by acquiring combinations of new highly mutable nucleotides in its genome.
    J Infect. 2023 Mar 6:S0163-4453(23)00133-0. doi: 10.1016/j.jinf.2023.
    >> Share

  152. QUILES-JIMENEZ A, Sousa M, Huse C, Dyrhol-Riise AM, et al
    Severely-ill COVID-19 patients have altered circulating levels of proteins controlling the epitranscriptome.
    J Infect. 2023 Mar 6:S0163-4453(23)00132-9. doi: 10.1016/j.jinf.2023.
    >> Share

  153. LIU P, Xu J
    Genomic surveillance of SARS-CoV-2 in mainland China after ending the zero-COVID policy, December 2022 - January 2023.
    J Infect. 2023 Mar 1:S0163-4453(23)00127-5. doi: 10.1016/j.jinf.2023.
    >> Share

    February 2023
  154. SCARPA F, Imperia E, Azzena I, Giovanetti M, et al
    Genetic and structural genome-based survey reveals the low potential for epidemiological expansion of the SARS-CoV-2 XBB.1.5 sublineage.
    J Infect. 2023 Feb 28:S0163-4453(23)00126-3. doi: 10.1016/j.jinf.2023.
    >> Share

  155. SHAVA E, Izu A, Gaolathe T, Walker A, et al
    Safety and incidence of COVID-19 following ChAdOx1(AZD1222) COVID-19 vaccination in Botswana.
    J Infect. 2023 Feb 28:S0163-4453(23)00123-8. doi: 10.1016/j.jinf.2023.
    >> Share

  156. DENG Y, Han S, Liu J, Guo L, et al
    The risks of death and hospitalizations associated with SARS-CoV-2 Omicron declined after lifting testing and quarantining measures.
    J Infect. 2023 Feb 27:S0163-4453(23)00118-4. doi: 10.1016/j.jinf.2023.
    >> Share

  157. GUO H, Zhao T
    Multiple mutations of IFITM3 are associated with COVID-19 susceptibility.
    J Infect. 2023 Feb 23:S0163-4453(23)00120-2. doi: 10.1016/j.jinf.2023.
    >> Share

  158. ZHOU P, Gong F, Ji T, Cao C, et al
    Enriched CXCR3(+) CXCR5(+) CD8(+) T cells in SARS-CoV-2 infected and vaccinated individuals effectively respond to the antigen in recall.
    J Infect. 2023 Feb 23:S0163-4453(23)00109-3. doi: 10.1016/j.jinf.2023.
    >> Share

  159. UELAND T, Aikas LAO, Dahl TB, Gregersen I, et al
    Low-Density Lipoprotein Particles Carrying Proinflammatory Proteins with Altered Aggregation Pattern Detected in COVID-19 Patients 3 Months After HospitalizationRunning title: Low-Density Lipoprotein Particles in COVID-19 Patients.
    J Infect. 2023 Feb 21:S0163-4453(23)00111-1. doi: 10.1016/j.jinf.2023.
    >> Share

  160. ZHANG K, Chen R, Jiang Q
    Allopurinol Increased the Risk of COVID-19 Hospitalization Mediated by E-Selectin Downregulation.
    J Infect. 2023 Feb 21:S0163-4453(23)00116-0. doi: 10.1016/j.jinf.2023.
    >> Share

  161. PUTRI DU, Huang CK, Ou TY, Lin CF, et al
    Persistent dysregulation of cellular immunity following COVID-19 recovery despite minimal post-COVID-19 sequelae manifestationRunning title: Occult post-COVID immune dysregulation.
    J Infect. 2023 Feb 21:S0163-4453(23)00112-3. doi: 10.1016/j.jinf.2023.
    >> Share

  162. MEI R, Kwok SLL, Lau EHY, Lo THK, et al
    Battle of Polio eradication in the Western Pacific Region in the transition to COVID-19 endemicity.
    J Infect. 2023 Feb 21:S0163-4453(23)00113-5. doi: 10.1016/j.jinf.2023.
    >> Share

  163. WAN EYF, Wang B, Mathur S, Chan CIY, et al
    Molnupiravir and nirmatrelvir-ritonavir reduce mortality risk during post-acute COVID-19 phase.
    J Infect. 2023 Feb 21:S0163-4453(23)00117-2. doi: 10.1016/j.jinf.2023.
    >> Share

  164. YANG F, Zhang N, Meng R, Wang K, et al
    Non-causal Association of COVID-19 with Systemic Lupus Erythematosus: Evidence from a Bidirectional Mendelian RandomizationRunning title: Association of COVID-19 with SLE.
    J Infect. 2023 Feb 21:S0163-4453(23)00115-9. doi: 10.1016/j.jinf.2023.
    >> Share

  165. VALENTINI D, Carfi A, Di Paola A, Yarci-Carrion A, et al
    Factor associated with SARS-CoV-2 vaccination serological efficacy in adolescents and adults with Down syndrome: data from an international, collaborative initiative of the Trisomy 21 Research SocietyRUNNING TITLE: Factors determining COVID-19 vaccine
    J Infect. 2023 Feb 20:S0163-4453(23)00090-7. doi: 10.1016/j.jinf.2023.
    >> Share

  166. POWELL AA, Ireland G, Leeson R, Lacey A, et al
    National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021.
    J Infect. 2023 Feb 15:S0163-4453(23)00085-3. doi: 10.1016/j.jinf.2023.
    >> Share

  167. BIRD PW, Pan D, Martin CA, Gogoi M, et al
    Awareness of HIV, Hepatitis B, Hepatitis C, Tuberculosis and COVID-19 in Migrant Students in the UK - A Pilot Survey from an Institute of Higher Education.
    J Infect. 2023 Feb 14:S0163-4453(23)00086-5. doi: 10.1016/j.jinf.2023.
    >> Share

  168. ZHANG W, Sun M, Zhang P, Liang Y, et al
    Epidemiological characteristics of Cytomegalovirus infection in children before and after the COVID-19 pandemic in Henan, China, 2016 - 2022.
    J Infect. 2023 Feb 10:S0163-4453(23)00081-6. doi: 10.1016/j.jinf.2023.
    >> Share

  169. MENG R, Zhang N, Yang F, Xu Z, et al
    Blood Transcriptome Analysis Revealed the Crosstalk Between Severe COVID-19 and Systemic Lupus Erythematosus.
    J Infect. 2023 Feb 10:S0163-4453(23)00080-4. doi: 10.1016/j.jinf.2023.
    >> Share

  170. LI L, Song X, Sun H, Ma J, et al
    Changes of pathogen distribution in children with wound infections before and after the COVID-19 pandemic in Henan, China.
    J Infect. 2023 Feb 9:S0163-4453(23)00079-8. doi: 10.1016/j.jinf.2023.
    >> Share

  171. HSU WH, Tsai YW, Wu JY, Liu TH, et al
    Post-acute hospitalization and mortality of nirmatrelvir plus ritonavir for COVID-19 survivors.
    J Infect. 2023 Feb 9:S0163-4453(23)00076-2. doi: 10.1016/j.jinf.2023.
    >> Share

  172. HU S, Zhang S, You Y, Tang J, et al
    Olfactory dysfunction after COVID-19; metanalysis reveals persistence in one third of patients six months after initial infection.
    J Infect. 2023 Feb 9:S0163-4453(23)00068-3. doi: 10.1016/j.jinf.2023.
    >> Share

  173. LI L, Jia R, Zhang Y, Sun H, et al
    Changes of parainfluenza virus infection in children before and after the COVID-19 pandemic in Henan, China.
    J Infect. 2023 Feb 9:S0163-4453(23)00078-6. doi: 10.1016/j.jinf.2023.
    >> Share

  174. EVANS A, Qi C, Adebayo JO, Underwood J, et al
    Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: a retrospective cohort study.
    J Infect. 2023 Feb 9:S0163-4453(23)00082-8. doi: 10.1016/j.jinf.2023.
    >> Share

  175. LI R, Wang M, Li D, Zhang Y, et al
    The impact of the COVID-19 pandemic on the number of hand, foot, and mouth disease due to enterovirus 71 infections.
    J Infect. 2023 Feb 8:S0163-4453(23)00075-0. doi: 10.1016/j.jinf.2023.
    >> Share

  176. CAILLARD S, Laugel E, Benotmane I, Kremer SF, et al
    Molecular evolution of the SARS-CoV-2 omicron BA.2 variant in kidney transplant recipients with prolonged viral shedding.
    J Infect. 2023 Feb 8:S0163-4453(23)00070-1. doi: 10.1016/j.jinf.2023.
    >> Share

  177. GRAY EJ, Nguyen-Van-Tam JS
    Molnupiravir for SARS-CoV-2 infection: Public health and policy implications.
    J Infect. 2023;86:121-122.
    >> Share

    January 2023
  178. AMANO M, Ichikawa Y, Uemura Y, Matsumoto S, et al
    Comparison of neutralization activity against Omicron BA.2/BA.5 in sera from HCWs receiving heterologous/homologous COVID-19 vaccines.
    J Infect. 2023 Jan 31:S0163-4453(23)00066-X. doi: 10.1016/j.jinf.2023.
    >> Share

  179. LIANG J, Liu R, He W, Zeng Z, et al
    70% COVID-19 infection within three weeks in the population of Macao, China.
    J Infect. 2023 Jan 30:S0163-4453(23)00035-X. doi: 10.1016/j.jinf.2023.
    >> Share

  180. CHANG YH, Liu TH, Wu JY, Lai CC, et al
    The association between corticosteroids and aspergillosis among COVID-19 patients.
    J Infect. 2023 Jan 27:S0163-4453(23)00055-5. doi: 10.1016/j.jinf.2023.
    >> Share

  181. RANA MS, Usman M, Alam MM, Tahir M, et al
    The emergence of Mumps after the COVID-19 Pandemic in Pakistan: time to consider MMR vaccination strategies.
    J Infect. 2023 Jan 26:S0163-4453(23)00057-9. doi: 10.1016/j.jinf.2023.
    >> Share

  182. NISAR MI, Ansari N, Malik AA, Shahid S, et al
    Assessing the effectiveness of COVID-19 vaccines in Pakistan: a test-negative case-control study.
    J Infect. 2023 Jan 25:S0163-4453(23)00021-X. doi: 10.1016/j.jinf.2023.
    >> Share

  183. HANI E, Bertran M, Powell A, Williams H, et al
    Significantly lower infection fatality rates associated with SARS-CoV-2 Omicron (B.1.1.529) infection in children and young people: active, prospective national surveillance, January-March 2022, England.
    J Infect. 2023 Jan 24:S0163-4453(23)00037-3. doi: 10.1016/j.jinf.2023.
    >> Share

  184. KELLENI MT
    Evolution of SARS CoV-2 Omicron Subvariants BF.7 and XBB.1.5: Time to follow Africa and abort all COVID Restrictions.
    J Infect. 2023 Jan 23:S0163-4453(23)00030-0. doi: 10.1016/j.jinf.2023.
    >> Share

  185. GENTRY CA, Nguyen P, Thind SK, Kurdgelashvili G, et al
    Characteristics and outcomes of US Veterans at least 65 years of age at high risk of severe SARS-CoV-2 infection with or without receipt of oral antiviral agents.
    J Infect. 2023 Jan 23:S0163-4453(23)00023-3. doi: 10.1016/j.jinf.2023.
    >> Share

  186. WU JY, Liu TH, Huang PY, Tsai YW, et al
    The effect of zinc on the outcome of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials.
    J Infect. 2023 Jan 21:S0163-4453(23)00028-2. doi: 10.1016/j.jinf.2023.
    >> Share

  187. ZHAN H, Yang L, Liu Y, Li H, et al
    Acceptance, safety and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in adults with tuberculosis.
    J Infect. 2023 Jan 21:S0163-4453(23)00034-8. doi: 10.1016/j.jinf.2023.
    >> Share

  188. LIANG Y, Hou L, Hou G, Zhang X, et al
    The influences of the COVID-19 pandemic on Epstein-Barr virus infection in children, Henan, China.
    J Infect. 2023 Jan 20:S0163-4453(23)00026-9. doi: 10.1016/j.jinf.2023.
    >> Share

  189. LIU X, Lv Z, Wang J, Zhou Y, et al
    IL1RA Mediated the Effects of Aspirin on Covid-19 severity: a Mendelian Randomization Study.
    J Infect. 2023 Jan 20:S0163-4453(23)00031-2. doi: 10.1016/j.jinf.2023.
    >> Share

  190. SALTO-ALEJANDRE S, Carretero-Ledesma M, Camacho-Martinez P, Berastegui-Cabrera J, et al
    Serum IFN-gamma and RNAemia temporal profiles as biomarkers of severe COVID-19 in solid organ transplant and immunocompetent patients.
    J Infect. 2023 Jan 20:S0163-4453(23)00024-5. doi: 10.1016/j.jinf.2023.
    >> Share

  191. KANG SW, Kim JW, Kim JY, Lim SY, et al
    Characteristics and risk factors of prolonged viable virus shedding in immunocompromised patients with COVID-19: a prospective cohort study.
    J Infect. 2023 Jan 19:S0163-4453(23)00029-4. doi: 10.1016/j.jinf.2023.
    >> Share

  192. RANA MS, Usman M, Alam MM, Tahir M, et al
    Changes in the prevalence of infectious diseases before and after the COVID-19 pandemic in Pakistan.
    J Infect. 2023 Jan 19:S0163-4453(23)00025-7. doi: 10.1016/j.jinf.2023.
    >> Share

  193. SHAH RA, Mentzer AJ, James T, Cox S, et al
    A novel near-patient host-protein score predicts COVID-19 deterioration at presentation to secondary care.
    J Infect. 2023 Jan 18:S0163-4453(23)00022-1. doi: 10.1016/j.jinf.2023.
    >> Share

  194. RU X, Chen S, Zhang T, Ding Z, et al
    Nonpharmaceutical intervention is an effective measure to block respiratory virus coinfections with SARS-CoV-2.
    J Infect. 2023 Jan 18:S0163-4453(23)00018-X. doi: 10.1016/j.jinf.2023.
    >> Share

  195. KANG SW, Park H, Kim JY, Lim SY, et al
    Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1/BA.2 and omicron BA.5 variants: A prospective cohort study.
    J Infect. 2023 Jan 18:S0163-4453(23)00020-8. doi: 10.1016/j.jinf.2023.
    >> Share

  196. LIU TH, Wu JY, Huang PY, Tsai YW, et al
    The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients.
    J Infect. 2023 Jan 14:S0163-4453(23)00017-8. doi: 10.1016/j.jinf.2023.
    >> Share

  197. LI X, Li T, Chen N, Kang P, et al
    Changes of Mycoplasma pneumoniae infection in children before and after COVID-19 pandemic in Henan, China.
    J Infect. 2023 Jan 13:S0163-4453(23)00012-9. doi: 10.1016/j.jinf.2022.
    >> Share

  198. TSAI YW, Tsai CF, Wu JY, Huang PY, et al
    The risk of methicillin-resistant Staphylococcus aureus infection following COVID-19 and influenza: A retrospective cohort study from the TriNetX network.
    J Infect. 2023 Jan 9:S0163-4453(23)00007-5. doi: 10.1016/j.jinf.2023.
    >> Share

  199. DING X, Liang H, Qi X, Sun G, et al
    Changes of Klebsiella pneumoniae infection and carbapenem resistance in ICU elderly infected patients before and after the COVID-19 pandemic in Zhengzhou, China.
    J Infect. 2023 Jan 9:S0163-4453(23)00009-9. doi: 10.1016/j.jinf.2023.
    >> Share

  200. XU J, Wang Y, Duan G, Liu F, et al
    Impact of non-pharmaceutical interventions during COVID-19 pandemic on measles and mumps in mainland China.
    J Infect. 2023 Jan 9:S0163-4453(23)00008-7. doi: 10.1016/j.jinf.2023.
    >> Share

  201. PATIL S, Chen H, Dong S, Liu S, et al
    Klebsiella pneumoniae infection in the paediatric population before and after the COVID-19 pandemic in Shenzhen, China.
    J Infect. 2023 Jan 8:S0163-4453(23)00004-X. doi: 10.1016/j.jinf.2023.
    >> Share

  202. LI Y, Liang H, Ding X, Cao Y, et al
    Effectiveness of COVID-19 vaccine in children and adolescents with the Omicron variant: A systematic review and meta-analysis.
    J Infect. 2023 Jan 6:S0163-4453(23)00001-4. doi: 10.1016/j.jinf.2023.
    >> Share

  203. YU Z, Xu S, Li L, Li M, et al
    Changes of Cytomegalovirus infection in neonates before and after the COVID19 pandemic in Zhengzhou, China.
    J Infect. 2023 Jan 5:S0163-4453(23)00002-6. doi: 10.1016/j.jinf.2023.
    >> Share

  204. ZHAO S, Sha T, Xue Y, Chen H, et al
    Flattening the Curve is Imperative: When China Relaxes the Dynamic Zero COVID-19 Policy.
    J Infect. 2023 Jan 2:S0163-4453(22)00748-4. doi: 10.1016/j.jinf.2022.
    >> Share

  205. HIROTSU Y, Omata M
    Detection of the Omicron BA.2.75 subvariant in Japan.
    J Infect. 2023;86:e5-e7.
    >> Share

  206. CAMACHO J, Zulaica J, Gimenez E, Rusu L, et al
    Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naive individuals in the general population.
    J Infect. 2023 Jan 1:S0163-4453(22)00755-1. doi: 10.1016/j.jinf.2022.
    >> Share

    December 2022
  207. CILLONIZ C, Motos A, Castaneda T, Gabarrus A, et al
    Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study.
    J Infect. 2022 Dec 31:S0163-4453(22)00753-8. doi: 10.1016/j.jinf.2022.
    >> Share

  208. LIANG Y, Li J, Hou L, Zhang X, et al
    Changes of Staphylococcus aureus infection in children before and after the COVID-19 pandemic, Henan, China.
    J Infect. 2022 Dec 28:S0163-4453(22)00751-4. doi: 10.1016/j.jinf.2022.
    >> Share

  209. FERNANDEZ-DE-LAS-PENAS C, Arendt-Nielsen L, Diaz-Gil G, Gil-Crujera A, et al
    ACE1 rs1799752 Polymorphism is not Associated with Long-COVID Symptomatology in Previously Hospitalized COVID-19 Survivors.
    J Infect. 2022 Dec 27:S0163-4453(22)00752-6. doi: 10.1016/j.jinf.2022.
    >> Share

  210. LI Y, Cao Y, Ding X, Yang D, et al
    Influence of the COVID-19 pandemic on Staphylococcus aureus bloodstream infection in children, Henan, China.
    J Infect. 2022 Dec 25:S0163-4453(22)00746-0. doi: 10.1016/j.jinf.2022.
    >> Share

  211. SCHILDGEN O, Lusebrink J, Schildgen V
    Recommendation for broad use of Covid-19 mRNA vaccine boosters due to waning vaccine effectiveness is taking the easy way out.
    J Infect. 2022 Dec 24:S0163-4453(22)00744-7. doi: 10.1016/j.jinf.2022.
    >> Share

  212. KRONE M, Wagenhauser I, Knies K, Hofmann D, et al
    Clinical accuracy of SARS-CoV-2 rapid antigen testing in screening children and adolescents.
    J Infect. 2022 Dec 21:S0163-4453(22)00740-X. doi: 10.1016/j.jinf.2022.
    >> Share

  213. JANKUNAS R, Sakalauskas L, Zamaryte-Sakaviciene K, Stakisaitis D, et al
    COMMENTARY ON THE IMPACT OF THE COVID-19 PASSPORTS IN LITHUANIA.
    J Infect. 2022 Dec 20:S0163-4453(22)00703-4. doi: 10.1016/j.jinf.2022.
    >> Share

  214. C O, H W, R B, E L, et al
    Following the Omicron wave, the majority of children in England have evidence of previous COVID infection.
    J Infect. 2022 Dec 18:S0163-4453(22)00701-0. doi: 10.1016/j.jinf.2022.
    >> Share

  215. LI X, Peng K, Cheng FW, Lam DC, et al
    Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac).
    J Infect. 2022 Dec 17:S0163-4453(22)00706-X. doi: 10.1016/j.jinf.2022.
    >> Share

  216. LIANG Y, Zhang P, Du B, Zhang X, et al
    Changes of Mycoplasma pneumoniae infection in children before and after the COVID - 19 pandemic, Henan, China.
    J Infect. 2022 Dec 15:S0163-4453(22)00705-8. doi: 10.1016/j.jinf.2022.
    >> Share

  217. ZHANG M, Gao J, Guo Q, Zhang X, et al
    Changes of respiratory syncytial virus infection in children before and after the COVID-19 pandemic in Henan, China.
    J Infect. 2022 Dec 15:S0163-4453(22)00702-2. doi: 10.1016/j.jinf.2022.
    >> Share

  218. LI L, Ma J, Guo P, Gao K, et al
    Changes of coagulase-negative Staphylococci infections in children before and after the COVID-19 pandemic in Zhengzhou, China.
    J Infect. 2022 Dec 12:S0163-4453(22)00698-3. doi: 10.1016/j.jinf.2022.
    >> Share

  219. XU J, Wang Y, Liu F, Yang H, et al
    Changes of tuberculosis infection in mainland China before and after the COVID-19 pandemic.
    J Infect. 2022 Dec 11:S0163-4453(22)00699-5. doi: 10.1016/j.jinf.2022.
    >> Share

  220. KELLENI MT
    Real-life Practice of the Egyptian Kelleni's Protocol in the Current Tripledemic: COVID-19, RSV and Influenza.
    J Infect. 2022 Dec 10:S0163-4453(22)00697-1. doi: 10.1016/j.jinf.2022.
    >> Share

  221. CHENG P, Li L, Sun H, Zhu C, et al
    Changes of pathogen distribution in children with bacterial meningitis before and after the COVID-19 pandemic in Zhengzhou, China.
    J Infect. 2022 Dec 10:S0163-4453(22)00696-X. doi: 10.1016/j.jinf.2022.
    >> Share

  222. HANNAWI S, Safeldin L, Abuquta A, Alamadi A, et al
    Safety and Immunogenicity of a Bivalent SARS-CoV-2 Protein Booster Vaccine, SCTV01C in Adults Previously Vaccinated with Inactivated Vaccine: A Randomized, Double-blind, Placebo-controlled Phase 1/2 Clinical Trial.
    J Infect. 2022 Dec 9:S0163-4453(22)00693-4. doi: 10.1016/j.jinf.2022.
    >> Share

  223. POZO-BALADO MDM, Ramos A, Rodriguez VG, Martinez IO, et al
    LONGITUDINAL AGE DIFFERENCES IN HUMORAL RESPONSES TO THE BNT162b2 VACCINE IN THE ELDERLY ARE LOST AFTER THE THIRD DOSE.
    J Infect. 2022 Dec 8:S0163-4453(22)00692-2. doi: 10.1016/j.jinf.2022.
    >> Share

  224. LIANG Y, Qin X, Hou G, Zhang X, et al
    Changes of Moraxella catarrhalis infection in children before and after the COVID-19 pandemic, Zhengzhou, China.
    J Infect. 2022 Dec 6:S0163-4453(22)00691-0. doi: 10.1016/j.jinf.2022.
    >> Share

  225. LI L, Yu Z, Li M, Sun H, et al
    Changes of Acinetobacter baumannii infections in children before and after the COVID-19 pandemic in Zhengzhou, China.
    J Infect. 2022 Dec 2:S0163-4453(22)00689-2. doi: 10.1016/j.jinf.2022.
    >> Share

  226. LI K, Wang D, Qu H, Rui J, et al
    Viral Dynamics of Omicron BA.2.76 Variant of SARS-CoV-2 in a Cohort of COVID-19 Patients.
    J Infect. 2022 Dec 2:S0163-4453(22)00688-0. doi: 10.1016/j.jinf.2022.
    >> Share

  227. KAKIMOTO M, Miyamori D, Omori K, Kobayashi T, et al
    Impact of the early phase of COVID-19 on the trends of isolated bacteria in the national database of Japan: an interrupted time-series analysis.
    J Infect. 2022 Dec 1:S0163-4453(22)00686-7. doi: 10.1016/j.jinf.2022.
    >> Share

  228. CHEEMA HA, Shafiee A, Athar MMT, Shahid A, et al
    No evidence of clinical efficacy of famotidine for the treatment of COVID-19: a systematic review and meta-analysis.
    J Infect. 2022 Dec 1:S0163-4453(22)00683-1. doi: 10.1016/j.jinf.2022.
    >> Share

  229. JIANG L, Tang L, Zhu L, Zhu Y, et al
    Viral dynamics during SARS-CoV-2 omicron infection highlight presymptomatic and asymptomatic infectiousness.
    J Infect. 2022 Dec 1:S0163-4453(22)00687-9. doi: 10.1016/j.jinf.2022.
    >> Share

  230. ABDULJALIL JM, Elfiky AA
    Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective.
    J Infect. 2022;85:702-769.
    >> Share

    November 2022
  231. TANG Y, Dang X, Lv M, Norris SL, et al
    Changes in the prevalence of respiratory pathogens in children due to the COVID-19 pandemic: a systematic review and meta-analysis.
    J Infect. 2022 Nov 29:S0163-4453(22)00685-5. doi: 10.1016/j.jinf.2022.
    >> Share

  232. DENG YK, Shi KT, Liu Z, Zeng M, et al
    Persistent olfactory dysfunction 2 years after onset of COVID-19.
    J Infect. 2022 Nov 29:S0163-4453(22)00684-3. doi: 10.1016/j.jinf.2022.
    >> Share

  233. LV L, Li A, Jiang L, Zhang L, et al
    Deficiency of HTR4 and ADRB1 caused by SARS-CoV-2 spike may partially explain multiple COVID-19 related syndromes including depression, cognitive impairment, loss of appetite, heart failure, and hypertension.
    J Infect. 2022 Nov 28:S0163-4453(22)00682-X. doi: 10.1016/j.jinf.2022.
    >> Share

  234. CHEN D, Pan Y, Wang Y, Chen X, et al
    Serological response to COVID-19 vaccine and its predictors in patients with solid malignancies: a systematic review and meta-analysis of 16 cohort studies.
    J Infect. 2022 Nov 26:S0163-4453(22)00673-9. doi: 10.1016/j.jinf.2022.
    >> Share

  235. ZHENG M
    China plans to strike a balance between socio-economic development and anti-COVID-19 policy: report from the 20th National Congress of China.
    J Infect. 2022 Nov 25:S0163-4453(22)00680-6. doi: 10.1016/j.jinf.2022.
    >> Share

  236. TRKULJA V
    There is no reasonable evidence to support efficacy of fluvoxamine in prevention of disease deterioration in COVID-19 outpatients: a comment on two recent meta-analyses advocating its use.
    J Infect. 2022 Nov 24:S0163-4453(22)00677-6. doi: 10.1016/j.jinf.2022.
    >> Share

  237. LI L, Song C, Li P, Li Y, et al
    Changes of Escherichia coli infection in children before and after the COVID-19 pandemic in Zhengzhou, China.
    J Infect. 2022 Nov 24:S0163-4453(22)00678-8. doi: 10.1016/j.jinf.2022.
    >> Share

  238. ZHAO Y, Zhao Y, Zhou Y, Zhang Z, et al
    Inactivated COVID-19 vaccination and maternal renal function during early pregnancy: a retrospective cohort study of 6397 Chinese pregnant women.
    J Infect. 2022 Nov 22:S0163-4453(22)00676-4. doi: 10.1016/j.jinf.2022.
    >> Share

  239. YARCI-CARRION A, Esparcia-Pinedo L, Mateo-Jimenez G, Alfranca A, et al
    Effect of a SARS-CoV-2 booster vaccine dose on the immune response of adults with Down syndrome.
    J Infect. 2022 Nov 20:S0163-4453(22)00675-2. doi: 10.1016/j.jinf.2022.
    >> Share

  240. WANG X, Sima L
    Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis.
    J Infect. 2022 Nov 20:S0163-4453(22)00674-0. doi: 10.1016/j.jinf.2022.
    >> Share

  241. WANG G, Zhao K, Han J, Hu Z, et al
    Safety and Immunogenicity of a Bivalent SARS-CoV-2 Recombinant Protein Vaccine, SCTV01C in Unvaccinated Adults: A Randomized, Double-blinded, Placebo-controlled, Phase I Clinical Trial.
    J Infect. 2022 Nov 17:S0163-4453(22)00649-1. doi: 10.1016/j.jinf.2022.
    >> Share

  242. ROMBAUTS A, Infante C, de Lagos MDAM, Alba J, et al
    Impact of SARS-CoV-2 RNAemia and other risk factors on long-COVID: A prospective observational multicentre cohort study.
    J Infect. 2022 Nov 17:S0163-4453(22)00650-8. doi: 10.1016/j.jinf.2022.
    >> Share

  243. MARCEC R, Dodig VM, Likic R
    A meta-analysis regarding fluvoxamine and hospitalization risk of COVID-19 patients: TOGETHER making a difference.
    J Infect. 2022 Nov 17:S0163-4453(22)00672-7. doi: 10.1016/j.jinf.2022.
    >> Share

  244. HOQUE SA, Kotaki T, Pham NTK, Onda Y, et al
    Abundance of viral gastroenteritis before and after the emergence of COVID-19: Molecular evidence on wastewater.
    J Infect. 2022 Nov 17:S0163-4453(22)00648-X. doi: 10.1016/j.jinf.2022.
    >> Share

  245. LI T, Li X, Gao K, Dong G, et al
    Changes in pathogen distribution in the blood culture of neonates before and after the COVID-19 pandemic, Henan, China.
    J Infect. 2022 Nov 10. pii: S0163-4453(22)00644.
    >> Share

  246. HU S, You Y, Zhang S, Tang J, et al
    Multidrug-resistant infection in COVID-19 patients: a meta-analysis.
    J Infect. 2022 Nov 5. pii: S0163-4453(22)00640.
    >> Share

  247. MASHIMO Y, Yamazaki K, Kageyama T, Tanaka S, et al
    Germline variants of IGHV3-53 / V3-66 are determinants of antibody responses to the BNT162b2 mRNA COVID-19 vaccine.
    J Infect. 2022 Nov 2. pii: S0163-4453(22)00614.
    >> Share

  248. ZHANG N, Hu T, Zhang J, Mai W, et al
    Probable close contact transmission in a restaurant in China.
    J Infect. 2022;85:573-607.
    >> Share

  249. MARCEC R, Dodig VM, Likic R
    Regdanvimab improves disease mortality and morbidity in patients with COVID-19: Too optimistic and too early to say?
    J Infect. 2022 Nov 1. pii: S0163-4453(22)00627.
    >> Share

    October 2022
  250. COSTA R, Signes-Costa J, Olea B, Tarraso J, et al
    Initial SARS-CoV-2 RNA load in nasopharyngeal specimens is not associated with severity and midterm resolution of pneumonia in COVID-19 patients.
    J Infect. 2022 Oct 28. pii: S0163-4453(22)00629.
    >> Share

  251. KANDEL C, Lee Y, Taylor M, Llanes A, et al
    Viral Dynamics of the SARS-CoV-2 Omicron Variant Among Household Contacts with 2 or 3 COVID-19 Vaccine Doses.
    J Infect. 2022 Oct 22. pii: S0163-4453(22)00625.
    >> Share

  252. NISHIKIMI A, Nakagawa T, Fujiwara M, Watanabe K, et al
    Humoral and cellular responses to the third COVID-19 BNT162b2 vaccine dose in research institute workers in Japan.
    J Infect. 2022 Oct 20. pii: S0163-4453(22)00621.
    >> Share

  253. GUO Y, Zhang Y, Hu Y
    COVID-19 subgroups may slow down biological age acceleration.
    J Infect. 2022 Oct 20. pii: S0163-4453(22)00616.
    >> Share

  254. ZHANG Y, Han S, Yao M, Guo X, et al
    Breakthrough Infection shapes humoral immunity against SARS-CoV-2 Omicron Variant.
    J Infect. 2022 Oct 20. pii: S0163-4453(22)00620.
    >> Share

  255. ASTURIAS EJ, Bai X, Bettinger JA, Borrow R, et al
    Meningococcal disease in North America: Updates from the Global Meningococcal Initiative.
    J Infect. 2022 Oct 20. pii: S0163-4453(22)00623.
    >> Share

  256. SHINGLETON J, Williams H, Oligbu G, Powell A, et al
    The changing epidemiology of PIMS-TS across COVID-19 waves: prospective national surveillance, January 2021 to July 2022, England.
    J Infect. 2022 Oct 20. pii: S0163-4453(22)00617.
    >> Share

  257. ZHOU J, Zhao P, Nie M, Gao K, et al
    Changes of Haemophilus influenzae infection in children before and after the COVID-19 pandemic, Henan, China.
    J Infect. 2022 Oct 20. pii: S0163-4453(22)00615.
    >> Share

  258. ZHENG Q, Wang M, Cheng Y, Liu J, et al
    Antibody response and safety of COVID-19 vaccine in peritoneal dialysis patients.
    J Infect. 2022 Oct 17. pii: S0163-4453(22)00612.
    >> Share

  259. CHEEMA HA, Jafar U, Elrashedy AA, Shahid A, et al
    Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: a systematic review and meta-analysis.
    J Infect. 2022 Oct 13. pii: S0163-4453(22)00608.
    >> Share

  260. WANG B, Yu Y, Yu Y, Wang N, et al
    Clinical features and outcomes of hospitalized patients with COVID-19 during the Omicron wave in Shanghai, China.
    J Infect. 2022 Oct 11. pii: S0163-4453(22)00466.
    >> Share

  261. LEE J, Park S, Kim JY, Lim SY, et al
    No correlation of neutralizing antibody titers against the Omicron variant after a booster dose of COVID-19 vaccines with subsequent breakthrough Omicron infections among healthcare workers.
    J Infect. 2022 Oct 9. pii: S0163-4453(22)00600.
    >> Share

  262. ELFIKY AA, Ibrahim IM, Ibrahim MN, Elshemey WM, et al
    Host-cell recognition of SARS-CoV-2 spike receptor binding domain from different variants.
    J Infect. 2022 Oct 8. pii: S0163-4453(22)00601.
    >> Share

  263. CAI H, Yan J, Wang J, Che X, et al
    Efficacy of Paxlovid in patients with acute kidney injury who developed COVID-19.
    J Infect. 2022 Oct 8. pii: S0163-4453(22)00562.
    >> Share

  264. RAFFERTY H, Cann A, Daunt A, Cooke GS, et al
    Changing patterns of clinical presentation of COVID-19 in hospital admissions: a single centre prospective cohort study.
    J Infect. 2022 Oct 7. pii: S0163-4453(22)00563.
    >> Share

  265. GREGERSEN I, Ueland T, Holter JC, Olsen MB, et al
    CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19.
    J Infect. 2022 Oct 7. pii: S0163-4453(22)00559.
    >> Share

  266. BERTRAN M, Pereira SMP, Nugawela MD, Stephenson T, et al
    The relationship between Post COVID symptoms in young people and their parents.
    J Infect. 2022 Oct 7. pii: S0163-4453(22)00560.
    >> Share

    September 2022
  267. ZHENG Q, Ma P, Wang M, Chen Y, et al
    Efficacy and safety of Paxlovid for COVID-19:a meta-analysis.
    J Infect. 2022 Sep 30. pii: S0163-4453(22)00557.
    >> Share

  268. CHANDRA A, Hoeg TB
    Lack of correlation between school mask mandates and paediatric Covid-19 cases in a large cohort.
    J Infect. 2022 Sep 29. pii: S0163-4453(22)00550.
    >> Share

  269. LIU P, Xu J
    Resurgence of influenza virus activity during COVID-19 pandemic in Shanghai, China.
    J Infect. 2022 Sep 29. pii: S0163-4453(22)00555.
    >> Share

  270. LA Y, Hong JY, Lee HS, Lee EH, et al
    Increase of Multidrug-Resistant Bacteria After the COVID-19 Pandemic in South Korea: Time-series Analyses of a Long-term Multicenter Cohort.
    J Infect. 2022 Sep 29. pii: S0163-4453(22)00556.
    >> Share

  271. HUANG J, Xia L, Zhao Y, Wu X, et al
    Coronavirus disease 2019 vaccination and live birth outcome after fresh embryo transfer.
    J Infect. 2022 Sep 26. pii: S0163-4453(22)00552.
    >> Share

  272. AO G, Li A, Wang Y, Tran C, et al
    The effect of SARS-CoV-2 double vaccination on the outcomes of hemodialysis patients with COVID-19: a meta-analysis.
    J Infect. 2022 Sep 26. pii: S0163-4453(22)00553.
    >> Share

  273. YIN Y, Lin J, Yuan S, Tong S, et al
    A booster shot of vaccine against SARS-CoV-2 should be rigorously promoted and implemented in China.
    J Infect. 2022 Sep 25. pii: S0163-4453(22)00546.
    >> Share

  274. CHOI MJ, Choi JY, Hyun H, Nham E, et al
    Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: comparison between prior SARS-CoV-2-infected and infection-naive individuals.
    J Infect. 2022 Sep 23. pii: S0163-4453(22)00548.
    >> Share

  275. YAN F, Gao F
    RBD-ACE2 binding properties in five SARS-CoV-2 variants of concern with new perspectives in the design of pan-coronavirus peptide inhibitors.
    J Infect. 2022 Sep 14. pii: S0163-4453(22)00541.
    >> Share

  276. XU QY, Zheng XQ, Jia ZJ, Wu MJ, et al
    Developing new COVID-19 vaccine against the variants is urgently needed rather than boosters: A longitudinal cohort study.
    J Infect. 2022 Sep 12. pii: S0163-4453(22)00539.
    >> Share

  277. MOUSSAOUI ME, Desmecht S, Tashkeev A, Lambert N, et al
    Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naive people living with HIV.
    J Infect. 2022 Sep 9. pii: S0163-4453(22)00534.
    >> Share

  278. ATTI A, Insalata F, Carr EJ, Otter AD, et al
    Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: a nested case-control within the SIREN study.
    J Infect. 2022 Sep 8. pii: S0163-4453(22)00535.
    >> Share

  279. WONG LSY, Loo EXL, Huang CH, Yap GC, et al
    Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodies.
    J Infect. 2022 Sep 3. pii: S0163-4453(22)00515.
    >> Share

  280. SHI T, Dai M, Liu F, Hu J, et al
    Dynamics of immune responses to inactivated COVID-19 vaccination over 8 months in China.
    J Infect. 2022 Sep 2. pii: S0163-4453(22)00521.
    >> Share

  281. DIMEGLIO C, Tremeaux P, Herin F, Da-Silva I, et al
    Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population.
    J Infect. 2022 Sep 2. pii: S0163-4453(22)00522.
    >> Share

  282. PATAPNYAN E, Ronen O
    Parallel reduction in the prevalence of Bell's palsy, idiopathic sudden sensorineural hearing loss and viral infection diseases during the COVID-19 pandemic.
    J Infect. 2022 Sep 2. pii: S0163-4453(22)00518.
    >> Share

  283. COOPER DJ, Lear S, Watson L, Shaw A, et al
    A prospective study of risk factors associated with seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a large UK teaching hospital.
    J Infect. 2022 Sep 1. pii: S0163-4453(22)00514.
    >> Share

  284. YIN Y, Lin J, Yuan S, Tong S, et al
    The relationship between early isolation and the duration of viral shedding of mild and asymptomatic infection with SARS-CoV-2 Omicron BA.2 variant.
    J Infect. 2022 Sep 1. pii: S0163-4453(22)00520.
    >> Share

    August 2022
  285. LAI CK, Lui GC, Wei Y, Chong KC, et al
    Remdesivir reduced upper respiratory tract SARS-CoV-2 viral RNA concentration in COVID-19 patients who developed pneumonitis.
    J Infect. 2022 Aug 31. pii: S0163-4453(22)00513.
    >> Share

  286. LINA L, Zhendong G, Sevalie S, Fangfang Z, et al
    Comparison of the amount of SARS-CoV-2 exhaled by Delta and Omicron patients.
    J Infect. 2022 Aug 28. pii: S0163-4453(22)00512.
    >> Share

  287. KIM SH, Kyu Cho H, Jeon CH, Sung Ock H, et al
    Diagnostic value of serum KL-6 and IL-6 levels in critically ill patients with COVID-19-associated pneumonia.
    J Infect. 2022 Aug 27. pii: S0163-4453(22)00477.
    >> Share

  288. WANG Y, Zheng J, Zhu K, Wang B, et al
    The effect of tixagevimab-cilgavimab on clinical outcomes in patients with COVID-19: A systematic review with meta-analysis.
    J Infect. 2022 Aug 25. pii: S0163-4453(22)00506.
    >> Share

  289. GIDARI A, Schiaroli E, Sabbatini S, Bastianelli S, et al
    Impact of SARS-CoV-2 Omicron Variants on Serum Neutralization in a Cohort of Healthcare Workers Vaccinated with BNT162b2.
    J Infect. 2022 Aug 25. pii: S0163-4453(22)00507.
    >> Share

  290. BAYHAN GI, Korkmaz IO, Seyda E, Tekeli N, et al
    Are SARS-CoV-2 viral loads in children lower than in adults?
    J Infect. 2022 Aug 24. pii: S0163-4453(22)00509.
    >> Share

  291. LI K, Ruan F, Zhao Z, Guo Z, et al
    Comparative analysis of transmission and vaccine effectiveness in Omicron and Delta variant outbreaks in China.
    J Infect. 2022 Aug 22. pii: S0163-4453(22)00502.
    >> Share

  292. SUN YK, Xing JB, Xu ZY, Gao H, et al
    Re-emergence of Severe Acute Diarrhea Syndrome Coronavirus (SADS-CoV) in Guangxi, China, 2021.
    J Infect. 2022 Aug 21. pii: S0163-4453(22)00504.
    >> Share

  293. MIZOUE T, Yamamoto S, Konishi M, Oshiro Y, et al
    Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants.
    J Infect. 2022 Aug 19. pii: S0163-4453(22)00480.
    >> Share

  294. WANG Y, Chen X, Xiao W, Zhao D, et al
    Rapid COVID-19 rebound in a severe COVID-9 patient during 20-day course of Paxlovid.
    J Infect. 2022 Aug 19. pii: S0163-4453(22)00478.
    >> Share

  295. NOLASCO S, Vitale F, Geremia A, Tramuto F, et al
    First case of monkeypox virus, SARS-CoV-2 and HIV co-infection.
    J Infect. 2022 Aug 19. pii: S0163-4453(22)00479.
    >> Share

  296. WAN EYF, Mok AHY, Yan VKC, Wang B, et al
    Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study.
    J Infect. 2022 Aug 16. pii: S0163-4453(22)00472.
    >> Share

  297. GOMEZ-CARBALLA A, Martinon-Torres F, Salas A
    Is SARS-CoV-2 an oncogenic virus?
    J Infect. 2022 Aug 9. pii: S0163-4453(22)00469.
    >> Share

  298. CHANG YC, Hsiao CT, Chen WL, Su YD, et al
    BioFire FilmArray Respiratory Panel RP2.1 for SARS-CoV-2 detection: The pitfalls.
    J Infect. 2022 Aug 8. pii: S0163-4453(22)00468.
    >> Share

  299. AIELLO TF, Puerta-Alcalde P, Chumbita M, Monzo P, et al
    Infection with the Omicron variant of SARS-CoV-2 is associated with less severe disease in hospitalized patients with COVID-19.
    J Infect. 2022 Aug 5. pii: S0163-4453(22)00461.
    >> Share

  300. WU Y, Ma Z, Zhang Y, Zhang M, et al
    The role of cyclophilins in viral infec and the immune response.
    J Infect. 2022 Aug 4. pii: S0163-4453(22)00464.
    >> Share

  301. BASSETTI M, Zuccaro V, Asperges E, Scudeller L, et al
    Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, nonneutropenic, adult patients: an update including COVID-19 data.
    J Infect. 2022 Aug 4. pii: S0163-4453(22)00465.
    >> Share

  302. AO Y, Li J, Wei Z, Wang Z, et al
    Clinical and virological characteristics of SARS-CoV-2 Omicron BA.2.2 variant outbreaks during April to May, 2022, Shanghai, China.
    J Infect. 2022 Aug 4. pii: S0163-4453(22)00462.
    >> Share

    July 2022
  303. NOH JY, Cheong HJ, Kim WJ, Choi JY, et al
    Robust neutralizing antibody responses after single-dose BNT162b2 vaccination at long intervals from prior SARS-CoV-2 infection and ceiling effect with repeated vaccination: Running title: Optimal vaccination interval and ceiling effect.
    J Infect. 2022 Jul 31. pii: S0163-4453(22)00456.
    >> Share

  304. BOJKOVA D, Stack R, Rothenburger T, Kandler JD, et al
    Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants.
    J Infect. 2022 Jul 30. pii: S0163-4453(22)00455.
    >> Share

  305. MURPHY SL, Halvorsen B, Barratt-Due A, Am DR, et al
    Remdesivir modifies interferon response in hospitalized COVID-19 patients.
    J Infect. 2022 Jul 29. pii: S0163-4453(22)00450.
    >> Share

  306. DZINAMARIRA T, Moyo E, Moyo P, Pierre G, et al
    Childhood immunization services accessibility and utilization during the COVID-19 pandemic in Africa.
    J Infect. 2022 Jul 29. pii: S0163-4453(22)00445.
    >> Share

  307. PASCARELLA S, Ciccozzi M, Benvenuto D, Borsetti A, et al
    Peculiar Variations of the Electrostatic Potential of Spike Protein N-terminal Domain Associated with the Emergence of Successive SARS-CoV-2 Omicron Lineages.
    J Infect. 2022 Jul 28. pii: S0163-4453(22)00426.
    >> Share

  308. LINA L, Fangfang Z, Sevalie S, Dawei Z, et al
    Characteristics of SARS-CoV-2 exhaled by COVID-19 patients.
    J Infect. 2022 Jul 28. pii: S0163-4453(22)00424.
    >> Share

  309. FU J, Luo Y, Fang X, Lu J, et al
    Genetic variation of Golgi membrane protein 1 is associated with COVID-19 disease.
    J Infect. 2022 Jul 22. pii: S0163-4453(22)00420.
    >> Share

  310. VELLAS C, Kamar N, Izopet J
    Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment.
    J Infect. 2022 Jul 22. pii: S0163-4453(22)00422.
    >> Share

  311. LI M, Luo Q, Gong C, Li AH, et al
    Prospective Surveillance of Human Adenovirus in Acute Respiratory Infections Reveals Epidemiological Features and the Disappearance of Species B During the COVID-19 Pandemic in Beijing, China.
    J Infect. 2022 Jul 22. pii: S0163-4453(22)00423.
    >> Share

  312. HUANG L
    Adjusted control rate closely associated with the epidemiologic evolution of the recent COVID-19 wave in Shanghai, with 94.3% of all new cases being asymptomatic on first diagnosis.
    J Infect. 2022 Jul 14. pii: S0163-4453(22)00418.
    >> Share

  313. HAGIYA H, Hikita T, Habu T, Asada M, et al
    Poor vaccine responsiveness towards third-dose mRNA vaccine of COVID-19 in Japanese older people.
    J Infect. 2022 Jul 11. pii: S0163-4453(22)00413.
    >> Share

  314. KHANNA R, Htun HL, Lianjie AL, Kyaw WM, et al
    Staff and patient surveillance in hospitals: good sentinels for the emergence of new SARS-CoV-2 variants.
    J Infect. 2022 Jul 7. pii: S0163-4453(22)00411.
    >> Share

  315. VERA-LISE I, Dominik E, Elisabeth R, Kerstin H, et al
    "Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants".
    J Infect. 2022 Jul 7. pii: S0163-4453(22)00412.
    >> Share

  316. LI M, Yu T
    Statistical concern on evaluating the consistency between gargle samples and nasopharyngeal (NP) swabs in RT-qPCR-based mass screening approach for the diagnosis of COVID-19.
    J Infect. 2022 Jul 6. pii: S0163-4453(22)00408.
    >> Share

  317. MARTIN-BLONDEL G, Marcelin AG, Soulie C, Kaisaridi S, et al
    Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2.
    J Infect. 2022 Jul 5. pii: S0163-4453(22)00406.
    >> Share

  318. YAN Y, Davgadorj C, Lyu C, Zhang S, et al
    Immunogenicity of a third dose of inactivated COVID-19 vaccine in people living with HIV-1, HBV, and tuberculosis during the Omicron variant epidemic: a cross-sectional study.
    J Infect. 2022 Jul 5. pii: S0163-4453(22)00407.
    >> Share

  319. GAO X, Zhang S, Gou J, Wen Y, et al
    Spike-mediated ACE2 down-regulation involved in the pathogenesis of SARS-CoV-2 infection.
    J Infect. 2022 Jul 3. pii: S0163-4453(22)00404.
    >> Share

  320. YUAN W, Hou Y, Lin Q, Chen L, et al
    How China responds to Omicron.
    J Infect. 2022;85:90-122.
    >> Share

  321. YANG M, Li A, Wang Y, Tran C, et al
    Monoclonal antibody therapy improves severity and mortality of COVID-19 in organ transplant recipients: a meta-analysis.
    J Infect. 2022 Jul 1. pii: S0163-4453(22)00384.
    >> Share

    June 2022
  322. CARBONELL R, Urgeles S, Salgado M, Rodriguez A, et al
    NEGATIVE PREDICTIVE VALUE OF PROCALCITONIN TO RULE OUT BACTERIAL RESPIRATORY CO-INFECTION IN CRITICAL COVID-19 PATIENTS.
    J Infect. 2022 Jun 30. pii: S0163-4453(22)00380.
    >> Share

  323. SACERDOTE C, Milani L, Castiglione A, Pagano E, et al
    Risk of Intensive Care Unit admission or mortality in patients hospitalised for COVID-19 during the first two waves: an Italian cohort study.
    J Infect. 2022 Jun 30. pii: S0163-4453(22)00379.
    >> Share

  324. O'MORAIN N, Stack R, Doherty J, Tosetto M, et al
    Research Letter: Faecal calprotectin as a potential biomarker of disease severity in SARS-CoV-2 infection.
    J Infect. 2022 Jun 26. pii: S0163-4453(22)00372.
    >> Share

  325. REN Y, Liu Y, Zhang Z, Liu Y, et al
    SNX27-mediated endocytic recycling of GLUT1 is suppressed by SARS-CoV-2 spike, possibly explaining neuromuscular disorders in patients with COVID-19.
    J Infect. 2022 Jun 26. pii: S0163-4453(22)00377.
    >> Share

  326. FOURGEAUD J, Toubiana J, Chappuy H, Delacourt C, et al
    No durable impact of COVID-19 measures on the hospital burden of Respiratory Syncytial Virus (France, 2018-2022).
    J Infect. 2022 Jun 24. pii: S0163-4453(22)00375.
    >> Share

  327. YIN Y, Li X, Qian C, Cheng B, et al
    Antibody efficacy of inactivated vaccine boosters (CoronaVac) against Omicron variant from a 15-month follow-up study.
    J Infect. 2022 Jun 24. pii: S0163-4453(22)00374.
    >> Share

  328. YANG M, Li A, Jiang L, Wang Y, et al
    Regdanvimab improves disease mortality and morbidity in patients with COVID-19: a meta-analysis.
    J Infect. 2022 Jun 18. pii: S0163-4453(22)00369.
    >> Share

  329. NIYOMNAITHAM S, Toh ZQ, Licciardi PV, Wongprompitak P, et al
    Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: a randomized trial.
    J Infect. 2022 Jun 18. pii: S0163-4453(22)00370.
    >> Share

  330. RICHARDS A, Muddassir M, Sampson F, MacLachlan L, et al
    Evaluation of pre-hospital COVID-19 rapid antigen tests by paramedics and their use in a direct admission pathway: Pre-Hospital COVID-19 rapid antigen tests.
    J Infect. 2022 Jun 18. pii: S0163-4453(22)00371.
    >> Share

  331. PENG H, Wu X, Xiong S, Li C, et al
    Gout and susceptibility and severity of COVID-19: a bidirectional Mendelian randomization analysis.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00366.
    >> Share

  332. HATCHER J, Gil E, Storey N, Brown JR, et al
    Reactivation/relapse of SARS-CoV-2 in a child following haematopoietic stem cell transplantation, confirmed by whole genome sequencing, following apparent viral clearance.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00367.
    >> Share

  333. COCHINO AV, Farkas OM, Ioan A
    Pediatric Patients with Immune-Mediated Diseases on Immunosuppressants Have Low Risk of Severe COVID-19 and No Increase in Flare Rate after SARS CoV-2 Exposure.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00365.
    >> Share

  334. COULSON JM, Adams A, Gray LA, Evans A, et al
    COVID-19 "Rebound" associated with nirmatrelvir/ritonavir pre-hospital therapy.
    J Infect. 2022 Jun 16. pii: S0163-4453(22)00363.
    >> Share

  335. LAZARUS R, Taucher C, Brown C, Corbic I, et al
    Safety and immunogenicity of the inactivated whole-virus adjuvanted vaccine VLA2001: a randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults.
    J Infect. 2022 Jun 16. pii: S0163-4453(22)00361.
    >> Share

  336. WORSLEY CM, van der Mescht MA, Hoffman D, Meyer PWA, et al
    Decline in antibody responses to SARS-CoV-2 post-vaccination poses a risk to health care workers.
    J Infect. 2022 Jun 12. pii: S0163-4453(22)00360.
    >> Share

  337. KANG SW, Kim JY, Park H, Lim SY, et al
    Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection.
    J Infect. 2022 Jun 12. pii: S0163-4453(22)00355.
    >> Share

  338. GABBI C, Renieri A, Strandvik B
    Geographical distribution of cystic fibrosis carriers as population genetic determinant of COVID-19 spread and fatality in 37 countries.
    J Infect. 2022 Jun 11. pii: S0163-4453(22)00359.
    >> Share

  339. SANG L, Cheng B, Yu Y, Xi Y, et al
    The efficacy and safety of IBI314 on Delta and Omicron variant of SARS-CoV-2: first-in-human evidence.
    J Infect. 2022 Jun 9. pii: S0163-4453(22)00354.
    >> Share

  340. XU QY, Li QL, Jia ZJ, Wu MJ, et al
    Is the fourth COVID-19 vaccine dose urgently needed? Revelation from a prospective cohort study.
    J Infect. 2022 Jun 9. pii: S0163-4453(22)00356.
    >> Share

  341. LV P, Hu B, Hua R, Zhang J, et al
    A novelly designed protein antagonist confers potent neutralization against SARS-COV-2 variants of concern.
    J Infect. 2022 Jun 3. pii: S0163-4453(22)00350.
    >> Share

  342. IJAZ S, Dicks S, Jegatheesan K, Parker E, et al
    Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: antibody dynamics and linkage to severity of COVID-19 in hospital inpatients.
    J Infect. 2022 Jun 3. pii: S0163-4453(22)00339.
    >> Share

  343. ABDI B, Ndoadoumgue AL, Djebara S, Zafilaza K, et al
    High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients.
    J Infect. 2022 Jun 2. pii: S0163-4453(22)00346.
    >> Share

  344. MELLON G, Rouquette A, Fac C, Carton B, et al
    SARS-CoV-2 seroprevalence in the adult detainees of the Paris area in 2021: A multicenter cross-sectional study.
    J Infect. 2022 Jun 2. pii: S0163-4453(22)00345.
    >> Share

  345. GUO Z, Zhao S, Ryu S, Mok CKP, et al
    Superspreading potential of infection seeded by the SARS-CoV-2 Omicron BA.1 variant in South Korea.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00344.
    >> Share

  346. ZHANG Y, Li J, Jiang L, Chen Q, et al
    Comparison of SARS-CoV-2 aerosol emission from patients with Omicron BA.1 or BA.2 subvariant infection.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00342.
    >> Share

  347. STANKUNAS M, Dziugys A, Skarbalius G, Misiulis E, et al
    EVALUATING THE POTENTIAL IMPACT OF COVID-19 PASSPORTS IN LITHUANIA.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00340.
    >> Share

  348. LI Y, Guo Y, Duan Y
    Changes in Streptococcus pneumoniae infection in children before and after the COVID-19 pandemic in Zhengzhou, China.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00348.
    >> Share

    May 2022
  349. WANG B, Fu J, Lu A, Yang J, et al
    Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer.
    J Infect. 2022 May 31. pii: S0163-4453(22)00337.
    >> Share

  350. GIANNONE D, Vecchione MB, Czernikier A, Polo ML, et al
    SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent individuals with HIV.
    J Infect. 2022 May 27. pii: S0163-4453(22)00315.
    >> Share

  351. KAMALI Z, Vonk JM, Thio CHL, Vaez A, et al
    A Mendelian randomization cytokine screen reveals IL-13 as causal factor in risk of severe COVID-19.
    J Infect. 2022 May 23. pii: S0163-4453(22)00313.
    >> Share

  352. SA R, Isidro J, Borges V, Duarte S, et al
    Unravelling the hurdles of a large COVID-19 epidemiological investigation by viral genomics.
    J Infect. 2022 May 21. pii: S0163-4453(22)00302.
    >> Share

  353. SOVIK S, Barrat-Due A, Kasine T, Olasveengen T, et al
    Corticosteroids and superinfections in COVID-19 patients on invasive mechanical ventilation.
    J Infect. 2022 May 20. pii: S0163-4453(22)00305.
    >> Share

  354. NISHIKIMI A, Watanabe K, Watanabe A, Yasuoka M, et al
    Immune responses to COVID-19 vaccine BNT162b2 in workers at a research institute in Japan: 6-month follow-up survey.
    J Infect. 2022 May 20. pii: S0163-4453(22)00307.
    >> Share

  355. LIU L, Fan X, Guan Q, Yu C, et al
    Bioavailable testosterone level is associated with COVID-19 severity in female: A sex-stratified Mendelian randomization study.
    J Infect. 2022 May 13. pii: S0163-4453(22)00287.
    >> Share

  356. WU X, Peng H, Xiong S, Li C, et al
    Novel evidence revealed genetic association between COVID-19 infection, severity and endometrial cancer: COVID-19 infection, severity and risk of endometrial cancer.
    J Infect. 2022 May 10. pii: S0163-4453(22)00261.
    >> Share

  357. VAN GRONINGEN KM, Dao BL, Gounder P
    Declines in invasive pneumococcal disease (IPD) during the COVID-19 pandemic in Los Angeles county.
    J Infect. 2022 May 9. pii: S0163-4453(22)00259.
    >> Share

  358. ZHANG YM, Liu XZ, Lin MM, Zan JC, et al
    Immunosuppression impaired the immunogenicity of inactivated SARS-CoV-2 vaccine in non-dialysis kidney disease patients.
    J Infect. 2022 May 9. pii: S0163-4453(22)00260.
    >> Share

  359. LUCIJANIC M, Cikara T, Bistrovic P, Papic I, et al
    Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis.
    J Infect. 2022 May 2. pii: S0163-4453(22)00251.
    >> Share

  360. WAN Z, Lu R, Zhao Y, Zhang C, et al
    Diagnostic strategy of SARS-CoV-2 for containment under China's zero-COVID-19 policy.
    J Infect. 2022 May 1. pii: S0163-4453(22)00250.
    >> Share

  361. FERNANDEZ-DE-LAS-PENAS C, Martin-Guerrero JD, Cancela-Cilleruelo I, Moro-Lopez-Menchero P, et al
    Exploring the recovery curves for long-term post-COVID functional limitations on daily living activities: The LONG-COVID-EXP-CM multicenter study.
    J Infect. 2022;84:722-746.
    >> Share

  362. MARIANI C, Borgonovo F, Capetti AF, Oreni L, et al
    Persistence of Long-COVID symptoms in a heterogenous prospective cohort.
    J Infect. 2022;84:722-746.
    >> Share

    April 2022
  363. HIROTSU Y, Maejima M, Shibusawa M, Natori Y, et al
    SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: genomic surveillance in Japan from September 2021 to March 2022.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00247.
    >> Share

  364. GIANNITRAPANI L, Augello G, Mirarchi L, Amodeo S, et al
    Outcome predictors in SARS-CoV-2 disease (COVID-19): the prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00245.
    >> Share

  365. JIMENEZ D, Martinez-Sanz J, Sainz T, Calvo C, et al
    Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00248.
    >> Share

  366. LI A, Zhang L
    Reduced incidence of acute pharyngitis and increased incidence of chornic pharyngitis under COVID-19 control strategy in Beijing.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00249.
    >> Share

  367. RANA MS, Usman MM, Ikram A, Salman M, et al
    The negative impact of the COVID-19 Pandemic on immunization and the positive impact on Polio eradication in Pakistan and Afghanistan. A dismal scenario.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00246.
    >> Share

  368. YUAN S, Jiang SC, Zhang ZW, Fu YF, et al
    Surface electrostatic shift on spike protein decreased antibody activities against SARS-CoV-2 Omicron variant.
    J Infect. 2022 Apr 23. pii: S0163-4453(22)00215.
    >> Share

  369. NGUYEN NN, Houhamdi L, Hoang VT, Stoupan D, et al
    High rate of reinfection with the SARS-CoV-2 Omicron variant.
    J Infect. 2022 Apr 23. pii: S0163-4453(22)00216.
    >> Share

  370. HE L, Zeng C, Xu W, Li Y, et al
    Dynamic changes of serum SARS-CoV-2 antibody levels in COVID-19 patients.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00214.
    >> Share

  371. AO G, Li A, Wang Y, Tran C, et al
    Lack of efficacy for sotrovimab use in patients with COVID-19: A meta-analysis.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00210.
    >> Share

  372. CIUFFREDA L, Alcoba-Florez J, Lorenzo-Salazar JM, Gil-Campesino H, et al
    Association of the Delta SARS-CoV-2 variant with 28-day hospital mortality between December 2020 and September 2021.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00212.
    >> Share

  373. LI Y, Wei L, He L, Sun J, et al
    Interferon-induced transmembrane protein 3 gene polymorphisms are associated with COVID-19 susceptibility and severity: A meta-analysis.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00208.
    >> Share

  374. YADAV PD, Sapkal GN, Sahay RR, Patil DY, et al
    Reduced neutralizing antibody response in naive Covishield vaccinees against Omicron emphasizes booster vaccination.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00213.
    >> Share

  375. PANDIT P, Bhatt P, Sahay RR, Joshi Y, et al
    A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional.
    J Infect. 2022 Apr 18. pii: S0163-4453(22)00205.
    >> Share

  376. CAI J, Hu S, Lin Q, Ren T, et al
    China's 'dynamic zero COVID-19 strategy' will face greater challenges in the future.
    J Infect. 2022 Apr 18. pii: S0163-4453(22)00209.
    >> Share

  377. DAVIES J, Gibani MM, Portone G, McGregor A, et al
    Cohorting inpatients with Omicron and Delta variants of Sars-CoV-2 does not increase rates of mixed infection.
    J Infect. 2022 Apr 12. pii: S0163-4453(22)00202.
    >> Share

  378. REN Y, Lv L, Li P, Zhang L, et al
    Inhibition of endocytic recycling of ACE2 by SARS-CoV-2 S protein partially explains multiple COVID-19 related diseases caused by ACE2 reduction.
    J Infect. 2022 Apr 11. pii: S0163-4453(22)00201.
    >> Share

  379. ZSIGMOND B, Breathnach AS, Mensah A, Ladhani SN, et al
    Very low rates of severe COVID-19 in children hospitalised with confirmed SARS-CoV-2 infection in London, England".
    J Infect. 2022 Apr 10. pii: S0163-4453(22)00203.
    >> Share

  380. WHITAKER H, Tsang RS, Button E, Andrews N, et al
    Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network.
    J Infect. 2022 Apr 8. pii: S0163-4453(22)00198.
    >> Share

  381. LIU X, Munro APS, Feng S, Janani L, et al
    Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: three month analyses of the COV-BOOST trial.
    J Infect. 2022 Apr 8. pii: S0163-4453(22)00200.
    >> Share

  382. SALVAGNO GL, Henry BM, Pighi L, De Nitto S, et al
    Serum C reactive protein predicts humoral response after BNT162b2 booster administration.
    J Infect. 2022 Apr 8. pii: S0163-4453(22)00197.
    >> Share

  383. YADAV PD, Sahay RR, Agrawal S, Shete A, et al
    Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00193.
    >> Share

  384. MARTIN-BLONDEL G, Marcelin AG, Soulie C, Kaisaridi S, et al
    Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S CoCoPrev study).
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00196.
    >> Share

  385. LIU Y, Li P, Yang L, Li P, et al
    High vaccination coverage slows down genetic diversity of SARS-CoV-2.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00191.
    >> Share

  386. BADDAL B, Bostanci A
    The impact of COVID-19 on the molecular epidemiology of seasonal viral respiratory infections, Cyprus.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00192.
    >> Share

  387. CHENG CY, Hsiao SH, Fang TC, Lin YC, et al
    SARS-CoV2 Antibody Response After a Third Dose of Heterologous ChAdOx1 nCoV-19 and Moderna Vaccine in Chronic Dialysis Patients.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00190.
    >> Share

  388. AKBAR S, Pan D, Ehdode A, Islam R, et al
    Prognostic value of maximum NEWS-2 scores in addition to ISARIC 4C scores for patients admitted to hospital with COVID-19.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00195.
    >> Share

  389. ONG JY, Wang CH, Ms YT, Chen FL, et al
    Nosocomial septicemia in COVID-19 Nosocomial K. pneumoniae, A. baumannii, and Elizabethkingia meningoseptica Septicemia in a Patient of COVID-19.
    J Infect. 2022 Apr 5. pii: S0163-4453(22)00188.
    >> Share

  390. SONG W, Yang Y, Huang Y, Chen L, et al
    Acute respiratory infections in children, before and after the COVID-19 pandemic, a sentinel study.
    J Infect. 2022 Apr 5. pii: S0163-4453(22)00183.
    >> Share

  391. GAGNAIRE J, Bonjean P, Verot E, Boulamail B, et al
    SARS-CoV-2 rapid test versus RT-qPCR on noninvasive respiratory self-samples during a city mass testing campaign.
    J Infect. 2022 Apr 5. pii: S0163-4453(22)00184.
    >> Share

  392. BAEK YJ, Lee YJ, Kim JI, Lee S, et al
    Prolonged viral shedding in severely ill patients infected with SARS-CoV-2 Delta variants: a retrospective cohort study.
    J Infect. 2022 Apr 5. pii: S0163-4453(22)00186.
    >> Share

  393. DUVERGER C, Monteil C, Souyri V, Md SF, et al
    Decrease of carbapenemase-producing Enterobacteriaceae incidence during the first year of the COVID-19 pandemic.
    J Infect. 2022 Apr 1. pii: S0163-4453(22)00179.
    >> Share

    March 2022
  394. YOON JG, Yoo JS, Lee J, Hyun HJ, et al
    Viable SARS-CoV-2 Shedding Under Remdesivir and Dexamethasone Treatment.
    J Infect. 2022 Mar 26. pii: S0163-4453(22)00177.
    >> Share

  395. MENG J, Ge Q, Li J, Lu X, et al
    Protective trend of anti-androgen therapy during the COVID-19 pandemic: a meta-analysis.
    J Infect. 2022 Mar 24. pii: S0163-4453(22)00175.
    >> Share

  396. SCHILDGEN V, Lusebrink J, Schildgen O
    Compulsary SARS-CoV-2 (booster-) vaccination in healthcare facilities can not replace personal protection measures while dealing with vulnarable individuals.
    J Infect. 2022 Mar 23. pii: S0163-4453(22)00173.
    >> Share

  397. YADAV PD, Sapkal GN, Sahay RR, Patil DY, et al
    Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naive vaccinees.
    J Infect. 2022 Mar 19. pii: S0163-4453(22)00170.
    >> Share

  398. YANG G, Ren Z, Zou Y, Xu Q, et al
    Antimicrobial stewardship in non-COVID-19 patients with fever and respiratory symptoms in outpatient settings: lessons from the "dynamic zero-COVID policy" in mainland China.
    J Infect. 2022 Mar 18. pii: S0163-4453(22)00141.
    >> Share

  399. MURGIA F, Fiamma M, Serra S, Olla S, et al
    The impact of secondary infections in COVID-19 critically ill patients.
    J Infect. 2022 Mar 18. pii: S0163-4453(22)00171.
    >> Share

  400. DIMEGLIO C, Loubes JM, Migueres M, Saune K, et al
    Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and BA.2 sub-variants.
    J Infect. 2022 Mar 17. pii: S0163-4453(22)00140.
    >> Share

  401. RYAN P, Perez-Garcia F, Torres-Macho J, Bibiano C, et al
    Misdiagnosis rate of among negative COVID-19 patients in real-life with Panbio COVID-19 Antigen Rapid Test during 2021.
    J Infect. 2022 Mar 16. pii: S0163-4453(22)00139.
    >> Share

  402. AO G, Wang Y, Li A, Tran C, et al
    The effect of canakinumab on clinical outcomes in patients with COVID-19: a meta-analysis.
    J Infect. 2022 Mar 14. pii: S0163-4453(22)00137.
    >> Share

  403. CHEN C, Tang J, Wang C, Wen W, et al
    Meta-Analysis of Post-traumatic Stress Disorder and COVID-19 in Patients Discharged.
    J Infect. 2022 Mar 10. pii: S0163-4453(22)00134.
    >> Share

  404. XIANG B, Yang L, Ye Z, Ren T, et al
    Vaccination of Susceptible Animals Against SARS-CoV-2.
    J Infect. 2022 Mar 9. pii: S0163-4453(22)00131.
    >> Share

  405. FERRE VM, Lebourgeois S, Chenane HR, Menidjel R, et al
    Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays.
    J Infect. 2022 Mar 9. pii: S0163-4453(22)00126.
    >> Share

  406. BONNET B, Chabrolles H, Archimbaud C, Brebion A, et al
    Comparative T and B immune responses of four different anti-COVID-19 vaccine strategies 6 months after vaccination.
    J Infect. 2022 Mar 9. pii: S0163-4453(22)00132.
    >> Share

  407. FANTINI J, Devaux CA, Yahi N, Frutos R, et al
    The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans.
    J Infect. 2022 Mar 6. pii: S0163-4453(22)00129.
    >> Share

  408. AU WY, Ye C, Briner SL, Suarez GD, et al
    Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00123.
    >> Share

  409. GIMENEZ E, Albert E, Burgos JS, Peiro S, et al
    SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty(R) COVID-19 vaccine.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00124.
    >> Share

  410. BONGIOVANNI M, Spada E, De Angelis C, Liuzzi G, et al
    SARS-CoV-2: about reinfection, vaccination and neutralizing antibodies.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00125.
    >> Share

  411. SYED MA DR, A/Qotba HA Dr, Al Nuaimi AS Dr
    Effectiveness of COVID-19 vaccines in Qatar.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00121.
    >> Share

  412. HAO M, Zhu Y, Fan S, Wu X, et al
    Detection of human respiratory viruses among hospitalized children aged
    J Infect. 2022;84:418-467.
    >> Share

    February 2022
  413. PUTRI DU, Lin CF, Hung CS, Huang CK, et al
    Distinct B and NKT cell Responses Shape the Delayed Response to ChAdOx1 nCoV-19 Vaccine in End-Stage Renal Disease.
    J Infect. 2022 Feb 28. pii: S0163-4453(22)00116.
    >> Share

  414. HAYASHI JY, Simizo A, Miyamoto JG, Costa LVS, et al
    Humoral and Cellular Responses to Vaccination with Homologous CoronaVac or ChAdOx1 and Heterologous Third Dose with BNT162b2.
    J Infect. 2022 Feb 27. pii: S0163-4453(22)00115.
    >> Share

  415. KONIG S, Hohenstein S, Leiner J, Hindricks G, et al
    National mortality data for Germany before and throughout the pandemic: there is an excess mortality exceeding COVID-19-attributed fatalities.
    J Infect. 2022 Feb 26. pii: S0163-4453(22)00113.
    >> Share

  416. SALVAGNO GL, Henry BM, Pighi L, De Nitto S, et al
    SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load.
    J Infect. 2022 Feb 26. pii: S0163-4453(22)00114.
    >> Share

  417. PASCARELLA S, Ciccozzi M, Bianchi M, Benvenuto D, et al
    The value of electrostatic potentials of the Spike Receptor binding and N-terminal domains in addressing transmissibility and infectivity of SARS-CoV-2 Variants. of Concern.
    J Infect. 2022 Feb 23. pii: S0163-4453(22)00112.
    >> Share

  418. DE MICHELENA P, Torres I, Ramos-Garcia A, Gozalbes V, et al
    Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant.
    J Infect. 2022 Feb 22. pii: S0163-4453(22)00110.
    >> Share

  419. SAHAY RR, Patil DY, Sapkal GN, Deshpande GR, et al
    SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera.
    J Infect. 2022 Feb 19. pii: S0163-4453(22)00082.
    >> Share

  420. TANG K, Wu X, Luo Y, Wei Z, et al
    Meta-analysis of Immunologic response after COVID-19 mRNA vaccination in solid organ transplant recipients.
    J Infect. 2022 Feb 19. pii: S0163-4453(22)00081.
    >> Share

  421. SAEED A, Ahmad B, Majaz S, Nouroz F, et al
    Targeting Omicron and other reported SARS-CoV-2 lineages by Potent inhibitors of Main Protease 3CL Mpro: Molecular Simulation Analysis.
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00079.
    >> Share

  422. KWOK KO, Wei WI, Ma BHM, Ip M, et al
    Antibiotic use among COVID-19 patients in Hong Kong, January 2018 to March 2021.
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00078.
    >> Share

  423. LIPPI G, Nocini R, Henry BM
    Is SARS-CoV-2 Omicron (B.1.1.529) variant causing different symptoms?
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00077.
    >> Share

  424. ZHENG J, Wang Z, Li J, Zhang Y, et al
    High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant infection.
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00075.
    >> Share

  425. FERRI S, Polidoro A, Ciacciarelli M, Ceratti U, et al
    Decline of immune humoral response after BNT162b2 Vaccine.
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00076.
    >> Share

  426. TRE-HARDY M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, et al
    Assessment 2 months after the administration of a 3rd dose mRNA: A new variant-adapted vaccine is expected.
    J Infect. 2022 Feb 15. pii: S0163-4453(22)00073.
    >> Share

  427. BLANCO I, Violan C, Suner C, Garcia-Prieto J, et al
    Comparison between mid-nasal swabs and buccal swabs for SARS-CoV-2 detection in mild COVID-19 patients.
    J Infect. 2022 Feb 13. pii: S0163-4453(22)00072.
    >> Share

  428. YADAV PD, Sapkal GN, Sahay RR, Potdar VA, et al
    Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concerns.
    J Infect. 2022 Feb 11. pii: S0163-4453(22)00070.
    >> Share

  429. RIGHI E, Mirandola M, Mazzaferri F, Dossi G, et al
    Determinants of Persistence of Symptoms and Impact on Physical and Mental Wellbeing in Long COVID: A Prospective Cohort Study.
    J Infect. 2022 Feb 9. pii: S0163-4453(22)00065.
    >> Share

  430. MIGUERES M, Dimeglio C, Tremeaux P, Abravanel F, et al
    Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant.
    J Infect. 2022 Feb 7. pii: S0163-4453(22)00054.
    >> Share

  431. ZHOU W, Zhong L, Tang X, Huang T, et al
    The early warning and monitoring of COVID-19 by using Baidu Search Index in China.
    J Infect. 2022 Feb 6. pii: S0163-4453(22)00063.
    >> Share

  432. LAZOR-BLANCHET C, Zygoura P, Dafni U, Lamoth F, et al
    Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period.
    J Infect. 2022 Feb 5. pii: S0163-4453(22)00062.
    >> Share

  433. WESTROP SJ, Whitaker HJ, Powell AA, Power L, et al
    Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England.
    J Infect. 2022 Feb 4. pii: S0163-4453(22)00055.
    >> Share

  434. CUI H, Liu J, Zhang L
    The high expression of key components of inflammasome and pyroptosis might lead to severe COVID-19 infection in cancer patients.
    J Infect. 2022 Feb 3. pii: S0163-4453(22)00057.
    >> Share

  435. DIMEGLIO C, Migueres M, Mansuy JM, Saivin S, et al
    Antibody titers and breakthrough infections with Omicron SARS-CoV-2.
    J Infect. 2022 Feb 3. pii: S0163-4453(22)00060.
    >> Share

  436. KIVIT C, Groen K, Jongbloed M, Linssen C, et al
    An off-season outbreak of human metapneumovirus infections after ending of a COVID-19 lockdown.
    J Infect. 2022 Feb 3. pii: S0163-4453(22)00058.
    >> Share

  437. ESTOFOLETE CF, Fares GF, Banho CA, Sacchetto L, et al
    Predictors of death in COVID-19 vaccine breakthrough infections in Brazil.
    J Infect. 2022 Feb 2. pii: S0163-4453(22)00059.
    >> Share

  438. LI Z, Tao B, Hu Z, Yi Y, et al
    Effects of short-term ambient particulate matter exposure on the risk of severe COVID-19.
    J Infect. 2022 Feb 1. pii: S0163-4453(22)00052.
    >> Share

    January 2022
  439. XU W, Tang J, Chen C, Wang C, et al
    Safety and Efficacy of the Covid-19 Vaccine in children andor adolescents: A meta-analysis.
    J Infect. 2022 Jan 30. pii: S0163-4453(22)00050.
    >> Share

  440. MATTIUZZI C, Lippi G
    COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections.
    J Infect. 2022 Jan 30. pii: S0163-4453(22)00051.
    >> Share

  441. LIVINGSTONE R, Lin H, Brendish NJ, Poole S, et al
    Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19.
    J Infect. 2022 Jan 30. pii: S0163-4453(22)00049.
    >> Share

  442. JI G, Chen C, Zhou M, Wen W, et al
    Post-COVID-19 Fatigue among COVID-19 in patients discharged from hospital: A meta-analysis.
    J Infect. 2022 Jan 28. pii: S0163-4453(22)00031.
    >> Share

  443. MENSAH AA, Lacy J, Stowe J, Seghezzo G, et al
    Evaluation of disease severity during SARS-COV-2 reinfection, January 2020 to April 2021, England: an observational study.
    J Infect. 2022 Jan 24. pii: S0163-4453(22)00010.
    >> Share

  444. RANA MS, Usman MM, Alam MM, Ikram A, et al
    Impact of previous SARS-CoV-2 infection on the rate of mortality in dengue. A preliminary report from Pakistan.
    J Infect. 2022 Jan 23. pii: S0163-4453(22)00027.
    >> Share

  445. SCHEPERS M, Zanger P, Jahn K, Konig J, et al
    Multi-household social gatherings contribute to the second SARS-CoV-2 wave in Rhineland-Palatinate.
    J Infect. 2022 Jan 23. pii: S0163-4453(22)00028.
    >> Share

  446. GAO R, Xu Y, Zhu G, Zhou S, et al
    Genetic variation associated with COVID-19 is also associated with endometrial cancer.
    J Infect. 2022 Jan 22. pii: S0163-4453(22)00026.
    >> Share

  447. FAVRESSE J, Bayart JL, David C, Dogne JM, et al
    Nucleocapsid Serum Antigen Determination in SARS-CoV-2 Infected Patients Using the Single Molecule Array Technology and Prediction of Disease Severity.
    J Infect. 2022 Jan 21. pii: S0163-4453(22)00022.
    >> Share

  448. DUCLOUX D, Bamoulid J, Chabannes M, Colladant M, et al
    Current vaccine strategies against SARS_CoV-2 only poorly protect kidney transplant recipients.
    J Infect. 2022 Jan 21. pii: S0163-4453(22)00020.
    >> Share

  449. MAO Q, Wang C, Zhou M, Wen W, et al
    A meta-analysis of the association between calprotectin and the severity of COVID-19.
    J Infect. 2022 Jan 21. pii: S0163-4453(22)00023.
    >> Share

  450. ELFIKY AA, Ibrahim IM
    Host-cell recognition through Cs-GRP78 is enhanced in the new Omicron variant of SARS-CoV-2, in silico structural point of view.
    J Infect. 2022 Jan 18. pii: S0163-4453(22)00015.
    >> Share

  451. ZHANG Y, Jiang N, Qi W, Li T, et al
    Intra-host SARS-CoV-2 Single-Nucleotide Variants Emerged During the Early Stage of COVID-19 Pandemic Forecast Population Fixing Mutations.
    J Infect. 2022 Jan 15. pii: S0163-4453(22)00017.
    >> Share

  452. XU Y, Gao R, Zhu G, Zhou S, et al
    Genetic variation of allergic disease is associated with the susceptibility to COVID-19.
    J Infect. 2022 Jan 14. pii: S0163-4453(22)00016.
    >> Share

  453. PILECKY M, Harm S, Bauer C, Zottl J, et al
    Performance of lateral flow assays for SARS-CoV-2 compared to RT-qPCR.
    J Infect. 2022 Jan 14. pii: S0163-4453(22)00011.
    >> Share

  454. THANH TT, Nhan NTT, Anh NT, Chung LT, et al
    SARS-CoV-2 RNA loads in Vietnamese children.
    J Infect. 2022 Jan 13. pii: S0163-4453(22)00012.
    >> Share

  455. LIN M, Chen H, Wang Y, Qiu S, et al
    A Model Study on Predicting New COVID-19 Cases in China Based on Social and News Media.
    J Infect. 2022 Jan 9. pii: S0163-4453(22)00009.
    >> Share

  456. CHEN JM, Chen YQ, Sun YX
    Control of COVID-19 in China likely reduced the burden of multiple other infectious diseases.
    J Infect. 2022 Jan 8. pii: S0163-4453(22)00001.
    >> Share

  457. HAN X, Xu P, Wang H, Mao J, et al
    Incident changes in the prevalence of respiratory virus among children during COVID-19 pandemic in Hangzhou, China.
    J Infect. 2022 Jan 8. pii: S0163-4453(22)00006.
    >> Share

  458. FAUSTINI S, Shields A, Banham G, Wall N, et al
    Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals.
    J Infect. 2022 Jan 8. pii: S0163-4453(22)00002.
    >> Share

  459. DE MICHELENA P, Torres I, Albert E, Bracho A, et al
    Impact of time elapsed since full vaccination on SARS-CoV-2 RNA load in Delta-variant breakthrough COVID-19.
    J Infect. 2022 Jan 8. pii: S0163-4453(22)00007.
    >> Share

  460. BORMAN AM, Fountain H, Guy R, Casale E, et al
    Increased mortality in COVID-19 patients with fungal co- and secondary infections admitted to intensive care or high dependency units in NHS hospitals in England.
    J Infect. 2022 Jan 4. pii: S0163-4453(21)00665.
    >> Share

  461. WHITAKER HJ, Tsang RS, Byford R, Andrews NJ, et al
    Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response among individuals in clinical risk groups.
    J Infect. 2022 Jan 3. pii: S0163-4453(21)00664.
    >> Share

  462. XU B, Ma FQ, He C, Wu ZQ, et al
    Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China.
    J Infect. 2022 Jan 2. pii: S0163-4453(21)00659.
    >> Share

  463. MARRAMS ARM, Kobayashi T, Suzuki H, Alsuhaibani M, et al
    Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: a systematic literature review and meta-analysis.
    J Infect. 2022 Jan 1. pii: S0163-4453(21)00658.
    >> Share

    December 2021
  464. SIMIONATTO VZ, Evaristo M, Santos EV, Mello R, et al
    SARS-CoV-2 SEROLOGICAL CROSS-REACTIVITY TESTING IN BRAZILIAN BLOOD DONORS, OCTOBER-DECEMBER, 2019.
    J Infect. 2021 Dec 31. pii: S0163-4453(21)00660.
    >> Share

  465. FINCH LS, Harris A, Lester C, Veal D, et al
    Implementation study of SARS-CoV-2 antigen lateral flow tests in men's professional (Premiership) rugby union sports squads in England during the COVID-19 pandemic.
    J Infect. 2021 Dec 30. pii: S0163-4453(21)00657.
    >> Share

  466. KAWAHARA T, Ueki Y, Nawa N, Miyamae S, et al
    Who is a super-spreader? Determinants of people with higher PCR copy number of SARS-CoV-2 during Mar 2020 to June 2021 in Japan.
    J Infect. 2021 Dec 30. pii: S0163-4453(21)00656.
    >> Share

  467. ARORA U, Priyadarshi M, Katiyar V, Soneja M, et al
    Novel risk factors for Coronavirus disease-associated mucormycosis(CAM): a case-control study during the outbreak in India.
    J Infect. 2021 Dec 30. pii: S0163-4453(21)00654.
    >> Share

  468. ZENG C, Ye Z, Fu L, Ye Y, et al
    Prediction analysis of porcine AXL protein as a potential receptor for SARS-CoV-2.
    J Infect. 2021 Dec 30. pii: S0163-4453(21)00655.
    >> Share

  469. VENTERO MP, Moreno-Perez O, Molina-Pardines C, Paytuvi-Gallart A, et al
    Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients: a retrospective cohort study in a Mediterranean area.
    J Infect. 2021 Dec 25. pii: S0163-4453(21)00647.
    >> Share

  470. XU B, Ma FQ, He C, Wu ZQ, et al
    Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China.
    J Infect. 2021 Dec 25. pii: S0163-4453(21)00642.
    >> Share

  471. LAI X, Wang J, Duan J, Gong Y, et al
    Apoptosis inhibitor of macrophage differentiates bacteria from influenza or COVID-19 in hospitalized adults with community-acquired pneumonia.
    J Infect. 2021 Dec 23. pii: S0163-4453(21)00640.
    >> Share

  472. RUBESHKUMAR P, John A, Narnaware M, M J, et al
    Persistent Post COVID-19 Symptoms and Functional Status after 12-14 weeks of recovery, Tamil Nadu, India, 2021.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00632.
    >> Share

  473. QIN G, Yang J, Zhao C, Ren J, et al
    The COVID-19 susceptibility of cancer patients might due to the high expression of SARS-CoV-2 required host factors.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00634.
    >> Share

  474. VINER R, Waddington C, Mytton O, Booy R, et al
    Transmission of SARS-CoV-2 by children and young people in households and schools: a meta-analysis of population-based and contact-tracing studies.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00633.
    >> Share

  475. SYED-ABDUL S, Babu AS, Bellamkonda RS, Itumalla R, et al
    Using Artificial Intelligence-based models to predict the risk of Mucormycosis among COVID-19 Survivors: An Experience from a public hospital in India.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00639.
    >> Share

  476. GENG Y, Zhang L
    The impact of non-pharmaceutical interventions during COVID-19 pandemic on three children infectious diseases in China.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00645.
    >> Share

  477. COLTELLA L, Ranno S, Piccioni L, Linardos G, et al
    Quantitative SARS-CoV-2 antigen test as a tool able to predict the stage of the infection.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00636.
    >> Share

  478. KHURRAM M, Ali G, Awan UA, Afzal MS, et al
    COVID-19 and alarming dengue co-epidemics in the dilapidated healthcare system in Pakistan: Where to focus!
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00638.
    >> Share

  479. MAANI AA, Wahaibi AA, Nazer W, Al-Zadjali N, et al
    The utilization of HCWs surveillance as an early warning of COVID-19 epidemic activity in the community.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00629.
    >> Share

  480. GAO P, Zhang X, Zhang S, Yu Y, et al
    COVID-19 persists: Current risk of a recurrence of the epidemic in China.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00643.
    >> Share

  481. COSTA R, Olea B, Bracho MA, Albert E, et al
    RNA viral loads of SARS-CoV-2 Alpha and Delta variants in nasopharyngeal specimens at diagnosis stratified by age, clinical presentation and vaccination status.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00641.
    >> Share

  482. ORENES-PINERO E, Navas-Carrillo D, Moreno-Docon A, Ortega-Garcia JA, et al
    Confirmation of SARS-CoV-2 airborne dissemination indoors using "COVID-19 traps".
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00630.
    >> Share

  483. YAN F, Gao F
    Mutant EK1 with Q1004E/N1006I: a promising fusion inhibitor for the HR1 domain of SARS-CoV-2.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00644.
    >> Share

  484. WANG R
    Genetic variation of interleukin-1 receptor type 1 is associated with severity of COVID-19 disease.
    J Infect. 2021 Dec 21. pii: S0163-4453(21)00631.
    >> Share

  485. MANOLACHE NG, Ursachi V, Scohy A, Desmet C, et al
    Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases.
    J Infect. 2021 Dec 14. pii: S0163-4453(21)00597.
    >> Share

  486. OWEN SI, Williams CT, Garrod G, Fraser AJ, et al
    Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies.
    J Infect. 2021 Dec 11. pii: S0163-4453(21)00598.
    >> Share

  487. FANG X, Ming C, Cen Y, Lin H, et al
    Post-sequelae one year after hospital discharge among older COVID-19 patients: a multi-center prospective cohort study.
    J Infect. 2021 Dec 10. pii: S0163-4453(21)00596.
    >> Share

  488. MAK WA, Koeleman JGM, van der Vliet M, Keuren F, et al
    SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study.
    J Infect. 2021 Dec 9. pii: S0163-4453(21)00593.
    >> Share

  489. QUINTAO TSC, Slavov SN, de Oliveira PM, Bezerra RDS, et al
    Viral metagenomics in nasopharyngeal swabs of Brazilian patients negative for SARS-CoV-2 unveils the presence of Chikungunya virus infection.
    J Infect. 2021 Dec 5. pii: S0163-4453(21)00585.
    >> Share

    November 2021
  490. OESER C, Whitaker H, Linley E, Borrow R, et al
    Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.
    J Infect. 2021 Nov 30. pii: S0163-4453(21)00584.
    >> Share

  491. HAN X, Xu J, Hou H, Yang H, et al
    Significant association of pre-existing asthma with an increased risk for ICU admission among COVID-19 patients: Evidence based on a meta-analysis.
    J Infect. 2021 Nov 29. pii: S0163-4453(21)00582.
    >> Share

  492. MENTZER DAJ, James T, Yongya M, Cox S, et al
    Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients.
    J Infect. 2021 Nov 26. pii: S0163-4453(21)00580.
    >> Share

  493. ALDERSON MR, Arkwright PD, Bai X, Black S, et al
    Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review.
    J Infect. 2021 Nov 24. pii: S0163-4453(21)00578.
    >> Share

  494. BEHNOOD SA, Shafran R, Bennett SD, Zhang A, et al
    Persistent symptoms following SARS-CoV-2 infection among children and young people: a meta-analysis of controlled and uncontrolled studies.
    J Infect. 2021 Nov 20. pii: S0163-4453(21)00555.
    >> Share

  495. LEBOURGEOIS S, Menidjel R, Chenane HR, Ferre VM, et al
    Alpha (B.1.1.7) and Delta (B.1.617.2 - AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage.
    J Infect. 2021 Nov 19. pii: S0163-4453(21)00556.
    >> Share

  496. LUO L, Luo T, Du M, Mei H, et al
    Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: a systematic review and meta-analysis.
    J Infect. 2021 Nov 19. pii: S0163-4453(21)00557.
    >> Share

  497. PAN D, Kim JW, Nazareth J, Assadi S, et al
    Quantification and prognostic significance of interferon-gamma secreting SARS-CoV-2 responsive T cells in hospitalised patients with acute COVID-19.
    J Infect. 2021 Nov 18. pii: S0163-4453(21)00554.
    >> Share

  498. TSAI SC, Chang WW, Lee WS
    Analysis of an outbreak of COVID-19(alpha-variant) with rapid progression to mortality in Taipei, Taiwan.
    J Infect. 2021 Nov 17. pii: S0163-4453(21)00553.
    >> Share

  499. CHAPPELL H, Patel R, Driessens C, Tarr AW, et al
    Immunocompromised children and young people are at no increased risk of severe COVID-19.
    J Infect. 2021 Nov 13. pii: S0163-4453(21)00548.
    >> Share

  500. YAN X, Zhu S, Jin Z, Chen G, et al
    Persistence of anti-SARS-CoV-2 IgM in convalescent COVID-19 patients.
    J Infect. 2021 Nov 13. pii: S0163-4453(21)00550.
    >> Share

  501. BEN S, Xin J, Chen S, Jiang Y, et al
    Global internet search trends related to gastrointestinal symptoms predict regional COVID-19 outbreaks.
    J Infect. 2021 Nov 9. pii: S0163-4453(21)00546.
    >> Share

  502. MARTIN-VICENTE M, Berenguer J, Munoz-Gomez MJ, Diez C, et al
    Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19: Anti-SARS-CoV-2 S antibodies in PWH.
    J Infect. 2021 Nov 6. pii: S0163-4453(21)00545.
    >> Share

  503. BURGI JJ, Rosslein M, Hornung H, Jentsch J, et al
    Divergent humoral responses in mild to moderate SARS-CoV-2 infection over time - indication of persistence of the virus?: Indication of persistence of SARS-CoV-2?
    J Infect. 2021 Nov 5. pii: S0163-4453(21)00544.
    >> Share

  504. GIMENEZ E, Alberola J, Torres I, Albert E, et al
    Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty(R) COVID-19 vaccine.
    J Infect. 2021 Nov 2. pii: S0163-4453(21)00542.
    >> Share

  505. HESKIN J, Pallett SJC, Mughal N, Jones R, et al
    Healthcare worker perceptions of routine asymptomatic SARS-CoV-2 screening using lateral flow assays: a qualitative analysis across two London hospitals.
    J Infect. 2021 Nov 1. pii: S0163-4453(21)00537.
    >> Share

    October 2021
  506. NISHIKIMI A, Watanabe K, Watanabe A, Yasuoka M, et al
    Prevalence of SARS-CoV-2 antibodies after one-year follow up among workers in a research institute in Japan.
    J Infect. 2021 Oct 30. pii: S0163-4453(21)00538.
    >> Share

  507. YE Q, Liu H, Shang S
    Non-pharmaceutical interventions reduced the incidence and exacerbation of allergic diseases in children during the COVID-19 pandemic.
    J Infect. 2021 Oct 30. pii: S0163-4453(21)00541.
    >> Share

  508. WANG J, Zou H, Corpe C
    An observed association between angiotensin-converting enzyme 2 polymorphisms and COVID-19 severity in China.
    J Infect. 2021 Oct 30. pii: S0163-4453(21)00536.
    >> Share

  509. LUMLEY SF, Richens N, Lees E, Cregan J, et al
    Changes in paediatric respiratory infections at a UK teaching hospital 2016-2021; impact of the SARS-CoV-2 pandemic.
    J Infect. 2021 Oct 29. pii: S0163-4453(21)00540.
    >> Share

  510. LI X, Chen H, Lu L, Chen LL, et al
    High compliance to infection control measures prevented guest-to-staff transmission in COVID-19 quarantine hotels.
    J Infect. 2021 Oct 26. pii: S0163-4453(21)00533.
    >> Share

  511. CHONG Y, Tani N, Goto T, Yonekawa A, et al
    Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents.
    J Infect. 2021 Oct 20. pii: S0163-4453(21)00508.
    >> Share

  512. EPAULARD O, Buisson M, Nemoz B, Marechal ML, et al
    Persistence at one year of neutralising antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use.
    J Infect. 2021 Oct 20. pii: S0163-4453(21)00507.
    >> Share

  513. BORMAN AM, Fraser M, Patterson Z, McLachlan S, et al
    Fungal biomarker testing turn-around-times at the UK National Mycology Reference Laboratory: setting the record straight.
    J Infect. 2021 Oct 20. pii: S0163-4453(21)00509.
    >> Share

  514. GUPTA A, Bhoyar RC, Mirza S, Jolly B, et al
    SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker.
    J Infect. 2021 Oct 19. pii: S0163-4453(21)00506.
    >> Share

  515. AHMAD HA, Khan H, Shahzad M, Haq ZU, et al
    Suspected reinfections of SARS-COV-2 in Khyber Pakhtunkhwa, Pakistan - analysis of province-wide testing database.
    J Infect. 2021 Oct 9. pii: S0163-4453(21)00503.
    >> Share

  516. BOSHIER FAT, Venturini C, Stirrup O, Guerra-Assuncao JA, et al
    The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study.
    J Infect. 2021 Oct 2. pii: S0163-4453(21)00493.
    >> Share

  517. HUMBERT MV, Opurum PC, Brendish NJ, Poole S, et al
    A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries.
    J Infect. 2021 Oct 1. pii: S0163-4453(21)00492.
    >> Share

  518. FERNANDEZ-DE-LAS-PENAS C, Gomez-Mayordomo V, de-la-Llave-Rincon AI, Palacios-Cena M, et al
    Anxiety, depression and poor sleep quality as long-term post-COVID sequelae in previously hospitalized patients: A multicenter study.
    J Infect. 2021;83:496-522.
    >> Share

    September 2021
  519. A A, M F, J CO, Ejm M, et al
    Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study.
    J Infect. 2021 Sep 30. pii: S0163-4453(21)00489.
    >> Share

  520. FERRE VM, Lebourgeois S, Menidjel R, Collin G, et al
    Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine.
    J Infect. 2021 Sep 29. pii: S0163-4453(21)00488.
    >> Share

  521. LEMENAND O, Coeffic T, Thibaut S, Colomb-Cotinat M, et al
    Decreasing proportion of extended-spectrum beta-lactamase among E. coli infections during the COVID-19 pandemic in France.
    J Infect. 2021 Sep 29. pii: S0163-4453(21)00486.
    >> Share

  522. LECOINTRE L, Venkatasamy A, Wehr M, Koch A, et al
    Multicentric evaluation of a 3D-printed simulator for COVID- 19 nasopharyngeal swab collection in testing centers.
    J Infect. 2021 Sep 24. pii: S0163-4453(21)00485.
    >> Share

  523. DIMEGLIO C, Herin F, Martin-Blondel G, Miedouge M, et al
    Antibody titers and protection against a SARS-CoV-2 infection.
    J Infect. 2021 Sep 21. pii: S0163-4453(21)00483.
    >> Share

  524. ALEMANY A, Millat-Martinez P, Ouchi D, Corbacho-Monne M, et al
    Self-collected mid-nasal swabs and saliva specimens, compared with nasopharyngeal swabs, for SARS-CoV-2 detection in mild COVID-19 patients.
    J Infect. 2021 Sep 16. pii: S0163-4453(21)00481.
    >> Share

  525. MCMILLAN T, Jones C, O'Connor CJ, Nolan D, et al
    Risk factors associated with bloodstream infections among critically ill patients with COVID-19.
    J Infect. 2021 Sep 16. pii: S0163-4453(21)00480.
    >> Share

  526. LUNA-MUSCHI A, Borges IC, de Faria E, Barboza AS, et al
    Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers.
    J Infect. 2021 Sep 16. pii: S0163-4453(21)00474.
    >> Share

  527. FANG C, Zhou Z, Li J, Zhou M, et al
    Incident changes of rotavirus enteritis among children during the coronavirus disease-2019 pandemic in Hangzhou, China.
    J Infect. 2021 Sep 15. pii: S0163-4453(21)00478.
    >> Share

  528. AWAN UA, Malik MW, Khan MI, Khattak AA, et al
    Predicting COVID-19 incidence in war-torn Afghanistan: A timely response is required!
    J Infect. 2021 Sep 15. pii: S0163-4453(21)00473.
    >> Share

  529. CHEN H, Zhao X, Li L, Yan S, et al
    Mental health and physical symptoms of people quarantined during the COVID-19 outbreak.
    J Infect. 2021 Sep 15. pii: S0163-4453(21)00479.
    >> Share

  530. ZUO L, Ao G, Wang Y, Gao M, et al
    Bamlanivimab improves hospitalization and mortality rates in patients with COVID-19: A systematic review and meta-analysis.
    J Infect. 2021 Sep 14. pii: S0163-4453(21)00477.
    >> Share

  531. QIU S, Wang D, Zhang Y, Hu Y, et al
    Mendelian randomization reveals potential causal candidates for COVID-19 in 123 blood metabolites.
    J Infect. 2021 Sep 13. pii: S0163-4453(21)00471.
    >> Share

  532. OLEARO F, Norz D, Hoffman A, Grunwald M, et al
    Clinical performance and accuracy of a qPCR-based SARS-CoV-2 mass-screening workflow for healthcare-worker surveillance using pooled self-sampled gargling solutions: a cross-sectional study.
    J Infect. 2021 Sep 6. pii: S0163-4453(21)00451.
    >> Share

  533. QIU S, Zhang Y, Wang D, Hu Y, et al
    The high expression of SARS-CoV-2 cell receptors might lead to higher COVID-19 infection rates in cancer patients.
    J Infect. 2021 Sep 2. pii: S0163-4453(21)00449.
    >> Share

  534. ALKALAMOUNI H, Hitti E, Zaraket H
    Adopting fresh air ventilation may reduce the risk of airborne transmission of SARS-CoV-2 in COVID-19 unit.
    J Infect. 2021 Sep 1. pii: S0163-4453(21)00450.
    >> Share

  535. CHANDRA S, Rawal R
    The surge in Covid related mucormycosis.
    J Infect. 2021;83:381-412.
    >> Share

    August 2021
  536. SNELL LB, Awan AR, Charalampous T, Alcolea-Medina A, et al
    SARS-CoV-2 variants with shortened incubation periods necessitate new definitions for nosocomial acquisition.
    J Infect. 2021 Aug 30. pii: S0163-4453(21)00445.
    >> Share

  537. STRALIN K, Bruce D, Wahlstrom E, Walther S, et al
    Impact of the Alpha VOC on disease severity in SARS-CoV-2-positive adults in Sweden.
    J Infect. 2021 Aug 30. pii: S0163-4453(21)00448.
    >> Share

  538. BHATTACHARYA A, Collin SM, Stimson J, Thelwall S, et al
    Healthcare-associated COVID-19 in England: a national data linkage study.
    J Infect. 2021 Aug 30. pii: S0163-4453(21)00443.
    >> Share

  539. QIU S, Hu Y, Cheng L
    A genome-wide cross-trait analysis highlights the shared genetic structure between COVID-19 and Alzheimer's disease.
    J Infect. 2021 Aug 26. pii: S0163-4453(21)00442.
    >> Share

  540. MORALES-ORTEGA A, Farfan-Sedano AI, Izquierdo-Martinez A, Llarena-Barroso C, et al
    Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients.
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00436.
    >> Share

  541. GUIGON A, Faure E, Lemaire C, Chopin MC, et al
    Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance.
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00435.
    >> Share

  542. TRE-HARDY M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, et al
    Six-month interim analysis of ongoing immunogenicity surveillance of the mRNA-1273 vaccine in healthcare workers: A third dose is expected.
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00433.
    >> Share

  543. QIU S, Hu Y
    Are COVID-19 susceptibility genes related to lung cancer?
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00434.
    >> Share

  544. KRAL S, Banfi C, Niedrist T, Sareban N, et al
    Long-lasting immune response to a mild course of PCR-confirmed SARS-CoV-2 infection: A cohort study.
    J Infect. 2021 Aug 22. pii: S0163-4453(21)00419.
    >> Share

  545. TEYSSOU E, Delagreverie H, Visseaux B, Lambert-Niclot S, et al
    The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19.
    J Infect. 2021 Aug 19. pii: S0163-4453(21)00416.
    >> Share

  546. BRAMLEY A, Crocker-Buque T, Breuer J, Mahungu TW, et al
    Evidence of the reduction of acute circulating communicable viruses during the SARS-CoV-2 pandemic in London.
    J Infect. 2021 Aug 19. pii: S0163-4453(21)00418.
    >> Share

  547. WANG C, Kang K, Lan X, Fei D, et al
    Cytokinelevels in sputum, not serum, may be more helpful 1 for indicating the damage in the lung and the prognosis of severe COVID-19 - A Case Series.
    J Infect. 2021 Aug 19. pii: S0163-4453(21)00415.
    >> Share

  548. YOU YS, Kim JS
    Influenza and Anosmia: important prediction factors for severity and death of COVID-19.
    J Infect. 2021 Aug 18. pii: S0163-4453(21)00413.
    >> Share

  549. KRETSCHMER A, Kossow A, Grune B, Schildgen O, et al
    False positive rapid antigen tests for SARS-CoV-2 in the real-world and their economic burden.
    J Infect. 2021 Aug 17. pii: S0163-4453(21)00402.
    >> Share

  550. DOUXFILS J, Gillot C, Mullier F, Favresse J, et al
    Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ.
    J Infect. 2021 Aug 15. pii: S0163-4453(21)00405.
    >> Share

  551. LADHANI SN, Ireland G, Baawuah F, Beckmann J, et al
    Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: active prospective surveillance, December 2020 to March 2021, England.
    J Infect. 2021 Aug 13. pii: S0163-4453(21)00401.
    >> Share

  552. ARANDA J, Oriol I, Martin M, Feria L, et al
    Long-term impact of COVID-19 associated acute respiratory distress syndrome.
    J Infect. 2021 Aug 13. pii: S0163-4453(21)00396.
    >> Share

  553. WEY EQ, Bristow C, Nandani A, O'Farrell B, et al
    Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19.
    J Infect. 2021 Aug 13. pii: S0163-4453(21)00400.
    >> Share

  554. COSTA R, Bueno F, Gimenez E, Bracho A, et al
    Initial viral load and decay kinetics of SARS-CoV-2 lineage B.1.1.7 in the upper respiratory tract of adults and children.
    J Infect. 2021 Aug 11. pii: S0163-4453(21)00398.
    >> Share

  555. FURUSE Y, Tsnchiya N, Miyahara R, Yasuda D, et al
    COVID-19 case-clusters and transmission chains in the communities in Japan.
    J Infect. 2021 Aug 11. pii: S0163-4453(21)00399.
    >> Share

  556. DONG M, Luo M, Li A, Xie H, et al
    Changes in the pathogenic spectrum of acute respiratory tract infections during the COVID-19 epidemic in Beijing, China: A large-scale active surveillance study.
    J Infect. 2021 Aug 11. pii: S0163-4453(21)00395.
    >> Share

  557. ALLEN N, Brady M, Martin AIC, Domegan L, et al
    Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals.
    J Infect. 2021 Aug 9. pii: S0163-4453(21)00394.
    >> Share

  558. KHAN MI, Qureshi H, Khattak AA, Awan UA, et al
    Predicting COVID-19 incidence in Pakistan: It's time to act now!
    J Infect. 2021 Aug 9. pii: S0163-4453(21)00393.
    >> Share

  559. YAHI N, Chahinian H, Fantini J
    Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination ?
    J Infect. 2021 Aug 9. pii: S0163-4453(21)00392.
    >> Share

  560. FERNANDEZ-DE-LAS-PENAS C
    Post-COVID Functional Limitations on Daily Living Activities are Associated with Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection and Internal Care Unit Admission: A Multicenter Study.
    J Infect. 2021 Aug 7. pii: S0163-4453(21)00391.
    >> Share


  561. Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals.
    J Infect. 2021 Aug 6. pii: S0163-4453(21)00388.
    >> Share

  562. GOBBI F, Buonfrate D, Silva R, Martini D, et al
    Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine: SARS-CoV-2 infection early after the first vaccine dose.
    J Infect. 2021 Aug 6. pii: S0163-4453(21)00390.
    >> Share

  563. LAMB G, Heskin J, Randell P, Mughal N, et al
    Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis.
    J Infect. 2021 Aug 5. pii: S0163-4453(21)00383.
    >> Share


  564. Predominance of Delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021.
    J Infect. 2021 Aug 5. pii: S0163-4453(21)00387.
    >> Share

  565. TANNER AR, Phan H, Brendish NJ, Borca F, et al
    SARS-CoV-2 Viral load at presentation to hospital is independently associated with the risk of death.
    J Infect. 2021 Aug 4. pii: S0163-4453(21)00384.
    >> Share

  566. MILLER E, Waight PA, Andrews NJ, McOwat K, et al
    Transmission of SARS-CoV-2 in the household setting: a prospective cohort study in children and adults in England.
    J Infect. 2021 Aug 1. pii: S0163-4453(21)00380.
    >> Share

  567. FERNANDEZ-DE-LAS-PENAS C, Palacios-Cena D, Gomez-Mayordomo V, Rodriuez-Jimenez J, et al
    Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study.
    J Infect. 2021;83:237-279.
    >> Share

  568. FERNANDEZ-DE-LAS-PENAS C, Torres-Macho J, Velasco-Arribas M, Arias-Navalon JA, et al
    Similar prevalence of long-term post-COVID symptoms in patients with asthma: A case-control study.
    J Infect. 2021;83:237-279.
    >> Share

    July 2021
  569. LUMLEY SF, Constantinides B, Sanderson N, Rodger G, et al
    Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small number of highly infectious individuals.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00377.
    >> Share

  570. BENE MC, Bittencourt MC, Chevallier P
    Post-SARS-CoV-2 vaccination specific antibody decrease : let's get the half-full glass perspective.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00370.
    >> Share

  571. LIM SY, Kim JY, Lee JA, Kwon JS, et al
    Immune responses and reactogenicity after ChAdOx1 in individuals with past SARS-CoV-2 infection and those without.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00375.
    >> Share

  572. CIUFFREDA L, Salazar JML, Alcoba-Florez J, Rodriguez-Perez H, et al
    Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00373.
    >> Share

  573. RAJAMANICKAM A, Kumar NP, Padmapriyadarsini C, Nancy A, et al
    Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00372.
    >> Share

  574. RANA MS, Usman M, Salman M, Alam MM, et al
    Potential impact of COVID-19 Pandemic on escalating antimicrobial resistance in Pakistan.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00368.
    >> Share

  575. WHITTAKER R, Kristofferson AB, Seppala E, Salamanca BV, et al
    Trajectories of hospitalisation for patients infected with SARS-CoV-2 variant B.1.1.7 in Norway, December 2020 - April 2021.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00366.
    >> Share

  576. COSENTINO G, Bernard M, Ambroise J, Giannoli JM, et al
    SARS-CoV-2 viral dynamics in infections with Alpha and Beta variants of concern in the French community.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00374.
    >> Share

  577. AWAN UA, Malik MW, Khattak AA, Ahmed H, et al
    Emerging Polio Hotspots in Pakistan: Challenges and the way forward: COVID-19 and re-emergence of Polio in Pakistan.
    J Infect. 2021 Jul 26. pii: S0163-4453(21)00361.
    >> Share

  578. EBANKS D, Faustini S, Shields A, Parry H, et al
    Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays.
    J Infect. 2021 Jul 26. pii: S0163-4453(21)00363.
    >> Share

  579. ROBERT TANNER A
    Increase in circulation of non-SARS-CoV-2 respiratory viruses following easing of social distancing is associated with increasing hospital attendance.
    J Infect. 2021 Jul 25. pii: S0163-4453(21)00365.
    >> Share

  580. GIDARI A, Sabbatini S, Bastianelli S, Pierucci S, et al
    Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected.
    J Infect. 2021 Jul 25. pii: S0163-4453(21)00362.
    >> Share

  581. LAI CK, Lui GC, Chen Z, Cheung YY, et al
    Comparison of Self-collected Mouth Gargle with Deep-throat Saliva Samples for the diagnosis of COVID-19: Mouth gargle for diagnosis of COVID-19.
    J Infect. 2021 Jul 25. pii: S0163-4453(21)00354.
    >> Share

  582. BOU-KARROUM L, Khabsa J, Jabbour M, Hilal N, et al
    Public Health Effects of Travel-Related Policies on the COVID-19 Pandemic: A Mixed-Methods Systematic Review.
    J Infect. 2021 Jul 24. pii: S0163-4453(21)00360.
    >> Share

  583. LADHANI SN
    Crossing the Rubicon: a Fine Line between Waiting and Vaccinating Adolescents against COVID-19.
    J Infect. 2021 Jul 21. pii: S0163-4453(21)00357.
    >> Share

  584. GUDIOL C, Dura-Miralles X, Aguilar-Company J, Hernandez-Jimenez P, et al
    Co-infections and superinfections complicating COVID-19 in cancer patients: a multicenter, international study.
    J Infect. 2021 Jul 21. pii: S0163-4453(21)00356.
    >> Share

  585. GAO S, Lu Y, Luan J, Zhang L, et al
    Low incidence rate of diarrhoea in COVID-19 patients is due to integrin.
    J Infect. 2021 Jul 15. pii: S0163-4453(21)00348.
    >> Share

  586. MATTIUZZI C, Henry BM, Lippi G
    Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms?: Symptoms of COVID-19.
    J Infect. 2021 Jul 15. pii: S0163-4453(21)00347.
    >> Share

  587. VANCHEESWARAN R, Willcox ML, Stuart B, Knight M, et al
    Accuracy of Rapid Point-of-Care Antibody Test in patients with suspected or confirmed COVID-19.
    J Infect. 2021 Jul 14. pii: S0163-4453(21)00332.
    >> Share

  588. AVDEEV SN, Gaynitdinova VV, Merzhoeva ZM, Berikkhanov ZG, et al
    N-acetylcysteine for the treatment of COVID-19 among hospitalized patients.
    J Infect. 2021 Jul 10. pii: S0163-4453(21)00329.
    >> Share

  589. NIITSU T, Shiroyama T, Hirata H, Noda Y, et al
    Cytomegalovirus infection in critically ill patients with COVID-19.
    J Infect. 2021 Jul 9. pii: S0163-4453(21)00330.
    >> Share

  590. ANGELETTI S, Giovanetti M, Fogolari M, De Florio L, et al
    Detection of a SARS-CoV-2 P.1.1 variant lacking N501Y in a vaccinated Health Care worker in Italy.
    J Infect. 2021 Jul 5. pii: S0163-4453(21)00325.
    >> Share

  591. FAVRESSE J, Douxfils J
    Importance of Sample Dilution in the Evaluation of the Antibody Response after SARS-CoV-2 Vaccination.
    J Infect. 2021 Jul 4. pii: S0163-4453(21)00327.
    >> Share

  592. ROCHA AS, Meireles M, Vilaca H, Guimaraes TC, et al
    Outcomes of Covid-19 Organizing Pneumonia in Critically Ill Patients: OUTCOMES OF COVID-19 ORGANIZING PNEUMONIA.
    J Infect. 2021 Jul 1. pii: S0163-4453(21)00322.
    >> Share

  593. BARBOSA GR, Moreira LVL, Justo AFO, Perosa AH, et al
    Rapid spread and high impact of the variant of concern P.1 in the largest city of Brazil.
    J Infect. 2021;83:119-145.
    >> Share

    June 2021
  594. XIE D, Chu H, Yang D, Ding Q, et al
    A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV.
    J Infect. 2021 Jun 30. pii: S0163-4453(21)00315.
    >> Share

  595. HSU L, Wisplinghoff H, Kossow A, Hurrass J, et al
    Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.
    J Infect. 2021 Jun 29. pii: S0163-4453(21)00320.
    >> Share

  596. SALVAGNO GL, Henry BM, Pighi L, De Nitto S, et al
    Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.
    J Infect. 2021 Jun 29. pii: S0163-4453(21)00321.
    >> Share

  597. MENDEZ-BRITO A, Bcheraoui CE, Pozo-Martin F
    Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19.
    J Infect. 2021 Jun 20. pii: S0163-4453(21)00316.
    >> Share

  598. TRE-HARDY M, Cupaiolo R, Wilmet A, Beukinga I, et al
    Waning antibodies in SARS-CoV-2 naive vaccinees: results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers.
    J Infect. 2021 Jun 20. pii: S0163-4453(21)00314.
    >> Share

  599. BUSKERMOLEN M, Te Paske K, van Beek J, Kortbeek T, et al
    Relapse in the first 8 weeks after onset of COVID-19 disease in outpatients: viral reactivation or inflammatory rebound?
    J Infect. 2021 Jun 17. pii: S0163-4453(21)00310.
    >> Share

  600. DIMEGLIO C, Herin F, Miedouge M, Da-Silva I, et al
    One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection.
    J Infect. 2021 Jun 17. pii: S0163-4453(21)00312.
    >> Share

  601. HOMMA Y, Katsuta T, Oka H, Inoue K, et al
    The incubation period of the SARS-CoV-2 B.1.1.7 variant is shorter than that of other strains.
    J Infect. 2021 Jun 16. pii: S0163-4453(21)00306.
    >> Share

  602. ANDERSEN MP, Ostergaard L, Phelps M, Butt JH, et al
    Risk of Coronavirus Disease 2019 (Covid-19) Contraction and Severe Infection in Home- or Healthcare Professionals.
    J Infect. 2021 Jun 15. pii: S0163-4453(21)00305.
    >> Share

  603. CENDEJAS-BUENO E, Romero-Gomez MP, Escosa L, Jimenez-Rodriguez S, et al
    Lower nasopharyngeal viral loads in pediatric population. The missing piece to understand SARS-CoV-2 infection in children?
    J Infect. 2021 Jun 13. pii: S0163-4453(21)00289.
    >> Share

  604. LOFFREDO L, Oliva A, Paraninfi A, Ceccarelli G, et al
    An observed association between conjunctivitis and severity of COVID-19.
    J Infect. 2021 Jun 9. pii: S0163-4453(21)00286.
    >> Share

  605. KWOK KO, McNeil EB, Tsoi MTF, Wei VWI, et al
    Will achieving herd immunity be a road to success to end the COVID-19 pandemic?
    J Infect. 2021 Jun 9. pii: S0163-4453(21)00287.
    >> Share

  606. NOH JY, Song JY, Hyun HJ, Yoon JG, et al
    Risk factors for SARS-CoV-2 transmission in non-household clusters.
    J Infect. 2021 Jun 8. pii: S0163-4453(21)00284.
    >> Share

  607. RISTIC S, Pavlic SD, Nadalin S, Cizmarevic NS, et al
    ACE I/D polymorphism and epidemiological findings for COVID-19: one year after the pandemic outbreak in Europe.
    J Infect. 2021 Jun 4. pii: S0163-4453(21)00282.
    >> Share

  608. LORENZO VB, Nascimento-Carvalho C
    Differences between children with severe acute lower respiratory infection with or without SARS-Cov-2 infection.
    J Infect. 2021 Jun 3. pii: S0163-4453(21)00280.
    >> Share

  609. FANTINI J, Yahi N, Azzaz F, Chahinian H, et al
    Structural dynamics of SARS-CoV-2 variants: a health monitoring strategy for anticipating Covid-19 outbreaks.
    J Infect. 2021 Jun 2. pii: S0163-4453(21)00281.
    >> Share

  610. OLEA B, Albert E, Torres I, Gozalvo-Rovira R, et al
    Lower respiratory tract and plasma SARS-CoV-2 RNA load in critically ill adult COVID-19 patients: relationship with biomarkers of disease severity.
    J Infect. 2021 Jun 1. pii: S0163-4453(21)00279.
    >> Share

  611. STANG A, Robers J, Schonert B, Jockel KH, et al
    The performance of the SARS-CoV-2 RT-PCR test as a tool for detecting SARS-CoV-2 infection in the population.
    J Infect. 2021 Jun 1. pii: S0163-4453(21)00265.
    >> Share

    May 2021
  612. YAN X, Huang H, Wang C, Jin Z, et al
    Follow-up study of pulmonary function among COVID-19 survivors 1 year after recovery.
    J Infect. 2021 May 29. pii: S0163-4453(21)00276.
    >> Share

  613. KONTOGIANNI K, Cubas-Atienzar AI, Wooding D, Buist K, et al
    Lateral flow antigen tests can sensitively detect live cultured virus of the SARS-CoV-2 B.1.1.7 lineage.
    J Infect. 2021 May 29. pii: S0163-4453(21)00272.
    >> Share

  614. RAW RK, Kelly C, Rees J, Wroe C, et al
    Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination.
    J Infect. 2021 May 29. pii: S0163-4453(21)00277.
    >> Share

  615. ZHANG N, Chen X, Jia W, Jin T, et al
    Evidence for lack of transmission by close contact and surface touch in a restaurant outbreak of COVID-19.
    J Infect. 2021 May 29. pii: S0163-4453(21)00273.
    >> Share

  616. TANG JW, Bird PW, Holmes CW, Nicoara DC, et al
    The UK Leicester COVID-19 'exceedance' May-July 2020: An analysis of hospitalised cases.
    J Infect. 2021 May 29. pii: S0163-4453(21)00270.
    >> Share

  617. PEZZATI L, Giacomelli A, Mileto D, Conti F, et al
    Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: a cross-sectional study.: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine.
    J Infect. 2021 May 29. pii: S0163-4453(21)00271.
    >> Share

  618. THANGARAJ JWV, Kumar MS, Kumar CG, Kumar VS, et al
    Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020-21.
    J Infect. 2021 May 28. pii: S0163-4453(21)00268.
    >> Share

  619. BUTT AA, Khan T, Yan P, Shaikh OS, et al
    Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination.
    J Infect. 2021 May 28. pii: S0163-4453(21)00263.
    >> Share

  620. PALLOTTO C, Blanc P, Esperti S, Suardi LR, et al
    Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19).
    J Infect. 2021 May 28. pii: S0163-4453(21)00267.
    >> Share

  621. BREATHNACH AS, Duncan CJA, Bouzidi KE, Hanrath AT, et al
    Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies.
    J Infect. 2021 May 27. pii: S0163-4453(21)00266.
    >> Share

  622. CAPETTI AF, Borgonovo F, Mileto D, Gagliardi G, et al
    One-year durability of anti-spike IgG to SARS-CoV-2: preliminary data from the AntiCROWN prospective observational study One year durability of COVID-19 anti-spike IgG.
    J Infect. 2021 May 27. pii: S0163-4453(21)00264.
    >> Share

  623. VENTURAS J, Zamparini J, Shaddock E, Stacey S, et al
    Comparison of outcomes in HIV-positive and HIV-negative patients with COVID-19.
    J Infect. 2021 May 26. pii: S0163-4453(21)00262.
    >> Share

  624. J BP, Jolly B, John N, Bhoyar RC, et al
    Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India.
    J Infect. 2021 May 24. pii: S0163-4453(21)00260.
    >> Share

  625. YAMAMOTO S, Tanaka A, Oshiro Y, Ishii M, et al
    Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan.
    J Infect. 2021 May 24. pii: S0163-4453(21)00259.
    >> Share

  626. SZARPAK L
    Mucormycosis - a serious threat in the COVID-19 pandemic?
    J Infect. 2021 May 21. pii: S0163-4453(21)00257.
    >> Share

  627. HASAN MJ, Rabbani R, Anam AM, Huq SMR, et al
    Secukinumab in severe COVID-19 pneumonia: does it have a clinical impact?: Secukinumab in severe COVID-19.
    J Infect. 2021 May 21. pii: S0163-4453(21)00253.
    >> Share

  628. FONSECA V, de Jesus R, Adelino T, Reis AB, et al
    Genomic evidence of SARS-CoV-2 reinfection case with the emerging B.1.2 variant in Brazil.
    J Infect. 2021 May 21. pii: S0163-4453(21)00256.
    >> Share

  629. CARAMELLO V, Boccuzzi A, Basile V, Ferraro A, et al
    Are antigenic tests useful for detecting SARS-CoV-2 infections in patients accessing to emergency departments? Results from a North-West Italy Hospital.
    J Infect. 2021 May 20. pii: S0163-4453(21)00255.
    >> Share

  630. BORDI L, Parisi G, Sberna G, Amendola A, et al
    Effective screening strategy against SARS-CoV-2 on self-collected saliva samples in primary school setting: a pilot project.
    J Infect. 2021 May 20. pii: S0163-4453(21)00254.
    >> Share

  631. ZARIF A, Joy M, Sherlock J, Sheppard JP, et al
    The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort study.
    J Infect. 2021 May 15. pii: S0163-4453(21)00220.
    >> Share

  632. HOTHAM M
    Potential future implications of the COVID-19 pandemic on Norovirus infections in England.
    J Infect. 2021 May 13. pii: S0163-4453(21)00241.
    >> Share

  633. CHIRICO F, Nucera G, Szarpak L
    COVID-19 mortality in Italy: The first wave was more severe and deadly, but only in Lombardy region.
    J Infect. 2021 May 13. pii: S0163-4453(21)00248.
    >> Share

  634. KOROMPOKI E, Gavriatopoulou M, Hicklen RS, Ntanasis-Stathopoulos I, et al
    Epidemiology and organ specific sequelae of post-acute COVID19: A Narrative Review.
    J Infect. 2021 May 13. pii: S0163-4453(21)00247.
    >> Share

  635. MANN JA, Bird PW, Bandi S, Tang JW, et al
    Asymptomatic SARS-CoV-2-infected children attending hospital with non-COVID-19 diagnoses, March 2020-February 2021.
    J Infect. 2021 May 13. pii: S0163-4453(21)00240.
    >> Share

  636. WINCHESTER S, John S, Jabbar K, John I, et al
    Clinical Efficacy of Nitric Oxide Nasal Spray (NONS) for the Treatment of Mild COVID-19 Infection.
    J Infect. 2021 May 13. pii: S0163-4453(21)00251.
    >> Share

  637. KOW CS, Merchant HA, Hasan SS
    Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK.
    J Infect. 2021 May 13. pii: S0163-4453(21)00250.
    >> Share

  638. WHITAKER HJ, Elgohari S, Rowe C, Otter AD, et al
    Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021.
    J Infect. 2021 May 11. pii: S0163-4453(21)00224.
    >> Share

  639. FERNANDEZ-VILLA T, Vazquez-Casares A, Rivero-Rodriguez A, Carvajal-Urena A, et al
    Rapid antigen test for SARS-CoV-2 and primary health care.
    J Infect. 2021 May 7. pii: S0163-4453(21)00226.
    >> Share

  640. SANSONE E, Tiraboschi M, Sala E, Albini E, et al
    Effectiveness of BNT162b2 vaccine against the B.1.1.7 variant of SARS-CoV-2 among healthcare workers in Brescia, Italy.
    J Infect. 2021 May 6. pii: S0163-4453(21)00225.
    >> Share

  641. MACLOT F, Bontems S, Meex C, Artesi M, et al
    Development of a multiplex RT-qPCR using the drop out strategy to screen the SARS-CoV-2 South African 501Y.V2 variant.
    J Infect. 2021 May 3. pii: S0163-4453(21)00221.
    >> Share

  642. MATAKI N, Ohmura H, Kodama T, Nakamura S, et al
    Myxovirus resistance protein A in peripheral blood predicts supplemental oxygen need in COVID-19.
    J Infect. 2021;82:186-230.
    >> Share

  643. RICCO M, Ranzieri S, Marchesi F
    Rapid antigen tests for large-scale diagnostic campaigns: A case study from North-Eastern Italy.
    J Infect. 2021;82:e39-e40.
    >> Share

    April 2021
  644. DE PAULA CSY, Palandri GG, Fonseca TS, Vendramini TCA, et al
    Gastrointestinal manifestations are associated with severe pediatric COVID-19: a study in tertiary hospital.
    J Infect. 2021 Apr 30. pii: S0163-4453(21)00217.
    >> Share

  645. GARVEY MI, Wilkinson MAC, Holden E, Shields A, et al
    Early observations on the impact of a healthcare worker COVID-19 vaccination programme at a major UK tertiary centre.
    J Infect. 2021 Apr 29. pii: S0163-4453(21)00214.
    >> Share

  646. CHUDASAMA DY, Flannagan J, Collin SM, Charlett A, et al
    Household clustering of SARS-CoV-2 variant of concern B.1.1.7 (VOC-202012-01) in England.
    J Infect. 2021 Apr 29. pii: S0163-4453(21)00216.
    >> Share

  647. VUSIRIKALA A, Whitaker H, Jones S, Tessier E, et al
    Seroprevalence of SARS-CoV-2 Antibodies in University Students: cross-sectional study, December 2020, England.
    J Infect. 2021 Apr 29. pii: S0163-4453(21)00215.
    >> Share

  648. TEYSSOU E, Soulie C, Visseaux B, Lambert-Niclot S, et al
    The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.
    J Infect. 2021 Apr 28. pii: S0163-4453(21)00211.
    >> Share

  649. BAEK YJ, Lee YJ, Yoon JS, Sohn Y, et al
    Duration of culturable SARS-CoV-2 within different specimens among mild and severe COVID-19 patients: a longitudinal study.
    J Infect. 2021 Apr 28. pii: S0163-4453(21)00212.
    >> Share

  650. GARVEY MI, McMurray C, Casey AL, Ratcliffe L, et al
    Observations of SARS-CoV-2 variant of concern B.1.1.7 at the UK's largest hospital Trust.
    J Infect. 2021 Apr 28. pii: S0163-4453(21)00213.
    >> Share

  651. BONGIOVANNI M, Arienti R, Bini F, Bodini BD, et al
    Differences between the waves in Northern Italy: how the characteristics and the outcome of COVID-19 infected patients admitted to the emergency room have changed.
    J Infect. 2021 Apr 28. pii: S0163-4453(21)00210.
    >> Share

  652. GALOW L, Haag L, Kahre E, Blankenburg J, et al
    Lower household transmission rates of SARS-CoV-2 from children compared to adults.
    J Infect. 2021 Apr 27. pii: S0163-4453(21)00209.
    >> Share

  653. MARTIN-SANCHEZ M, Lim WW, Yeung A, Adam DC, et al
    COVID-19 transmission in Hong Kong despite universal masking.
    J Infect. 2021 Apr 22. pii: S0163-4453(21)00205.
    >> Share

  654. LI KK, Woo YM, Stirrup O, Hughes J, et al
    Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface.
    J Infect. 2021 Apr 22. pii: S0163-4453(21)00206.
    >> Share

  655. CHEN S, Zhang X, Zhou Y, Yang K, et al
    COVID-19 protective measures prevent the spread of respiratory and intestinal infectious diseases but not sexually transmitted and bloodborne diseases.
    J Infect. 2021 Apr 22. pii: S0163-4453(21)00204.
    >> Share

  656. FAROOQ HZ, Davies E, Brown B, Whitfield T, et al
    Real-world SARS CoV-2 Testing in Northern England during the first wave of the COVID-19 Pandemic.
    J Infect. 2021 Apr 20. pii: S0163-4453(21)00199.
    >> Share

  657. STOCKDALE AJ, Fyles F, Farrell C, Lewis J, et al
    Sensitivity of SARS-CoV-2 RNA polymerase chain reaction using a clinical and radiological reference standard: Clinical sensitivity of SARS-CoV-2 PCR.
    J Infect. 2021 Apr 20. pii: S0163-4453(21)00198.
    >> Share

  658. FU H, Zhang N, Zheng Y, Jiang N, et al
    Risk stratification of cardiac sequelae detected using cardiac magnetic resonance in late convalescence at the six-month follow-up of recovered COVID-19 patients.
    J Infect. 2021 Apr 19. pii: S0163-4453(21)00202.
    >> Share

  659. BARO B, Rodo P, Ouchi D, Bordoy AE, et al
    Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison.
    J Infect. 2021 Apr 18. pii: S0163-4453(21)00191.
    >> Share

  660. KODANA M, Kitagawa Y, Takahashi R, Matsuoka M, et al
    Concerns about the clinical usefulness of saliva specimens 1 for the diagnosis of COVID-19.
    J Infect. 2021 Apr 16. pii: S0163-4453(21)00194.
    >> Share

  661. ALCOBA-FLOREZ J, Lorenzo-Salazar JM, Gil-Campesino H, Inigo-Campos A, et al
    Monitoring the rise of the SARS-CoV-2 lineage B.1.1.7 in Tenerife (Spain) since mid-December 2020.
    J Infect. 2021 Apr 12. pii: S0163-4453(21)00168.
    >> Share

  662. DONADIO C, Rainone A, Gouronnec A, Belmin J, et al
    Asymptomatic COVID-19 cases among older patients despite BNT162b2 vaccination: a case series in a geriatric rehabilitation ward during an outbreak.
    J Infect. 2021 Apr 11. pii: S0163-4453(21)00167.
    >> Share

  663. BONGIOVANNI M, Marra AM, Bini F, Bodini BD, et al
    COVID-19 reinfection in healthcare workers: a case series.
    J Infect. 2021 Apr 8. pii: S0163-4453(21)00165.
    >> Share

  664. LIU Y, Chen H, Tan W, Kuang Y, et al
    Clinical characteristics and outcome of SARS-CoV-2 infection during pregnancy.
    J Infect. 2021 Apr 5. pii: S0163-4453(21)00163.
    >> Share

  665. TABOADA M, Gonzalez M, Alvarez A, Eiras M, et al
    First, second and third wave of COVID-19. What have we changed in the ICU management of these patients?
    J Infect. 2021 Apr 4. pii: S0163-4453(21)00160.
    >> Share

  666. NAYAGAM JS, Jeyaraj R, Mitchell T, Walder DP, et al
    Persistent cholestasis in survivors of SARS-CoV-2.
    J Infect. 2021 Apr 4. pii: S0163-4453(21)00162.
    >> Share

  667. OGURI S, Fujisawa S, Kamada K, Nakakubo S, et al
    Effect of varying storage conditions on diagnostic test outcomes of SARS-CoV-2.
    J Infect. 2021 Apr 3. pii: S0163-4453(21)00159.
    >> Share

  668. GARCIA-PACHON E, Grau-Delgado J, Soler-Sempere MJ, Zamora-Molina L, et al
    Low prevalence of post-COVID-19 syndrome in patients with asthma.
    J Infect. 2021 Apr 2. pii: S0163-4453(21)00156.
    >> Share

    March 2021
  669. TRE-HARDY M, Cupaiolo R, Papleux E, Wilmet A, et al
    Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers.
    J Infect. 2021 Mar 31. pii: S0163-4453(21)00158.
    >> Share

  670. MASIA M, Padilla S, Galiana A, Fernandez-Gonzalez M, et al
    Incidence of delayed asymptomatic COVID-19 recurrences in a 6-month longitudinal study.
    J Infect. 2021 Mar 29. pii: S0163-4453(21)00152.
    >> Share

  671. PILLAI A, Koduri K, Gokhale Y, Venkatesh M, et al
    Covid-19 Letter to the Editor.
    J Infect. 2021 Mar 28. pii: S0163-4453(21)00154.
    >> Share

  672. MULCHANDANI R, Taylor-Philips S, Jones HE, Ades AE, et al
    Association between self-reported signs and symptoms and SARS-CoV-2 antibody detection in UK key workers.
    J Infect. 2021 Mar 25. pii: S0163-4453(21)00151.
    >> Share

  673. WILLIAMS CM, Pan D, Decker J, Wisniewska A, et al
    Exhaled SARS-CoV-2 quantified by face-mask sampling in hospitalised patients with covid-19.
    J Infect. 2021 Mar 24. pii: S0163-4453(21)00135.
    >> Share

  674. CHAU DNVV
    Rapid whole-genome sequencing to inform COVID-19 outbreak response in Vietnam.
    J Infect. 2021 Mar 24. pii: S0163-4453(21)00133.
    >> Share

  675. HARRIS RJ, Whitaker HJ, Andrews NJ, Aiano F, et al
    Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers.
    J Infect. 2021 Mar 22. pii: S0163-4453(21)00132.
    >> Share

  676. HIROTSU Y, Omata M
    Discovery of a SARS-CoV-2 variant 1 from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan.
    J Infect. 2021 Mar 22. pii: S0163-4453(21)00130.
    >> Share

  677. MURRAY MJ, McIntosh M, Atkinson C, Mahungu T, et al
    Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay.
    J Infect. 2021 Mar 19. pii: S0163-4453(21)00127.
    >> Share

  678. THARMARAJAH E, Buazon A, Patel V, Hannah JR, et al
    IL-6 inhibition in the treatment of COVID-19: a meta-analysis and meta-regression.
    J Infect. 2021 Mar 18. pii: S0163-4453(21)00125.
    >> Share

  679. WILLIAMS P, McWilliams C, Soomro K, Harding I, et al
    The dynamics of procalcitonin in COVID-19 patients admitted to Intensive Care Unit - A multi-centre cohort study in the South West of England, UK.
    J Infect. 2021 Mar 18. pii: S0163-4453(21)00128.
    >> Share

  680. BIRD PW, Holmes C, Fletcher O, Badhwar V, et al
    Retrospective serosurveillance for anti-SARS-CoV-2 immunoglobulin during a time of low prevalence: A cautionary tale.
    J Infect. 2021 Mar 17. pii: S0163-4453(21)00124.
    >> Share

  681. GARVEY MI, Casey AL, Wilkinson MAC, Ratcliffe L, et al
    Details of SARS-CoV-2 reinfections at a major UK tertiary centre.
    J Infect. 2021 Mar 17. pii: S0163-4453(21)00122.
    >> Share

  682. REBOIRO MLL, Fuentetaja RS, Lopez RG, Castro-Conde BA, et al
    Role of lupus anticoagulant and von Willebrand factor in chronic reactive endotheliitis in COVID-19.
    J Infect. 2021 Mar 15. pii: S0163-4453(21)00123.
    >> Share

  683. CHAUDHRY Z, Shawe-Taylor M, Rampling T, Cutfield T, et al
    Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rate.
    J Infect. 2021 Mar 11. pii: S0163-4453(21)00115.
    >> Share

  684. YANG H, Hou H, Liang X, Xu J, et al
    Lack of significant association between dyslipidemia and COVID-19 mortality.
    J Infect. 2021 Mar 5. pii: S0163-4453(21)00114.
    >> Share

  685. MARTYN EM, Whitaker H, Gil E, Ighomereho P, et al
    Disproportionate impact of SARS-CoV-2 on ethnic minority and frontline healthcare workers: A cross-sectional seroprevalence survey at a North London hospital.
    J Infect. 2021 Mar 4. pii: S0163-4453(21)00098.
    >> Share

  686. YOUNG BC, Eyre DW, Jeffery K
    Use of lateral flow devices allows rapid triage of patients with SARS-CoV-2 on admission to hospital.
    J Infect. 2021 Mar 1. pii: S0163-4453(21)00096.
    >> Share

  687. BADDAL B, Bostanci A, Suer K, Sanlidag T, et al
    SARS-CoV-2 was already in circulation in Northern Cyprus in the prepandemic period.
    J Infect. 2021 Mar 1. pii: S0163-4453(21)00097.
    >> Share

    February 2021
  688. PETRONE L, Petruccioli E, Alonzi T, Vanini V, et al
    In-vitro evaluation of the immunomodulatory effects of baricitinib: implication for COVID-19 therapy.
    J Infect. 2021 Feb 24. pii: S0163-4453(21)00094.
    >> Share

  689. MENSAH AA, Sinnathamby M, Zaidi A, Coughlan L, et al
    SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: prospective, national observational cohort surveillance, July-December 2020, England.
    J Infect. 2021 Feb 24. pii: S0163-4453(21)00093.
    >> Share

  690. DENNY S, Abdolrasouli A, Elamin T, Gonzalo X, et al
    A retrospective multicenter analysis of candidaemia among COVID-19 patients during the first UK pandemic wave.
    J Infect. 2021 Feb 18. pii: S0163-4453(21)00090.
    >> Share

  691. SCIMECA M, Mauriello S, Servadei F, Caggiano B, et al
    Persistence of SARS-CoV-2 viral RNA in nasopharyngeal swabs after death.
    J Infect. 2021 Feb 17. pii: S0163-4453(21)00083.
    >> Share

  692. ANTONELLI M, Capdevila J, Chaudhari A, Granerod J, et al
    Optimal symptom combinations to aid COVID-19 case identification: analysis from a community-based, prospective, observational cohort.
    J Infect. 2021 Feb 13. pii: S0163-4453(21)00079.
    >> Share

  693. BULILETE O, Lorente P, Leiva A, Carandell E, et al
    Panbio rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care.
    J Infect. 2021 Feb 13. pii: S0163-4453(21)00080.
    >> Share

  694. TORRES I, Poujois S, Albert E, Alvarez G, et al
    Point-of-care evaluation of a rapid antigen test (CLINITEST() Rapid COVID-19 Antigen Test) for diagnosis of SARS-CoV-2 infection in symptomatic and asymptomatic individuals.
    J Infect. 2021 Feb 12. pii: S0163-4453(21)00075.
    >> Share

  695. YANG H, Liang X, Hou H, Xu J, et al
    The association of dementia with COVID-19 mortality: Evidence based on adjusted effect estimates.
    J Infect. 2021 Feb 11. pii: S0163-4453(21)00078.
    >> Share

  696. LORA-TAMAYO J, Maestro G, Lalueza A, Rubio-Rivas M, et al
    Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study.
    J Infect. 2021 Feb 11. pii: S0163-4453(21)00077.
    >> Share

  697. NADAL M, Lassel L, Denis M, Gibelin A, et al
    ROLE OF SUPER-SPREADER PHENOMENON IN A COVID-19 CLUSTER AMONG HEALTHCARE WORKERS IN A PRIMARY CARE HOSPITAL.
    J Infect. 2021 Feb 10. pii: S0163-4453(21)00074.
    >> Share

  698. SCUTT DG, Overall DA
    Single nucleotide polymorphisms in key aging pathways, and phenotypic markers of frailty are associated with increased odds of hospital admission with COVID-19.
    J Infect. 2021 Feb 10. pii: S0163-4453(21)00056.
    >> Share

  699. EIGNER U, Verstraeten T, Weil J
    Decrease in Norovirus infections in Germany following COVID-19 containment measures.
    J Infect. 2021 Feb 10. pii: S0163-4453(21)00076.
    >> Share

  700. KEVORKIAN JP, Lopes A, Sene D, Riveline JP, et al
    Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study.
    J Infect. 2021 Feb 9. pii: S0163-4453(21)00058.
    >> Share

  701. ADRIELLE DOS SANTOS L, Filho PGG, Silva AMF, Santos JVG, et al
    Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.
    J Infect. 2021 Feb 9. pii: S0163-4453(21)00043.
    >> Share

  702. LI G, Niu J, Fan X, Chen T, et al
    The chilly climate may increase the chance of infecting COVID-19.
    J Infect. 2021 Feb 8. pii: S0163-4453(21)00057.
    >> Share

  703. DE MONTMOLLIN E, Faille D, Andrieu V, Ajzenberg N, et al
    Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?
    J Infect. 2021 Feb 5. pii: S0163-4453(21)00054.
    >> Share

  704. MORALES-ORTEGA A, Rivas-Prado L, Frutos-Perez B, Jaenes-Barrios B, et al
    Early clinical experience with imatinib in COVID-19: searching for a dual effect.
    J Infect. 2021 Feb 4. pii: S0163-4453(21)00051.
    >> Share

  705. BELSKY JA, Tullius BP, Lamb MG, Sayegh R, et al
    COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients.
    J Infect. 2021 Feb 4. pii: S0163-4453(21)00045.
    >> Share

  706. TOOVEY OTR, Harvey KN, Bird PW, Tang JWW, et al
    Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK.
    J Infect. 2021 Feb 3. pii: S0163-4453(21)00047.
    >> Share

  707. BORGONOVO F, Passerini M, Piscaglia M, Morena V, et al
    Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study.
    J Infect. 2021 Feb 3. pii: S0163-4453(21)00048.
    >> Share

  708. WILSON-DAVIES ESW, Mahanama AIK, Samaraweera B, Ahmed N, et al
    Concerns regarding the sensitivity of the OptiGene direct SARS-CoV-2 LAMP assay and its suitability for use in at-risk groups and hospital staff.
    J Infect. 2021 Feb 2. pii: S0163-4453(21)00036.
    >> Share

  709. ALMHAWISH N, Karah N, Elferruh Y, Aksh A, et al
    Protecting healthcare workers in conflict zones during the COVID-19 pandemic: northwest Syria.
    J Infect. 2021 Feb 2. pii: S0163-4453(21)00046.
    >> Share

  710. TUBIANA S, Burdet C, Houhou N, Thy M, et al
    High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in in-hospital workers - the CoV-CONTACT cohort.
    J Infect. 2021 Feb 2. pii: S0163-4453(21)00049.
    >> Share

  711. FOWLER DV, Douglas DA, Godfrey PK, Williams PA, et al
    Critical evaluation of the methodology used by Wilson-Davies et al., (2020) entitled "Concerning the Optigene Direct LAMP assay, and it`s use in at-risk groups and hospital staff".
    J Infect. 2021;82:282-327.
    >> Share

    January 2021
  712. DIMEGLIO C, Miedouge M, Loubes JM, Mansuy JM, et al
    Side effect of a 6 p.m curfew for preventing the spread of SARS-CoV-2: a modelling study from Toulouse, France.
    J Infect. 2021 Jan 31. pii: S0163-4453(21)00044.
    >> Share

  713. RANA MS, Usman M, Alam MM, Ikram A, et al
    Impact of COVID-19 preventive measures on other infectious and non-infectious respiratory diseases in Pakistan.
    J Infect. 2021 Jan 29. pii: S0163-4453(21)00041.
    >> Share

  714. TANAKA A, Yamamoto S, Miyo K, Mizoue T, et al
    Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.
    J Infect. 2021 Jan 29. pii: S0163-4453(21)00032.
    >> Share

  715. T U, Am DR, Bm W, Ar H, et al
    Increased inflammatory markers reflecting fibrogenesis are independently associated with cardiac involvement in hospitalized COVID-19 patients.
    J Infect. 2021 Jan 28. pii: S0163-4453(21)00040.
    >> Share

  716. DOWNS LO, Eyre DW, O'Donnell D, Jeffery K, et al
    Home-based SARS-CoV-2 lateral flow antigen testing in hospital workers.
    J Infect. 2021 Jan 25. pii: S0163-4453(21)00033.
    >> Share

  717. ADACHI Y, Shiroyama T, Yamaguchi Y, Murakami T, et al
    Predicting recurrence of respiratory failure in critically ill patients with COVID-19: A preliminary study: Running head: Factors predicting respiratory failure in COVID-19.
    J Infect. 2021 Jan 24. pii: S0163-4453(21)00039.
    >> Share

  718. ELFIKY AA, Ibrahim IM
    Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico.
    J Infect. 2021 Jan 22. pii: S0163-4453(21)00038.
    >> Share

  719. DE FRANCESCO MA, Poiesi C, Gargiulo F, Bonfanti C, et al
    Co-infection of Chlamydia pneumoniae and Mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features.
    J Infect. 2021 Jan 19. pii: S0163-4453(21)00031.
    >> Share

  720. TANG JW, Toovey OTR, Harvey KN, Hui DDS, et al
    Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK.
    J Infect. 2021 Jan 17. pii: S0163-4453(21)00030.
    >> Share

  721. BREATHNACH DAS, Riley PA, Cotter MP, Houston AC, et al
    Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months.
    J Infect. 2021 Jan 12. pii: S0163-4453(21)00010.
    >> Share

  722. MORENO-PEREZ O, Merino E, Leon-Ramirez JM, Andres M, et al
    Post-acute COVID-19 Syndrome. Incidence and risk factors: a Mediterranean cohort study.
    J Infect. 2021 Jan 12. pii: S0163-4453(21)00009.
    >> Share

  723. GARCIA-ORTEGA A, Oscullo G, Calvillo P, Lopez-Reyes R, et al
    INCIDENCE, RISK FACTORS, AND THROMBOTIC LOAD OF PULMONARY EMBOLISM IN PATIENTS HOSPITALIZED FOR COVID-19 INFECTION.
    J Infect. 2021 Jan 10. pii: S0163-4453(21)00007.
    >> Share

  724. GARRATT AM, Ghanima W, Einvik G, Stavem K, et al
    Quality of life after COVID-19 without hospitalisation: good overall, but reduced in some dimensions.
    J Infect. 2021 Jan 9. pii: S0163-4453(21)00006.
    >> Share

  725. ALEMANY A, Baro B, Ouchi D, Rodo P, et al
    Analytical and Clinical Performance of the Panbio COVID-19 Antigen-Detecting Rapid Diagnostic Test.
    J Infect. 2021 Jan 6. pii: S0163-4453(21)00004.
    >> Share

  726. NISHI A, Lee LF, Tsuji H, Takasaki Y, et al
    Letter to the Editor: Revisiting the County/city-level Event Risk Assessment during the COVID-19 Pandemic.
    J Infect. 2021 Jan 3. pii: S0163-4453(21)00003.
    >> Share

  727. BONGIOVANNI M, Bini F, Giuliani G, Gianturco L, et al
    Insight into the reason of prolonged viral RNA shedding in patients with COVID-19 infection.
    J Infect. 2021 Jan 3. pii: S0163-4453(21)00002.
    >> Share

  728. XIE Y, Chen Y, Ma M, He D, et al
    Re-emergence of coronavirus disease in Chinese cities associated with chilled and frozen food products.
    J Infect. 2021 Jan 2. pii: S0163-4453(20)30789.
    >> Share

    December 2020
  729. LIU Y, Li M, Liu D, Luo JF, et al
    Developing a multivariable risk prediction model to predict prolonged viral clearance in patients with COVID-19.
    J Infect. 2020 Dec 30. pii: S0163-4453(20)30787.
    >> Share

  730. TANG JW, Tambyah PA, Hui DS
    Emergence of a new SARS-CoV-2 variant in the UK.
    J Infect. 2020 Dec 28. pii: S0163-4453(20)30786.
    >> Share

  731. YANG H, Xu J, Liang X, Shi L, et al
    Autoimmune diseases are independently associated with COVID-19 severity: Evidence based on adjusted effect estimates.
    J Infect. 2020 Dec 28. pii: S0163-4453(20)30785.
    >> Share

  732. HANRATH AT, Payne BAI, Duncan CJA, van der Loeff IS, et al
    Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection.
    J Infect. 2020 Dec 26. pii: S0163-4453(20)30781.
    >> Share

  733. CHAN HT, Chao CM, Lai CC
    Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: a meta-analysis.
    J Infect. 2020 Dec 26. pii: S0163-4453(20)30783.
    >> Share

  734. TABOADA M, Carinena A, Moreno E, Rodriguez N, et al
    Post-COVID-19 functional status six-months after Hospitalization.: Functional status after COVID-19.
    J Infect. 2020 Dec 26. pii: S0163-4453(20)30784.
    >> Share

  735. KONIG S, Hohenstein S, Ueberham L, Hindricks G, et al
    Regional and temporal disparities of excess all-cause mortality for Germany in 2020: Is there more than just COVID-19?
    J Infect. 2020 Dec 23. pii: S0163-4453(20)30777.
    >> Share

  736. WILSON-DAVIES DESW, Mahanama DAIK, Samaraweera DB, Ahmed DN, et al
    Insensitivity of the 'Moonshot' LAMP assay, unsuitable for use in at-risk groups and hospital staff.
    J Infect. 2020 Dec 22. pii: S0163-4453(20)30778.
    >> Share

  737. GANDINI O, Lubrano C
    Use of rapid ferritin test to predict clinical deterioration in at home COVID-19 patients.
    J Infect. 2020 Dec 20. pii: S0163-4453(20)30775.
    >> Share

  738. TURCATO G, Zaboli A, Pfeifer N, Ciccariello L, et al
    Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: a preliminary report.
    J Infect. 2020 Dec 18. pii: S0163-4453(20)30773.
    >> Share

  739. BELLANTI F, Buglio AL, Custodero G, Barbera L, et al
    Fatal relapse of COVID-19 after recovery? A case report of an older Italian patient.
    J Infect. 2020 Dec 16. pii: S0163-4453(20)30770.
    >> Share

  740. AGULLO V, Fernandez-Gonzalez M, Ortiz de la Tabla V, Gonzalo-Jimenez N, et al
    Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study.
    J Infect. 2020 Dec 9. pii: S0163-4453(20)30768.
    >> Share

  741. ZHOU H, Li C, Hu T, Liu T, et al
    Total Infectomes of 162 SARS-CoV-2 Cases Using Meta-Transcriptomic Sequencing.
    J Infect. 2020 Dec 8. pii: S0163-4453(20)30765.
    >> Share

  742. CHEN PJ, Chao CM, Lai CC
    Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients.
    J Infect. 2020 Dec 7. pii: S0163-4453(20)30766.
    >> Share

  743. BARRASA H, Martin A, Maynar J, Rello J, et al
    High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: a matter of time?
    J Infect. 2020 Dec 4. pii: S0163-4453(20)30761.
    >> Share

  744. SALMON D, Slama D, De Broucker T, Karmochkine M, et al
    Clinical, virological and imaging profile in patients with Persistent or Resurgent forms of COVID-19: a cross-sectional study.
    J Infect. 2020 Dec 4. pii: S0163-4453(20)30762.
    >> Share

  745. FRICKE LM, Glockner S, Dreier M, Lange B, et al
    Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden - a systematic review.
    J Infect. 2020 Dec 2. pii: S0163-4453(20)30756.
    >> Share

  746. FALCINELLI E, Petito E, Becattini C, De Robertis E, et al
    Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients.
    J Infect. 2020 Dec 1. pii: S0163-4453(20)30760.
    >> Share

  747. PIOVANI D, Christodoulou MN, Hadjidemetriou A, Pantavou K, et al
    Effect of early application of social distancing interventions on Covid-19 mortality over the first pandemic wave: an analysis of longitudinal data from 37 countries.
    J Infect. 2020 Dec 1. pii: S0163-4453(20)30751.
    >> Share

  748. PANDEY M, Sisodia S, Bandi S, Roland D, et al
    Incidence of spread of clinically relevant SARS-CoV2 infection between children in a tertiary emergency department: An evaluation.
    J Infect. 2020;81:979-997.
    >> Share

    November 2020
  749. FURUSE Y
    Risk at mass-gathering events and the usefulness of complementary events during COVID-19 pandemic.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30759.
    >> Share

  750. MOREIRA LVL, de Souza Luna LK, Barbosa GR, Perosa AH, et al
    Test on stool samples improves the diagnosis of hospitalized patients: detection of SARS-CoV-2 genomic and subgenomic RNA.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30753.
    >> Share

  751. MAANI AA, Al-Jardani A, Karrar H, Petersen E, et al
    COVID-19 in a case previously infected with MERS-CoV: no cross immunity.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30754.
    >> Share

  752. GURGEL RQ, de Sa LC, Souza DRV, Martins AF, et al
    SARS-CoV-2 has been circulating in northeastern Brazil since February 2019: evidence for antibody detection in asymptomatic patients.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30752.
    >> Share

  753. DUBOUCHER C
    SARS-CoV-2 and superimposed infection by trichomonads.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30757.
    >> Share

  754. JONES CR, Hamilton FW, Thompson A, Morris TT, et al
    SARS-CoV-2 IgG seroprevalence in healthcare workers and other staff at North Bristol NHS Trust: a sociodemographic analysis.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30755.
    >> Share

  755. FOWLER VL, Armson B, Gonzales JL, Wise EL, et al
    A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30731.
    >> Share

  756. LIU D, Yang J, Feng B, Lu W, et al
    Mendelian randomization analysis identified genes pleiotropically associated with the risk and prognosis of COVID-19.
    J Infect. 2020 Nov 28. pii: S0163-4453(20)30726.
    >> Share

  757. LAI CC, Chen SY, Yen MY, Lee PI, et al
    The impact of COVID-19 preventative measures on airborne/droplet-transmitted infectious diseases in Taiwan.
    J Infect. 2020 Nov 26. pii: S0163-4453(20)30724.
    >> Share

  758. LEVI M, Miglietta A, Romeo G, Bartolacci S, et al
    Letter in response to article in Journal of Infection: Impact of Routine Infant BCG Vaccination on COVID-19.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30718.
    >> Share

  759. BERASTEGUI-CABRERA J, Salto-Alejandre S, Valerio M, Perez-Palacios P, et al
    SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30719.
    >> Share

  760. SUI Z, Zhang Y, Tu J, Xie J, et al
    Evaluation of saliva as an alternative diagnostic specimen source for SARS-CoV-2 detection by RT-dPCR.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30716.
    >> Share

  761. ROMERO-GOMEZ MP, Gomez-Sebastian S, Cendejas-Bueno E, Montero-Vega MD, et al
    Ct value is not enough to discriminate patients harbouring infective virus.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30720.
    >> Share

  762. MAJRA D, Benson J, Pitts J, Stebbing J, et al
    SARS-CoV-2 (COVID-19) Superspreader Events.
    J Infect. 2020 Nov 24. pii: S0163-4453(20)30717.
    >> Share

  763. KOWALL B, Nonnemacher M, Brune B, Brinkmann M, et al
    A model to identify individuals with a high probability of a SARS-CoV-2 infection.
    J Infect. 2020 Nov 24. pii: S0163-4453(20)30721.
    >> Share

  764. VOICU S, Chousterman BG, Bonnin P, Deye N, et al
    Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients: Venous thrombosis prevention & COVID-19.
    J Infect. 2020 Nov 20. pii: S0163-4453(20)30714.
    >> Share

  765. CHAU NVV, Toan LM, Man DNH, Thao HP, et al
    Absence of SARS-CoV-2 antibodies in health care workers of a tertiary referral hospital for COVID-19 in southern Vietnam.
    J Infect. 2020 Nov 19. pii: S0163-4453(20)30713.
    >> Share

  766. XIONG X, Jiao X, Li H, Zeng S, et al
    Glucocorticoid benefits the ventilatory function of sever/critical COVID-19 patients.
    J Infect. 2020 Nov 18. pii: S0163-4453(20)30712.
    >> Share

  767. BAUER W, Diehl-Wiesenecker E, Ulke J, Galtung N, et al
    Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department.
    J Infect. 2020 Nov 17. pii: S0163-4453(20)30711.
    >> Share

  768. TORRES M, Collins K, Corbit M, Ramirez M, et al
    Comparison of Saliva and Nasopharyngeal Swab SARS-CoV-2 RT-qPCR Testing in a Community Setting.
    J Infect. 2020 Nov 17. pii: S0163-4453(20)30710.
    >> Share

  769. COLSON P, Finaud M, Levy N, Lagier JC, et al
    Evidence of SARS-CoV-2 re-infection with a different genotype.
    J Infect. 2020 Nov 15. pii: S0163-4453(20)30706.
    >> Share

  770. POOLE S, Brendish NJ, Clark TW
    SARS-CoV-2 has displaced other seasonal respiratory viruses: results from a prospective cohort study.
    J Infect. 2020 Nov 15. pii: S0163-4453(20)30707.
    >> Share

  771. AUNG AK, Aitken T, Teh BM, Yu C, et al
    Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study.
    J Infect. 2020 Nov 14. pii: S0163-4453(20)30708.
    >> Share

  772. HAMED E, Alnuaimi AS, Syed MA, Elhamid MA, et al
    Clinical characteristics of 51815 patients presenting with positive and negative SARS-CoV-2 swab results in primary health care settings.
    J Infect. 2020 Nov 13. pii: S0163-4453(20)30709.
    >> Share

  773. RANA MS
    Clinical and laboratory characteristics of recovered versus deceased COVID-19 patients in Islamabad, Pakistan.
    J Infect. 2020 Nov 13. pii: S0163-4453(20)30705.
    >> Share

  774. GARDINER T, Cooke G, Fidler S, Cooper N, et al
    The under-representation of BAME patients in the COVID-19 Recovery trial at a major London NHS Trust.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30699.
    >> Share

  775. CHAN RWY, Chan KC, Chan KYY, Lui GCY, et al
    SARS-CoV-2 detection by nasal strips: a superior tool for surveillance of pediatric population.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30704.
    >> Share

  776. YAN Y, Jiang X, Fu J, Huang J, et al
    Immune responses and residual SARS-CoV-2 in two critically ill COVID-19 patients before and after lung transplantation.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30701.
    >> Share

  777. CHARLTON M, Dashey S, Stubbs A, Lai FY, et al
    Comparing SARS-CoV-2 and influenza A(H1N1)pdm09-infected patients requiring ECMO - a single-centre, retrospective observational cohort experience.
    J Infect. 2020 Nov 9. pii: S0163-4453(20)30698.
    >> Share

  778. JI J, Wu M, Zhong L, Liu Z, et al
    Early, low-dose, short-term methylprednisolone decreased the mortality in critical COVID-19 patients: a multicenter retrospective cohort study.
    J Infect. 2020 Nov 8. pii: S0163-4453(20)30696.
    >> Share

  779. ROWLAND TAJ, Whitaker H, Jeffery-Smith A, Lang N, et al
    Seropositivity and risk factors for SARS-CoV-2 infection in staff working in care homes during the COVID-19 pandemic.
    J Infect. 2020 Nov 4. pii: S0163-4453(20)30695.
    >> Share

  780. ALANIO A, Delliere S, Voicu S, Bretagne S, et al
    The presence of Pneumocystis jirovecii in critically ill patients with COVID-19.
    J Infect. 2020 Nov 4. pii: S0163-4453(20)30694.
    >> Share

  781. SAITO S, Asai Y, Matsunaga N, Hayakawa K, et al
    First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics: Comparison of the two COVID-19 waves in Japan.
    J Infect. 2020 Nov 2. pii: S0163-4453(20)30693.
    >> Share

  782. SCHIRINZI A, Pesce F, Laterza R, D'Alise MG, et al
    Pentraxin 3: potential prognostic role in SARS-CoV-2 patients admitted to the emergency department.
    J Infect. 2020 Nov 1. pii: S0163-4453(20)30687.
    >> Share

    October 2020
  783. HAMED E
    Rates of recurrent positive SARS-CoV-2 swab results among patients attending primary care in Qatar.
    J Infect. 2020 Oct 31. pii: S0163-4453(20)30691.
    >> Share

  784. WANG X, Lin L, Xuan Z, Xu J, et al
    Risk communication on behavioral responses during COVID-19 among general population in China: a rapid national study.
    J Infect. 2020 Oct 31. pii: S0163-4453(20)30689.
    >> Share

  785. DIMEGLIO C, Loubes JM, Mansuy JM, Izopet J, et al
    Quantifying the impact of public health protection measures on the spread of SARS-CoV-2.
    J Infect. 2020 Oct 28. pii: S0163-4453(20)30686.
    >> Share

  786. ARAN D, Beachler DC, Lanes S, Overhage JM, et al
    Prior Presumed Coronavirus Infection Reduces COVID-19 Risk: A Cohort Study.
    J Infect. 2020 Oct 27. pii: S0163-4453(20)30683.
    >> Share

  787. MERLI M, Pasulo L, Perricone G, Travi G, et al
    Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients.
    J Infect. 2020 Oct 27. pii: S0163-4453(20)30685.
    >> Share

  788. GUETL K, Moazedi-Fuerst F, Rosskopf K, Brodmann M, et al
    SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia.
    J Infect. 2020 Oct 26. pii: S0163-4453(20)30684.
    >> Share

  789. CHEN CH, Lai CC, Chao CM, Tang HJ, et al
    Zero measles after COVID-19 pandemic in Taiwan Running title: measles and COVID-19.
    J Infect. 2020 Oct 26. pii: S0163-4453(20)30679.
    >> Share

  790. ALFEHAIDI A, Ahmed SA, Hamed E
    A case of SARS-CoV-2 re-infection.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30677.
    >> Share

  791. MASIA M, Fernandez-Gonzalez M, Garcia JA, Padilla S, et al
    Lack of detrimental effect of corticosteroids on antibody responses to SARS-CoV-2 and viral clearance in patients hospitalized with COVID-19.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30676.
    >> Share

  792. MORFELD P, Timmermann B, Gross JV, DeMatteis S, et al
    COVID-19: Spatial resolution of excess mortality in Germany and Italy.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30678.
    >> Share

  793. WELLBELOVE Z, Walsh C, Perinpanathan T, Lillie P, et al
    Comparing the 4C mortality score for COVID-19 to established scores (CURB65, CRB65, qSOFA, NEWS) for respiratory infection patients.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30673.
    >> Share

  794. DAHDOUH E, Lazaro-Perona F, Romero-Gomez MP, Mingorance J, et al
    Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load.
    J Infect. 2020 Oct 24. pii: S0163-4453(20)30675.
    >> Share

  795. GANDINI O, Criniti A, Gagliardi MC, Ballesio L, et al
    Sex-disaggregated data confirm serum ferritin as an independent predictor of disease severity both in male and female COVID-19 patients.
    J Infect. 2020 Oct 22. pii: S0163-4453(20)30654.
    >> Share

  796. MELE M, Henares D, Pino R, Asenjo S, et al
    Low impact of SARS-CoV-2 infection among paediatric acute respiratory disease hospitalizations.
    J Infect. 2020 Oct 21. pii: S0163-4453(20)30655.
    >> Share

  797. WELLS PM, Doores KJ, Couvreur S, Nunez RM, et al
    Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England.
    J Infect. 2020 Oct 14. pii: S0163-4453(20)30653.
    >> Share

  798. WALSH KA, Spillane S, Comber L, Cardwell K, et al
    The duration of infectiousness of individuals infected with SARS-CoV-2.
    J Infect. 2020 Oct 10. pii: S0163-4453(20)30651.
    >> Share

  799. RANA MS, Usman M, Alam MM, Ikram A, et al
    Impact of COVID-19 pandemic on Measles surveillance in Pakistan.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30650.
    >> Share

  800. SONG W, Jia X, Zhang X, Ling Y, et al
    Co-infection in COVID-19, a cohort study.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30648.
    >> Share

  801. JIA X, Xiao L, Liu Y
    False negative RT-PCR and false positive antibody tests-Concern and solutions in the diagnosis of COVID-19.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30649.
    >> Share

  802. BI J, Wang S, Wang Y, Yang D, et al
    Effect of Administering Subsequent Immune Checkpoint Inhibition in Cancer Patients with Prior COVID-19 Infection.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30647.
    >> Share

  803. MAO MH, Guo JJ, Qin LZ, Han ZX, et al
    Serial semiquantitative detection of SARS-CoV-2 in saliva samples.
    J Infect. 2020 Oct 5. pii: S0163-4453(20)30644.
    >> Share

  804. TANG JW, Kalliomaki P, Varila TM, Waris M, et al
    Nebulisers as a potential source of airborne virus.
    J Infect. 2020;81:647-679.
    >> Share

  805. GREEN ST, Cladi L
    High time for an efficient and effective internationally-supported Zoonosis Surveillance System?
    J Infect. 2020;81:647-679.
    >> Share

    September 2020
  806. DIMEGLIO C, Herin F, Miedouge M, Cambus JP, et al
    Screening for SARS-CoV-2 antibodies among healthcare workers in a University Hospital in Southern France.
    J Infect. 2020 Sep 30. pii: S0163-4453(20)30640.
    >> Share

  807. KUNDI H, Cetin EHO, Canpolat U, Aras S, et al
    The role of Frailty on Adverse Outcomes Among Older Patients with COVID-19.
    J Infect. 2020 Sep 28. pii: S0163-4453(20)30636.
    >> Share

  808. SIXT T, Moretto F, Devilliers H, Abdallahoui M, et al
    The usefulness of NEWS2 at day 7 of hospitalization in predicting COVID-19 evolution and as an early endpoint in therapeutic trials.
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30639.
    >> Share

  809. BRENDISH NJ, Poole S, Naidu VV, Mansbridge CT, et al
    Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: a comparison of patients with and without SARS-CoV-2 infection.
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30638.
    >> Share

  810. MOISEEV S, Brovko M, Tao E, Bulanov N, et al
    Sex differences in mortality in the intensive care unit patients with severe COVID-19.
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30635.
    >> Share

  811. HUANG W, Wu Q, Chen Z, Xiong Z, et al
    The potential indicators for pulmonary fibrosis in survivors of severe COVID-19.
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30632.
    >> Share

  812. MIYAZAWA DD
    Letter in response to article in journal of infection: "Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospective study".
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30637.
    >> Share

  813. SALTO-ALEJANDRE S, Roca-Oporto C, Martin-Gutierrez G, Aviles MD, et al
    A quick prediction tool for unfavourable outcome in COVID-19 inpatients:development and internal validation.
    J Infect. 2020 Sep 25. pii: S0163-4453(20)30619.
    >> Share

  814. SEATON RA, Gibbons CL, Cooper L, Malcolm W, et al
    Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
    J Infect. 2020 Sep 25. pii: S0163-4453(20)30616.
    >> Share

  815. WANG S, Fu L, Huang K, Han J, et al
    Neutrophil-to-lymphocyte ratio at admission is an independent risk factors for the severity and mortality in patients with coronavirus disease 2019.
    J Infect. 2020 Sep 23. pii: S0163-4453(20)30630.
    >> Share

  816. PAGANI G, Conti F, Giacomelli A, Bernacchia D, et al
    Seroprevalence of SARS-CoV-2 significantly varies with age: preliminary results from a mass population screening.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30629.
    >> Share

  817. JUAN HC, Chao CM, Lai CC, Tang HJ, et al
    Decline in invasive pneumococcal disease during COVID-19 pandemic in Taiwan.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30624.
    >> Share

  818. PAN D, Sze S, Rogers B, Bron J, et al
    Serial simultaneously self-swabbed samples from multiple sites show similarly decreasing SARS-CoV-2 loads in COVID-19 cases of differing clinical severity.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30623.
    >> Share

  819. KOW CS, Hasan SS
    The use of antimotility drugs in COVID-19 associated diarrhea.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30592.
    >> Share

  820. STANG A, Standl F, Kowall B, Brune B, et al
    Excess mortality due to COVID-19 in Germany.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30596.
    >> Share

  821. LI C, Zhang X, Zhu Y, Lin Q, et al
    Excess pneumonia and influenza death as herald wave of COVID-19 in England and Wales, United Kingdom.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30591.
    >> Share

  822. ORTH-HOLLER D, Eigentler A, Stiasny K, Weseslindtner L, et al
    Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30593.
    >> Share

  823. SORIANO MC, Vaquero C, Ortiz-Fernandez A, Caballero A, et al
    Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19.
    J Infect. 2020 Sep 18. pii: S0163-4453(20)30594.
    >> Share

  824. LADHANI SN, Chow JY, Atkin S, Brown KE, et al
    REGULAR MASS SCREENING FOR SARS-CoV-2 INFECTION IN CARE HOMES ALREADY AFFECTED BY COVID-19 OUTBREAKS: implications of false positive test results.
    J Infect. 2020 Sep 16. pii: S0163-4453(20)30621.
    >> Share

  825. GANDINI O, Criniti A, Ballesio L, Giglio S, et al
    Serum ferritin as an independent risk factor for acute respiratory distress syndrome in COVID-19 patients in Rome Italy.
    J Infect. 2020 Sep 15. pii: S0163-4453(20)30617.
    >> Share

  826. TANG HJ, Lai CC
    The association between corticosteroid uses and mortality among severe COVID-19 patients.
    J Infect. 2020 Sep 12. pii: S0163-4453(20)30599.
    >> Share

  827. ISHII M, Terai H, Kabata H, Masaki K, et al
    Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: a multicenter retrospective study.
    J Infect. 2020 Sep 10. pii: S0163-4453(20)30590.
    >> Share

  828. ELFIKY AA, Ibrahim IM, Ismail AM, Elshemey WM, et al
    A possible role for GRP78 in cross vaccination against COVID-19.
    J Infect. 2020 Sep 10. pii: S0163-4453(20)30598.
    >> Share

  829. RANA DMS, Usman MM, Alam DMM, Khalid DA, et al
    First trimester miscarriage in a pregnant woman infected with COVID-19 in Pakistan.
    J Infect. 2020 Sep 4. pii: S0163-4453(20)30587.